Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3004248	s-shbg	nmol/l (nmol/l)	15374	27884	0.00%
3004248	p-shbg	nmol/l (nmol/l)	461	780	0.00%
3004248	p-shbg	— (—)	414	751	100.00%	Distribution not available
3004248	s-shbg	nmol/l____ (nmol/l)	150	228	0.00%
3004248	shbg	nmol/l (nmol/l)	18	26	0.00%
3004248	s-shbg	nmol/L (nmol/l)	15	18	0.00%	Distribution not available
3004248	p-shbg	NMOL/L (nmol/l)	5	10	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Exclusions for E4_PCOS_BROAD

1482

2622

6.65

307.65

3.3

1.7

34.02

40.54

nmol/l

14.75

1435

2563

Polycystic ovarian syndrome, consortium definition

1090

1129

5.65

307.65

1.2

50.28

62.11

nmol/l

9.58

1083

1115

Testicular hypofunction

978

1193

21.84

307.65

3.5

1.7

30.10

37.55

nmol/l

22.30

969

1162

Testicular dysfunction

1096

1341

21.23

307.65

3.5

1.7

30.19

37.67

nmol/l

25.49

1086

1309

Polycystic ovarian syndrome, broad definition

711

580

13.93

307.65

1.2

48.87

59.71

nmol/l

4.86

705

574

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1599

3878

4.44

307.65

3.2

1.7

34.49

42.12

nmol/l

24.70

1546

3798

Sleep apnoea, including avohilmo

3470

9823

2.20

307.65

2.1

1.7

35.05

43.20

nmol/l

73.02

3390

9635

Hypogonadotropic hypogonadism

867

1080

23.34

307.65

3.9

1.9

26.85

36.48

nmol/l

34.88

831

1052

Sleep apnoea

3422

9790

2.28

307.65

2.2

1.8

34.46

42.78

nmol/l

82.08

3336

9600

Disorders of other endocrine glands

3042

5593

5.96

307.65

2.9

1.6

34.92

43.18

nmol/l

43.08

2979

5478

Hypopituitarism

1150

1500

11.42

307.65

3.7

1.7

29.55

38.66

nmol/l

34.70

1109

1463

Sleep disorders (combined)

3565

9206

2.07

297.97

2.0

1.7

37.06

43.76

nmol/l

44.56

3484

9033

Other antidepressants

3593

9492

1.98

263.90

2.1

1.7

38.88

41.93

nmol/l

9.87

3502

9323

Depression or dysthymia

2323

5732

2.28

247.01

2.1

1.7

38.76

42.43

nmol/l

9.39

2263

5622

Exclusions for E4_PCOS_CONSORTIUM

1875

4927

2.44

241.05

3.0

1.6

38.60

43.55

nmol/l

8.13

1819

4850

Endocrine, nutritional and metabolic diseases

3047

7838

2.02

233.64

2.2

1.6

36.42

43.23

nmol/l

35.29

2985

7718

Selective serotonin reuptake inhibitors

3347

9503

1.87

210.26

2.1

1.7

39.10

41.93

nmol/l

8.05

3269

9333

Behavioural syndromes associated with physiological disturbances and physical factors

3197

11988

1.85

204.11

2.1

1.8

39.57

40.73

nmol/l

1.64

3149

11753

Recurrent or chronic depression

1520

4525

2.42

194.70

2.1

1.7

37.39

40.98

nmol/l

6.27

1489

4460

Sleep disorders

2984

11739

1.79

172.83

2.1

1.8

39.38

40.60

nmol/l

1.71

2935

11515

Episodal and paroxysmal disorders

3272

9665

1.75

164.81

2.0

1.7

36.66

43.40

nmol/l

42.30

3207

9491

Insomnia

2879

11760

1.74

151.72

2.1

1.8

39.42

40.57

nmol/l

1.50

2831

11545

Medical observation and evaluation for suspected diseases and conditions

2296

6347

1.89

148.56

2.1

1.7

39.18

40.14

nmol/l

1.03

2197

6272

Depression medications

1381

3240

2.23

134.45

2.1

1.6

36.35

42.23

nmol/l

12.77

1350

3214

Diseases of male genital organs

2907

9074

1.68

120.44

2.1

1.9

37.30

37.88

nmol/l

0.81

2839

8916

Codeine

2872

9566

1.65

119.35

2.0

1.7

38.12

42.24

nmol/l

14.24

2803

9402

Used for control exclusion in common control thyroid runs

3404

11019

1.58

117.73

2.2

1.7

39.93

41.03

nmol/l

1.52

3329

10819

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1711

9174

1.85

115.95

2.1

1.8

38.07

41.02

nmol/l

6.20

1667

8998

Hypothyroidism (congenital or acquired)

1128

2921

2.25

115.67

2.3

1.6

38.59

43.27

nmol/l

5.91

1107

2897

Benign neoplasm of other and unspecified endocrine glands

476

1547

3.26

115.45

2.9

1.8

41.46

42.26

nmol/l

0.23

470

1497

Mood disorders, excluding more controls

2838

10399

1.63

114.72

2.1

1.8

39.21

41.11

nmol/l

3.06

2769

10217

Hypothyroidism, levothyroxine purchases

1118

2904

2.24

114.13

2.3

1.6

38.56

43.35

nmol/l

6.14

1097

2880

Hypothyroidism and >3 levothyroxin purchases

1118

2904

2.24

114.13

2.3

1.6

38.56

43.35

nmol/l

6.14

1097

2880

Impotence

422

1316

3.68

113.88

2.3

1.9

39.06

39.87

nmol/l

0.33

413

1274

Codeine or tramadol medication

3289

11512

1.58

113.53

2.0

1.8

38.19

42.14

nmol/l

15.66

3212

11298

Any death

366

7920

0.32

112.60

1.6

1.9

46.54

42.21

nmol/l

2.47

347

7720

Mood [affective] disorders

3066

12648

1.58

109.91

2.1

1.8

39.10

41.17

nmol/l

3.83

2995

12420

Neurological diseases

2567

7864

1.67

109.05

2.0

1.7

37.04

43.22

nmol/l

29.68

2511

7749

Mood disorders

3067

12653

1.58

109.03

2.1

1.8

39.08

41.17

nmol/l

3.90

2996

12424

Medical treatment for female infertility

365

1025

3.62

108.11

1.2

59.71

56.89

nmol/l

0.50

365

1013

Coxibs

844

1839

2.48

106.98

2.2

1.6

37.81

44.69

nmol/l

11.77

827

1809

Genitourinary diseases

2536

7882

1.66

102.95

2.0

1.9

38.09

38.00

nmol/l

0.06

2474

7764

Opioids

2934

9753

1.58

100.77

2.1

1.7

38.31

42.16

nmol/l

12.88

2872

9585

Depression

2863

12459

1.56

98.85

2.1

1.8

39.22

41.02

nmol/l

2.85

2803

12242

Exposure to other specified factors

2477

13536

1.60

98.60

2.0

1.8

39.10

41.25

nmol/l

4.70

2418

13288

Anxiety (asthma-related co-morbidities)

2023

9401

1.67

93.61

2.0

1.8

39.33

39.88

nmol/l

0.39

1981

9271

Tramadol

2239

8342

1.64

93.27

2.1

1.8

38.66

42.00

nmol/l

8.61

2187

8190

Anxiety disorders, excluding more controls

2464

10029

1.60

92.80

2.1

1.8

39.05

40.70

nmol/l

2.39

2407

9860

General examination and investigation of persons without complaint and reported diagnosis

2018

6347

1.68

89.22

2.1

1.7

39.55

40.14

nmol/l

0.49

1961

6272

Neurotic, stress-related and somatoform disorders

2675

12114

1.55

88.87

2.1

1.8

39.08

40.47

nmol/l

1.90

2618

11913

Anxiety disorders

2687

12155

1.54

87.95

2.1

1.8

39.15

40.50

nmol/l

1.82

2630

11953

Other dorsopathies, not elsewhere classified

2968

10338

1.51

84.74

2.0

1.8

39.91

41.39

nmol/l

2.28

2900

10154

All anxiety disorders

2053

10079

1.61

82.97

2.0

1.8

39.48

39.83

nmol/l

0.23

2009

9937

Obesity

1737

10001

1.67

82.82

2.0

1.8

32.58

43.69

nmol/l

60.37

1687

9806

Obesity and other hyperalimentation

1744

10040

1.66

82.69

2.0

1.8

32.60

43.66

nmol/l

60.13

1694

9845

Use of hypnotics and sedatives

2972

11525

1.49

81.73

2.1

1.8

40.40

41.15

nmol/l

0.87

2891

11309

Other diseases of upper respiratory tract

2922

10250

1.50

81.67

1.9

1.8

41.13

41.76

nmol/l

0.65

2846

10060

Other nutritional deficiencies

1827

10432

1.63

79.29

2.0

1.8

33.56

43.52

nmol/l

48.92

1778

10226

Oxicams

578

1332

2.53

78.78

2.1

1.6

41.49

45.96

nmol/l

3.60

563

1305

Acute upper respiratory infections of multiple and unspecified sites

2113

9901

1.58

78.59

1.9

1.8

38.72

42.04

nmol/l

8.11

2074

9702

Dislocation, sprain and strain of joints and ligaments of knee

1988

11637

1.57

74.52

2.0

1.8

39.12

40.83

nmol/l

2.76

1953

11423

Obesity related asthma

994

5389

1.89

73.96

2.2

1.8

34.21

41.87

nmol/l

26.48

970

5253

Dorsalgia

2835

10299

1.48

72.90

2.0

1.8

40.17

41.42

nmol/l

1.69

2773

10115

Neurological diseases, wide definition

1028

2729

1.94

71.39

2.1

1.6

36.03

43.29

nmol/l

16.48

1006

2700

Hypertrophy of breast in women and men

360

1300

2.84

71.33

2.1

1.7

48.26

44.86

nmol/l

1.16

341

1272

Nonorganic sleeping disorders, excluding more controls

688

3336

2.13

71.18

2.3

1.7

42.28

41.03

nmol/l

0.58

680

3287

Deviated nasal septum

1220

7128

1.76

70.86

2.0

1.9

38.09

40.63

nmol/l

4.27

1180

6977

Obesity due to excess calories

1283

7589

1.73

70.52

2.1

1.8

32.07

44.03

nmol/l

49.45

1237

7439

Sexual dysfunction

178

433

5.05

70.29

2.4

1.9

40.25

37.89

nmol/l

0.60

178

418

Exposure to unspecified factor

2816

13341

1.45

69.87

1.9

1.8

40.08

41.32

nmol/l

1.87

2752

13092

Psychiatric diseases

2660

9087

1.49

69.40

2.0

1.7

40.63

41.35

nmol/l

0.71

2591

8921

Acetic acid derivatives and related substances

720

1753

2.17

68.40

2.1

1.6

38.75

45.20

nmol/l

9.26

703

1723

Abnormalities of breathing

2536

9895

1.49

68.04

2.1

1.8

37.83

41.79

nmol/l

12.92

2492

9727

Special screening examination for infectious and parasitic diseases

1119

4642

1.81

68.01

1.9

1.7

40.54

38.36

nmol/l

2.10

1082

4602

Pain in throat and chest

2429

9752

1.49

67.58

2.0

1.8

39.13

41.51

nmol/l

4.84

2369

9584

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2746

12274

1.45

67.19

1.9

1.8

40.67

41.45

nmol/l

0.74

2700

12022

Symptoms and signs involving the circulatory and respiratory systems

2856

9989

1.45

66.15

2.0

1.8

38.52

41.71

nmol/l

9.57

2802

9820

Dorsopathies

2917

10363

1.44

65.86

2.0

1.8

39.84

41.36

nmol/l

2.34

2850

10179

Mouth breathing

1325

8081

1.68

65.19

2.2

1.9

36.47

40.90

nmol/l

10.92

1308

7892

Soft tissue disorders

2916

10521

1.44

64.53

2.0

1.8

39.72

41.30

nmol/l

2.54

2838

10351

Other special examinations and investigations of persons without complaint or reported diagnosis

1917

6348

1.55

61.60

2.0

1.7

40.20

40.14

nmol/l

0.04

1878

6272

Obesity, other/unspecified

855

4686

1.86

61.29

1.9

1.8

34.28

44.46

nmol/l

19.11

834

4597

Other joint disorders

2665

9741

1.45

61.06

2.0

1.7

39.39

41.44

nmol/l

4.11

2593

9582

Other intervertebral disc disorders

2229

9058

1.49

60.65

2.1

1.8

39.44

41.38

nmol/l

3.54

2182

8890

Transport accidents

1400

7302

1.62

59.64

2.0

1.8

40.50

41.74

nmol/l

1.01

1371

7191

Chronic rhinitis, nasopharyngitis and pharyngitis

836

4605

1.86

58.97

2.1

1.8

39.76

41.56

nmol/l

1.17

823

4513

Parasetamol

2406

8412

1.47

58.96

2.0

1.8

36.34

41.83

nmol/l

25.81

2344

8292

Injuries to the wrist and hand

2722

12916

1.41

57.90

1.9

1.8

40.84

41.43

nmol/l

0.59

2659

12671

Lumbar disc prolapse

1758

8626

1.53

57.34

2.1

1.8

39.22

41.33

nmol/l

3.47

1727

8461

Shoulder lesions

1968

7964

1.50

56.19

2.1

1.8

40.73

41.49

nmol/l

0.62

1906

7814

Pain (limb, back, neck, head abdominally)

2122

7252

1.49

55.65

2.0

1.8

39.06

41.11

nmol/l

3.75

2074

7127

Other anxiety disorders

1464

8034

1.58

55.52

2.0

1.8

40.63

40.13

nmol/l

0.25

1431

7925

Injuries to the shoulder and upper arm

2384

13036

1.43

55.14

2.0

1.8

39.45

40.43

nmol/l

1.23

2327

12786

Benign neoplasms

2996

11900

1.39

54.87

2.0

1.8

40.91

40.73

nmol/l

0.13

2934

11683

Pain in joint

1754

7155

1.53

54.81

2.1

1.8

39.95

41.21

nmol/l

1.33

1712

7032

Disorders of skin appendages

1372

8772

1.58

53.97

1.8

41.98

41.20

nmol/l

0.37

1346

8596

Nonorganic sleeping disorders

688

3679

1.93

53.93

2.3

1.8

42.28

40.54

nmol/l

0.94

680

3609

Inflammatory diseases of prostate (prostatitis)

586

3008

2.05

53.12

2.1

1.9

40.08

40.30

nmol/l

0.09

564

2924

Oter anti-inflammatory and antirheumatic agents, non-steroids

417

967

2.41

51.89

2.0

1.7

41.55

47.46

nmol/l

5.20

400

946

Hyperkinetic disorders, excluding more controls

538

2512

2.08

51.03

2.2

1.7

37.25

40.07

nmol/l

1.66

524

2492

Propionic acid derivatives

712

1897

1.92

49.10

1.9

1.6

39.07

44.44

nmol/l

6.80

691

1867

Diseases of the musculoskeletal system and connective tissue

1655

5544

1.52

48.24

2.0

1.7

38.30

41.38

nmol/l

5.42

1618

5477

Persons encountering health services for examination and investigation

1849

6348

1.48

47.71

2.0

1.7

39.70

40.14

nmol/l

0.34

1797

6272

Mycoses, including avohilmo

2458

13673

1.38

47.36

1.9

1.8

41.74

40.94

nmol/l

0.75

2408

13411

Chronic sinusitis

1014

6261

1.64

47.02

2.1

1.8

39.83

41.77

nmol/l

1.49

997

6140

Other specific joint derangements/joint disorders

2141

9501

1.42

46.72

2.1

1.7

39.89

41.54

nmol/l

2.38

2092

9346

Anti-inflammatory and antirheumatic products, non-steroids

697

1897

1.88

45.12

1.9

1.6

38.96

44.44

nmol/l

6.96

676

1867

Other headache syndromes

820

4832

1.72

45.02

2.0

1.7

39.44

45.26

nmol/l

8.95

799

4741

Acute upper respiratory infections

2404

10512

1.38

44.73

1.9

1.8

39.95

42.67

nmol/l

6.02

2352

10282

Chronic diseases of tonsils and adenoids

2117

9564

1.41

44.72

2.0

1.8

39.76

41.01

nmol/l

1.35

2078

9410

Arthropathies

2615

9747

1.37

44.27

2.0

1.7

39.17

41.43

nmol/l

4.42

2549

9588

Abdominal and pelvic pain

2892

10879

1.35

44.18

2.0

1.8

39.63

40.69

nmol/l

1.51

2822

10689

General symptoms and signs

2945

11090

1.34

43.86

2.0

1.8

39.99

40.81

nmol/l

0.91

2887

10889

Rotator cuff syndrome

1499

6985

1.50

43.65

2.1

1.8

40.62

41.72

nmol/l

1.04

1448

6846

Acute sinusitis

1413

8682

1.50

43.36

2.1

1.8

39.27

41.57

nmol/l

2.77

1392

8513

Polyuria

564

3043

1.90

42.92

2.0

1.8

44.62

43.86

nmol/l

0.30

540

2937

Intestinal infectious diseases, including avohilmo, including avohilmo

2881

12115

1.34

42.36

1.9

1.8

41.09

41.52

nmol/l

0.33

2828

11866

Other soft tissue disorders, not elsewhere classified

2454

10331

1.36

41.54

2.0

1.8

40.42

41.45

nmol/l

1.10

2389

10161

Examination and observation for other reasons

1621

6314

1.47

41.17

2.0

1.7

40.52

40.18

nmol/l

0.22

1590

6239

Antihypertensive medication - note that there are other indications

1899

7041

1.43

41.04

2.0

1.7

36.69

42.85

nmol/l

18.84

1863

6962

Restless leg syndrome

322

1442

2.30

40.87

2.2

1.9

40.16

41.88

nmol/l

0.64

315

1400

Other diseases of intestines

2890

12232

1.33

40.83

2.0

1.8

39.92

41.00

nmol/l

1.57

2824

12028

Hyperplasia of prostate

1384

5257

1.52

40.46

2.0

1.9

41.38

41.23

nmol/l

0.09

1337

5133

Any mental disorder

2760

10430

1.34

40.05

2.0

1.8

40.88

41.14

nmol/l

0.19

2684

10245

Injury of muscle and tendon at shoulder and upper arm level

1058

6896

1.57

39.72

2.0

1.9

39.01

41.41

nmol/l

2.95

1028

6726

Hernia

2363

11745

1.35

38.40

2.0

1.9

40.32

39.94

nmol/l

0.30

2308

11531

Migraine

1026

5148

1.57

38.19

1.9

1.7

41.56

44.80

nmol/l

2.86

1013

5063

Persons encountering health services in other circumstances, wide

3019

11961

1.31

37.86

2.0

1.8

40.39

40.84

nmol/l

0.41

2969

11714

Monoamine oxidase A inhibitors

277

1214

2.35

37.13

2.1

1.8

41.62

42.60

nmol/l

0.22

272

1184

Spondylopathies

1850

7889

1.40

37.11

2.0

1.8

41.41

41.35

nmol/l

0.03

1809

7727

Paracetamol or NSAID medication

476

1227

1.99

36.67

1.9

1.5

38.73

44.04

nmol/l

4.85

461

1213

Intracranial trauma

1496

7078

1.44

36.37

1.9

1.7

39.70

43.08

nmol/l

6.01

1459

6978

Symptoms and signs involving the digestive system and abdomen

2826

10879

1.31

36.28

2.0

1.8

39.42

40.69

nmol/l

2.03

2755

10689

Continuous positive airway pressure

585

2780

1.80

36.23

2.1

1.8

34.75

42.75

nmol/l

18.99

561

2741

Intestinal infectious diseases

2407

13586

1.33

35.94

1.9

1.8

40.42

41.19

nmol/l

0.59

2364

13317

Artrosis, including avohilmo

2195

8941

1.36

35.84

2.1

1.8

38.58

40.81

nmol/l

4.41

2140

8773

Injuries to the knee and lower leg

2969

12450

1.30

35.79

1.9

1.8

40.25

41.56

nmol/l

2.14

2905

12211

Diseases of the skin and subcutaneous tissue

2623

10029

1.32

35.66

2.0

1.8

40.87

40.66

nmol/l

0.13

2556

9848

Low back pain

1980

9858

1.37

35.46

2.0

1.8

39.76

41.74

nmol/l

2.77

1938

9678

Dermatophytosis, including avohilmo

1824

13141

1.38

35.36

1.9

1.8

41.29

40.31

nmol/l

0.92

1789

12877

Generalized anxiety disorder

500

2762

1.86

35.33

2.0

1.7

39.95

42.05

nmol/l

1.09

485

2724

Abnormalities of heart beat

737

4383

1.65

35.21

2.0

1.7

41.84

44.07

nmol/l

1.60

716

4283

Irritable bowel syndrome

566

3241

1.78

35.20

2.1

1.7

41.27

42.73

nmol/l

0.72

556

3177

Male infertility

371

1913

2.14

35.07

2.6

2.0

31.46

34.54

nmol/l

3.13

366

1889

Bronchitis

2631

12114

1.31

34.96

1.9

1.8

39.21

42.13

nmol/l

7.79

2581

11867

Disturbance of activity and attention

521

2868

1.83

34.76

2.2

1.7

37.46

39.88

nmol/l

1.30

507

2841

Vasomotor and allergic rhinitis

968

6210

1.55

34.73

2.0

1.8

39.82

40.84

nmol/l

0.57

945

6113

Benzodiazepine use

2522

13057

1.31

34.44

2.1

1.8

40.65

41.44

nmol/l

0.78

2450

12818

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1217

4118

1.51

34.20

2.1

1.7

36.74

40.24

nmol/l

6.50

1189

4073

Myalgia

519

2929

1.80

34.02

2.1

1.7

40.09

43.08

nmol/l

1.80

498

2876

Lower back pain or/and sciatica

2708

13037

1.30

33.92

2.0

1.8

40.24

41.53

nmol/l

1.82

2654

12780

Other disorders of penis

461

2541

1.90

33.84

2.1

1.9

39.65

38.55

nmol/l

0.51

448

2483

Other extrapyramidal and movement disorders in other diseases

486

2716

1.82

32.96

2.2

1.8

41.49

42.55

nmol/l

0.45

470

2632

Persistent mood disorders

463

2566

1.84

32.44

2.1

1.8

40.01

41.24

nmol/l

0.44

446

2512

Arthrosis

1797

7215

1.38

32.42

2.1

1.8

38.87

41.38

nmol/l

4.43

1753

7075

Neoplasms

2514

10164

1.31

32.07

2.1

1.8

38.88

40.09

nmol/l

1.42

2467

10004

Non-selective monoamine reuptake inhibitors

606

3475

1.69

31.94

2.1

1.7

41.24

43.17

nmol/l

1.05

594

3384

Internal derangement of knee

990

6590

1.51

31.87

2.0

1.8

39.65

41.79

nmol/l

2.52

953

6464

Concussion

1282

6985

1.44

31.43

2.0

1.7

39.08

42.98

nmol/l

7.12

1250

6885

Hyperkinetic disorders

538

3078

1.76

31.31

2.2

1.7

37.25

39.77

nmol/l

1.42

524

3047

Other arthrosis

1257

5889

1.45

30.99

2.1

1.8

40.68

41.76

nmol/l

0.86

1230

5763

Diseases of the ear and mastoid process

2987

11819

1.28

30.99

1.9

1.8

40.96

40.88

nmol/l

0.05

2920

11615

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2861

11958

1.28

30.93

2.0

1.8

40.44

40.84

nmol/l

0.34

2815

11711

Other and unspecified tonsillitis

1334

7925

1.43

30.69

1.9

1.8

37.02

40.29

nmol/l

5.70

1314

7800

Spondylosis

1150

6221

1.46

30.60

2.0

1.8

41.87

42.30

nmol/l

0.23

1119

6079

Impingement syndrome of shoulder

538

3170

1.73

30.47

1.9

1.8

42.12

43.05

nmol/l

0.37

510

3095

Visual disturbances

1016

6926

1.49

30.45

2.0

1.8

42.41

42.35

nmol/l

0.02

987

6762

Sciatica+with lumbago

1210

7528

1.44

30.31

2.0

1.8

40.28

42.00

nmol/l

1.65

1188

7381

Disease of hard tissues of teeth, NOS

1322

4869

1.44

30.08

2.0

1.8

39.37

41.55

nmol/l

2.88

1269

4799

Other disorders of male genital organs

243

1139

2.32

29.16

2.2

1.9

34.87

36.61

nmol/l

0.72

233

1109

Diarrhoea and gastroenteritis of presumed infectious origin

1849

12502

1.33

29.06

2.0

1.8

39.84

40.77

nmol/l

0.78

1817

12264

Visual disturbances and blindness

1057

7377

1.45

27.83

2.0

1.8

43.02

42.35

nmol/l

0.32

1027

7203

Headache

1678

9720

1.35

27.72

2.0

1.8

39.53

41.05

nmol/l

1.63

1642

9540

Use of pramipexole

382

2101

1.85

27.40

2.2

1.8

40.37

42.97

nmol/l

1.32

370

2032

Diseases of the eye and adnexa

2404

9421

1.29

27.20

2.0

1.8

40.58

39.70

nmol/l

0.90

2354

9276

Gastro-oesophageal reflux disease

1559

9845

1.35

26.35

2.0

1.8

41.91

41.65

nmol/l

0.15

1507

9650

Asthma, excluding more controls

1900

7430

1.32

26.25

2.0

1.8

38.15

41.95

nmol/l

9.29

1869

7302

Asthma

1933

7613

1.32

26.23

2.0

1.7

38.33

42.04

nmol/l

9.10

1902

7477

Other pulmonary diagnosis

2006

7713

1.31

26.13

2.0

1.7

39.59

41.96

nmol/l

4.18

1958

7574

Asthma (mode)

1909

7663

1.32

25.88

2.0

1.7

38.41

42.05

nmol/l

8.63

1881

7525

GASTRO-related operations

2140

8327

1.30

25.74

1.9

1.8

39.41

40.42

nmol/l

1.10

2096

8214

Any gastric operation

2140

8327

1.30

25.74

1.9

1.8

39.41

40.42

nmol/l

1.10

2096

8214

Cervical disc disorders

765

5106

1.52

25.64

2.1

1.8

40.64

42.27

nmol/l

1.13

741

4990

Haemorrhoids and perianal venous thrombosis

670

4314

1.56

25.57

2.0

1.8

42.63

42.89

nmol/l

0.11

650

4202

Personality disorders, excluding more controls

745

4948

1.53

25.50

2.0

1.8

40.06

40.40

nmol/l

0.12

729

4879

Hypothyroidism, other/unspecified

1750

8750

1.32

25.42

2.1

1.7

43.23

43.49

nmol/l

0.13

1711

8543

Pain, not elsewhere classified

644

4151

1.57

25.40

2.0

1.8

41.01

42.20

nmol/l

0.46

634

4055

Tinnitus

525

3231

1.65

25.28

2.0

1.8

40.60

41.72

nmol/l

0.53

512

3151

Gonarthrosis

1421

5908

1.37

25.23

2.1

1.8

40.11

42.20

nmol/l

2.92

1380

5779

Spinal stenosis

909

4597

1.47

25.16

2.0

1.8

41.68

43.81

nmol/l

2.01

893

4468

Factors influencing health status and contact with health services

1022

3571

1.46

24.74

2.1

1.8

37.73

39.29

nmol/l

1.42

994

3527

Infections with a predominantly sexual mode of transmission, including avohilmo

1091

7167

1.41

24.56

1.9

1.8

41.72

40.26

nmol/l

0.82

1058

7068

Benign neoplasm of colon, rectum, anus and anal canal

1187

7283

1.39

24.51

2.0

1.8

42.75

43.04

nmol/l

0.16

1149

7092

Postprocedural endocrine and metabolic disorders, not elsewhere classified

214

1002

2.18

24.45

2.1

1.7

45.69

43.44

nmol/l

0.49

209

981

Other enthesopathies

610

3916

1.58

24.44

2.1

1.8

39.90

41.96

nmol/l

1.30

596

3843

Statin medication

1778

7655

1.32

24.41

2.0

1.8

35.90

41.45

nmol/l

14.75

1738

7541

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

770

4535

1.51

24.27

2.1

1.7

38.79

39.76

nmol/l

0.38

754

4481

Disorders of lacrimal system

686

4444

1.53

24.27

2.1

1.8

43.58

43.18

nmol/l

0.13

667

4329

Meniscus derangement

1342

6580

1.37

24.03

2.1

1.8

40.08

41.39

nmol/l

1.25

1310

6445

Excluding asthma or asthma-COPD overlap

1983

7713

1.30

23.75

2.0

1.7

39.63

41.96

nmol/l

4.03

1933

7574

Certain infectious and parasitic diseases, including avohilmo

1707

6505

1.33

23.74

1.9

1.8

40.43

41.21

nmol/l

0.64

1665

6390

Acne, including avohilmo

679

3620

1.55

23.73

1.9

1.7

46.20

40.63

nmol/l

3.32

668

3576

Hypothyreosis and Thyroxine purchase for inclusion criteria

1758

8851

1.31

23.65

2.1

1.7

43.23

43.64

nmol/l

0.22

1719

8644

Symptoms and signs involving the urinary system

1729

10059

1.31

23.31

2.0

1.8

42.32

41.11

nmol/l

1.27

1668

9854

Temporomandibular joint disorders, including avohilmo

855

5753

1.45

23.18

1.9

1.7

45.20

43.37

nmol/l

0.89

839

5656

Disorders of the thyroid gland

2004

10190

1.28

23.18

2.1

1.8

43.80

42.99

nmol/l

0.56

1962

9959

Other disorders of lacrimal gland

576

3694

1.58

23.14

2.1

1.8

43.65

43.03

nmol/l

0.21

558

3599

ILD differential diagnosis

1964

7663

1.29

22.99

2.0

1.7

39.57

42.05

nmol/l

4.43

1918

7525

Dentofacial anomalies [including malocclusion]

1704

10299

1.31

22.90

1.9

1.8

42.25

40.17

nmol/l

2.22

1673

10123

Panic disorder

421

2519

1.71

22.83

2.1

1.7

37.29

41.46

nmol/l

2.77

409

2484

COPD differential diagnosis

1963

7669

1.29

22.77

2.0

1.7

39.59

42.05

nmol/l

4.38

1917

7530

Subjective visual disturbances

498

3104

1.63

22.74

2.0

1.8

41.90

42.00

nmol/l

0.03

482

3020

Nerve, nerve root and plexus disorders

2520

12215

1.25

22.48

2.0

1.8

39.62

41.66

nmol/l

3.98

2443

11996

Enthesopathies of lower limb, excluding foot

512

3227

1.61

22.38

2.1

1.8

39.80

41.23

nmol/l

0.72

499

3159

Cervicalgia

406

2413

1.71

22.35

2.1

1.8

41.90

42.22

nmol/l

0.09

390

2355

Voice disturbances

416

2486

1.70

22.35

1.8

45.41

44.49

nmol/l

0.28

411

2406

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1084

7582

1.38

21.98

2.0

1.8

41.72

40.83

nmol/l

0.48

1070

7464

Allergic conjunctivitis

1132

8013

1.37

21.92

2.0

1.8

41.46

40.86

nmol/l

0.30

1116

7881

First line medication for Crohn's disease

2835

12495

1.23

21.59

2.0

1.8

40.12

41.14

nmol/l

1.19

2781

12263

Pain in thoracic spine

336

1924

1.78

21.27

2.0

1.8

40.56

41.24

nmol/l

0.21

331

1882

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

126

2837

0.42

21.18

1.8

43.00

44.86

nmol/l

0.46

119

2736

Cardiovascular diseases

1858

7736

1.29

20.95

2.0

1.7

37.33

41.10

nmol/l

8.77

1825

7636

Benign neoplasm: Colon

965

6542

1.40

20.92

2.0

1.8

42.85

43.68

nmol/l

0.53

932

6356

Other disorders of adrenal gland

106

390

2.82

20.89

2.7

1.6

47.71

42.37

nmol/l

0.62

106

374

Allergic asthma (mode)

582

3750

1.54

20.65

1.9

1.7

38.18

41.83

nmol/l

3.40

575

3698

Other/unspecified dorsalgia

751

5150

1.46

20.59

2.1

1.8

39.71

42.11

nmol/l

2.12

734

5046

Bipolar affective disorders

518

3349

1.58

20.49

2.2

1.8

37.33

40.85

nmol/l

2.30

506

3295

Symptoms and signs involving speech and voice

520

3353

1.57

20.49

1.8

45.09

44.36

nmol/l

0.24

509

3248

Migraine without aura

371

2205

1.71

20.42

1.9

1.6

42.18

47.22

nmol/l

1.95

365

2173

Other metabolic disorders

229

1179

1.98

20.30

2.1

1.8

44.97

43.26

nmol/l

0.37

224

1152

Artificial joint operation, meniscal resection

2073

10613

1.26

20.24

2.0

1.9

40.18

40.90

nmol/l

0.76

2021

10383

Osteoporosis

268

1327

1.87

20.21

1.8

50.04

43.47

nmol/l

3.00

256

1283

Allergic asthma (mode), excluding more controls

582

3768

1.53

20.19

1.9

1.7

38.18

41.87

nmol/l

3.45

575

3713

ILD medications

2857

12714

1.22

20.16

1.9

1.8

39.89

41.25

nmol/l

1.94

2802

12475

Type 2 diabetes

2337

10958

1.24

20.15

1.9

34.70

42.63

nmol/l

36.66

2271

10768

Extrapyramidal and movement disorders

649

4405

1.49

20.09

2.1

1.8

41.93

43.86

nmol/l

1.35

629

4259

Viral hepatitis, IBD co-morbidity

209

1060

2.05

19.80

2.3

1.7

48.65

39.90

nmol/l

4.53

198

1045

Somatoform disorder

330

1926

1.74

19.57

2.1

1.8

41.49

41.57

nmol/l

0.02

324

1886

Disturbances of skin sensation

605

4077

1.50

19.56

1.9

1.8

40.80

41.60

nmol/l

0.36

587

3993

Malaise and fatigue

1070

6231

1.36

19.55

2.1

1.8

43.72

42.87

nmol/l

0.45

1050

6080

Type 2 diabetes, strict (exclude DM1)

2202

10347

1.25

19.55

1.9

33.37

42.92

nmol/l

57.31

2141

10161

Other reaction to severe stress, and adjustment disorders

895

6479

1.40

19.45

1.9

1.8

41.59

40.69

nmol/l

0.37

875

6385

Type 2 diabetes, definitions combined

2194

10320

1.25

19.30

1.9

33.38

42.92

nmol/l

56.81

2133

10135

Type 2 diabetes, definitions combined, including avohilmo

2210

10341

1.24

19.23

1.9

33.19

42.95

nmol/l

60.43

2146

10162

Injuries to the head

2685

13161

1.22

19.15

1.9

1.8

40.52

41.30

nmol/l

0.94

2617

12922

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

808

5796

1.42

18.81

2.1

1.9

28.39

43.30

nmol/l

93.07

777

5672

Glucagon-like peptide-1 (GLP-1) analogues

808

5796

1.42

18.81

2.1

1.9

28.39

43.30

nmol/l

93.07

777

5672

Social phobias

302

1747

1.78

18.81

2.1

1.8

38.19

38.90

nmol/l

0.15

292

1724

Disorders of thyroid, IBD co-morbidities

344

1381

1.73

18.68

1.7

1.6

49.32

48.18

nmol/l

0.22

336

1364

Phobic anxiety disorders

418

2628

1.62

18.60

2.1

1.7

38.15

39.99

nmol/l

0.63

407

2591

Redundant prepuce, phimosis and paraphimosis

980

7188

1.38

18.46

2.0

1.9

35.62

36.86

nmol/l

1.23

963

7062

Asthma, including avohilmo

2885

13250

1.21

18.42

2.0

1.8

38.47

41.64

nmol/l

9.81

2836

12985

Gestational diabetes (for exclusion)

376

1558

1.67

18.37

1.2

49.74

58.07

nmol/l

2.70

370

1546

1049

7804

1.35

18.23

2.1

1.8

35.83

40.83

nmol/l

11.58

1033

7663

2423

10082

1.22

17.96

1.9

1.8

40.37

42.66

nmol/l

4.32

2367

9864

Other diseases of hard tissues of teeth

1244

4890

1.33

17.91

2.0

1.8

39.66

41.66

nmol/l

2.41

1202

4819

Gastrointestinal diseases

1555

6092

1.29

17.88

1.9

1.8

38.73

40.75

nmol/l

2.77

1525

6003

Diaphragmatic hernia

555

3743

1.50

17.80

2.0

1.8

43.01

42.75

nmol/l

0.07

542

3628

Disorders of adult personality and behaviour

815

5915

1.40

17.76

2.0

1.8

39.58

40.27

nmol/l

0.30

799

5817

Diabetes mellitus

2457

11711

1.22

17.71

1.9

1.8

36.18

42.41

nmol/l

23.25

2392

11512

Diabetes, varying definitions

2446

11704

1.22

17.66

1.9

1.8

36.00

42.45

nmol/l

27.00

2381

11505

Triptan medication for migraine, min. 3 purchases

1075

6038

1.34

17.60

1.9

1.8

43.23

42.31

nmol/l

0.39

1064

5934

Metabolic disorders

2245

11032

1.23

17.58

2.1

1.9

38.93

40.95

nmol/l

3.27

2190

10828

Other functional intestinal disorders

790

5163

1.40

17.56

2.0

1.7

43.51

43.27

nmol/l

0.09

765

5042

COPD, early/later onset

390

5122

0.63

17.46

1.9

1.8

43.72

44.93

nmol/l

0.39

371

4945

Cough

745

4965

1.41

17.39

2.0

1.7

43.24

43.66

nmol/l

0.17

726

4851

Symptoms and signs involving the skin and subcutaneous tissue

1468

10930

1.28

17.29

1.9

1.8

42.70

42.26

nmol/l

0.25

1422

10704

Stroke, including SAH

677

6834

0.70

17.19

1.8

1.9

43.28

42.87

nmol/l

0.17

650

6650

Fenamates

224

807

1.91

17.05

1.7

1.6

42.32

49.67

nmol/l

3.09

213

790

ILD medications: prednisolone, methylprednisolone, prednisone

2677

12429

1.20

16.93

2.0

1.8

39.93

41.29

nmol/l

1.89

2625

12195

Certain infectious and parasitic diseases

2321

9563

1.22

16.93

1.9

1.8

41.74

40.97

nmol/l

0.59

2268

9391

Infections with a predominantly sexual mode of transmission

738

5294

1.41

16.92

1.9

1.8

41.93

40.57

nmol/l

0.63

713

5217

COPD, hospital admissions

387

5065

0.64

16.79

1.9

1.8

43.68

44.92

nmol/l

0.40

368

4890

Other disorders of patella

403

2579

1.59

16.73

2.0

1.8

38.58

41.39

nmol/l

1.97

388

2534

Other (not insulin) diabetes medications

2216

10692

1.22

16.71

1.9

1.8

33.28

42.93

nmol/l

53.04

2144

10501

Other and unspecified polyneuropathies, also in other diseases

405

2596

1.59

16.70

1.8

1.9

42.61

42.91

nmol/l

0.10

395

2501

Cervicobrachial syndrome

410

2633

1.58

16.64

2.1

1.8

40.12

42.42

nmol/l

1.22

400

2574

Acne

348

2151

1.65

16.53

1.9

1.8

45.61

40.02

nmol/l

1.78

343

2121

Tonsillectomy and adenotomy

1610

8950

1.26

16.51

1.9

39.20

39.48

nmol/l

0.15

1586

8813

Biguanides

2145

10636

1.22

16.41

1.9

1.8

33.38

43.36

nmol/l

54.78

2076

10444

Mental and behavioural disorders due to opioids

191

1014

2.00

16.33

2.7

2.0

44.42

35.37

nmol/l

4.75

180

998

Diseases of the respiratory system

1356

5284

1.29

16.23

2.0

1.7

39.40

43.35

nmol/l

7.27

1319

5179

Allergic rhinitis

767

5521

1.39

16.16

2.1

1.8

39.73

40.56

nmol/l

0.35

750

5431

Stroke, excluding SAH

619

6310

0.70

16.15

1.8

43.43

43.15

nmol/l

0.11

595

6130

All-cause Heart Failure

586

5813

0.69

16.12

1.8

1.9

42.58

43.84

nmol/l

0.68

559

5629

Heart failure, strict

606

5967

0.70

16.05

1.8

1.9

42.14

43.69

nmol/l

0.94

579

5781

Diseases of appendix

1830

13335

1.24

16.05

1.9

39.96

40.98

nmol/l

0.83

1802

13067

Appendicitis, broad definition

1821

13321

1.24

15.94

1.9

39.94

40.97

nmol/l

0.84

1793

13053

Diabetes mellitus in pregnancy

344

1332

1.65

15.93

1.2

48.72

57.45

nmol/l

2.79

338

1320

Adrenocortical insufficiency

311

2.77

15.92

2.7

1.6

53.63

42.37

nmol/l

1.34

297

Fissure and fistula of anal and rectal regions

567

3936

1.46

15.91

2.0

1.8

40.94

41.21

nmol/l

0.09

549

3843

Atherosclerosis, excluding cerebral and coronary sclerosis

298

3812

0.61

15.84

1.7

1.8

44.36

45.77

nmol/l

0.43

281

3668

Dysphagia

430

2827

1.54

15.70

1.9

1.8

43.80

43.31

nmol/l

0.15

414

2745

Haemorrhage from respiratory passages

674

4263

1.41

15.68

1.8

41.32

43.41

nmol/l

1.50

651

4153

Melanocytic naevi

627

4443

1.43

15.64

1.8

43.88

42.26

nmol/l

0.67

621

4343

Deforming dorsopathies

515

3525

1.48

15.43

2.2

1.8

40.68

41.98

nmol/l

0.64

498

3453

Sleep disorders, other/unspecified

111

486

2.38

15.41

2.4

1.7

42.92

41.27

nmol/l

0.25

111

475

Secondary polycythaemia

100

423

2.52

15.29

2.9

2.0

32.00

37.67

nmol/l

2.48

100

409

Personality disorders

745

5469

1.38

15.21

2.0

1.8

40.06

40.28

nmol/l

0.08

729

5378

Asthma (only as main-diagnosis), excluding more controls

1668

7430

1.25

15.19

2.0

1.8

38.41

41.95

nmol/l

7.40

1640

7302

Dental pulpitis, including avohilmo

2419

12988

1.20

15.18

1.9

1.8

38.56

41.07

nmol/l

4.90

2353

12766

Diabetes medication

2442

11959

1.20

15.01

1.9

1.8

36.07

42.44

nmol/l

23.98

2371

11756

Pain in limb

1880

9784

1.23

14.98

1.9

1.7

41.02

41.93

nmol/l

0.76

1836

9619

Fall on same level

2843

12865

1.18

14.93

1.9

1.8

40.88

41.04

nmol/l

0.11

2762

12646

Umbilical hernia

772

5723

1.37

14.86

2.1

1.9

36.37

41.30

nmol/l

8.64

749

5585

Acute appendicitis

1729

13125

1.23

14.78

1.9

39.72

40.86

nmol/l

0.94

1705

12861

Disorders of refraction and accommodation

655

4707

1.40

14.78

1.8

40.91

41.30

nmol/l

0.13

643

4620

Disorders of ocular muscles, binocular movement, accommodation and refraction

1081

8315

1.30

14.77

1.8

41.57

41.33

nmol/l

0.11

1057

8144

Symptoms and signs involving the nervous and musculoskeletal systems

1093

8490

1.30

14.74

2.0

1.8

42.35

42.74

nmol/l

0.18

1072

8278

Heart failure,strict

587

5744

0.71

14.72

1.8

1.9

42.02

43.51

nmol/l

0.87

560

5575

Other external causes of accidental injury

1812

7396

1.23

14.61

1.8

41.01

42.00

nmol/l

0.88

1761

7282

COPD, hospital admissions 1, only main diagnosis

245

3515

0.59

14.59

2.0

1.8

45.55

45.44

nmol/l

0.02

233

3374

Gonarthrosis [arthrosis of knee](FG)

1604

7445

1.25

14.56

2.1

1.9

40.44

42.10

nmol/l

2.24

1555

7275

Other and unspecified nerve root and plexus disorders, also in other diseases

508

3518

1.47

14.54

2.1

1.9

39.23

40.81

nmol/l

0.89

494

3446

Other chronic obstructive pulmonary disease, including avohilmo

558

6446

0.70

14.46

1.9

1.8

43.22

43.78

nmol/l

0.20

532

6255

Other chronic obstructive pulmonary disease

388

4773

0.66

14.41

1.9

1.8

43.74

44.60

nmol/l

0.26

369

4614

Other shoulder lesions

219

1247

1.79

14.41

2.1

1.8

41.99

40.99

nmol/l

0.13

213

1218

Viral warts, including avohilmo

570

4039

1.43

14.41

2.0

1.8

40.96

40.00

nmol/l

0.33

561

3955

Malignant neoplasm of digestive organs

368

4276

0.65

14.36

1.7

1.9

46.02

43.51

nmol/l

0.83

348

4147

Orchitis and epididymitis

338

2169

1.61

14.28

2.0

1.9

38.82

38.73

nmol/l

0.03

330

2111

Polyneuropathies and other disorders of the peripheral nervous system

449

3050

1.49

14.18

1.8

1.9

42.00

42.83

nmol/l

0.36

438

2946

Spondylolisthesis/Spondylolysis

322

2035

1.60

14.13

2.3

1.8

39.14

42.17

nmol/l

1.81

307

1985

Asthma and allergy

323

2019

1.61

14.08

1.9

1.7

37.69

41.67

nmol/l

2.43

318

1988

Asthma and allergy, excluding more controls

323

2024

1.60

13.96

1.9

1.7

37.69

41.73

nmol/l

2.49

318

1995

Asthma (only as main-diagnosis)

1673

7613

1.24

13.92

2.0

1.7

38.46

42.04

nmol/l

7.60

1644

7477

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2114

13772

1.20

13.91

2.0

1.8

41.31

41.16

nmol/l

0.09

2072

13503

COPD, hospital admissions 3, with asthma pneumonia sepsis

174

2687

0.55

13.86

1.9

1.8

44.05

45.65

nmol/l

0.29

164

2577

Peripheral artery disease

366

4362

0.66

13.83

1.7

1.8

43.68

45.17

nmol/l

0.55

346

4205

COPD, hospital admission 2, with asthma infections

250

3523

0.60

13.80

1.9

1.8

42.99

44.97

nmol/l

0.54

239

3389

Accidents

1801

7396

1.23

13.73

1.8

41.05

42.00

nmol/l

0.83

1751

7282

Migraine without aura and triptan purchases

284

1754

1.64

13.70

1.9

1.6

43.27

45.51

nmol/l

0.45

278

1732

Diseases of external ear

745

5556

1.35

13.66

2.0

1.8

42.19

42.09

nmol/l

0.02

705

5424

Spermatocele

243

1453

1.72

13.65

2.0

1.8

42.22

41.34

nmol/l

0.29

238

1404

Lateral epicondylitis

294

1837

1.63

13.64

2.2

1.8

38.84

41.16

nmol/l

0.93

288

1795

Asthma, hospital admission 2, infections

1248

9705

1.26

13.56

2.0

1.8

36.58

41.62

nmol/l

13.40

1229

9503

Asthma-related infections

1248

9705

1.26

13.56

2.0

1.8

36.58

41.62

nmol/l

13.40

1229

9503

Diseases of oesophagus, stomach and duodenum

2461

12308

1.19

13.52

2.0

1.8

41.52

40.95

nmol/l

0.51

2395

12089

Anomalies of dental arch relationship, including avohilmo

470

2933

1.47

13.52

2.0

1.8

40.63

40.35

nmol/l

0.07

462

2876

Other medical care

461

5545

0.69

13.35

1.9

1.8

43.88

43.73

nmol/l

0.05

448

5388

Diseases of oral cavity, salivary glands and jaws

1206

4893

1.28

13.27

2.0

1.8

40.25

41.66

nmol/l

1.21

1166

4822

Specific personality disorders

617

4500

1.39

13.20

2.1

1.8

40.42

40.89

nmol/l

0.16

606

4421

Other viral diseases, including avohilmo

1020

7915

1.29

13.07

2.0

1.8

38.24

40.13

nmol/l

1.53

1003

7778

COPD

426

5009

0.68

13.05

1.9

1.8

43.90

44.34

nmol/l

0.12

404

4848

Other symptoms and signs involving the digestive system and abdomen

200

1139

1.77

13.01

2.2

1.7

42.44

43.90

nmol/l

0.33

192

1107

Autoimmune diseases

2842

12386

1.17

12.94

1.9

1.8

42.39

40.36

nmol/l

3.73

2782

12149

Anogenital herpesviral [herpes simplex] infection, including avohilmo

266

1646

1.65

12.90

2.0

1.7

44.40

41.94

nmol/l

0.49

255

1618

Injuries to the ankle and foot

1841

13108

1.21

12.89

1.9

1.8

40.64

40.43

nmol/l

0.12

1806

12874

Chronic laryngitis and laryngotracheitis

228

1356

1.71

12.79

1.9

1.8

42.08

43.33

nmol/l

0.33

216

1317

Hypertensive diseases (excluding secondary)

1435

6762

1.25

12.78

2.1

1.8

34.24

40.29

nmol/l

15.97

1404

6665

Caries of enamel

2351

13071

1.18

12.71

1.9

1.8

40.11

40.63

nmol/l

0.40

2281

12844

Candidiasis, including avohilmo

495

3498

1.43

12.61

1.9

1.7

43.28

43.92

nmol/l

0.19

484

3417

Abnormal findings on examination of blood, without diagnosis

1065

7613

1.28

12.60

1.9

1.8

42.77

42.71

nmol/l

0.03

1047

7397

Dental operations

1324

5458

1.26

12.58

2.0

1.8

40.05

41.79

nmol/l

1.86

1286

5364

Other inflammation of eyelid, including avohilmo

953

7438

1.29

12.56

2.1

1.8

39.31

41.52

nmol/l

2.07

939

7292

Disorders of lipoprotein metabolism and other lipidaemias

1904

9663

1.20

12.52

2.0

1.9

37.95

40.86

nmol/l

6.04

1852

9469

Malignant neoplasm of digestive organs, including Hilmo

442

4640

0.69

12.47

1.7

1.9

45.77

43.21

nmol/l

1.03

421

4504

Blepharochalasis

306

1971

1.56

12.33

1.7

1.8

44.44

45.43

nmol/l

0.32

300

1892

COPD related to multimorbidity

329

4172

0.66

12.24

2.0

1.8

43.02

45.53

nmol/l

0.92

312

4013

Cerebrovascular diseases

932

8251

0.78

12.19

1.9

42.92

42.34

nmol/l

0.32

896

8051

Cardiovascular diseases (excluding rheumatic etc)

1804

8594

1.21

12.15

2.1

1.8

36.59

41.08

nmol/l

11.30

1772

8479

Substance abuse, excluding more controls

1478

10145

1.23

12.14

2.0

1.8

40.44

40.79

nmol/l

0.22

1431

9961

Other diseases of blood and blood-forming organs

164

906

1.86

12.11

2.5

2.0

35.85

39.74

nmol/l

1.47

159

873

Heart failure, not strict

1015

8613

0.79

12.08

1.9

41.19

41.79

nmol/l

0.34

978

8418

Sequelae of injuries, of poisoning and of other consequences of external causes

643

4793

1.36

12.06

1.9

39.78

39.49

nmol/l

0.12

626

4694

Soft tissue disorders related to use, overuse and pressure

508

3641

1.41

12.00

2.1

1.8

41.01

41.79

nmol/l

0.30

490

3563

Benign neoplasm: Sigmoid colon

334

2213

1.53

11.98

1.8

1.9

42.17

43.36

nmol/l

0.42

322

2135

Diverticular disease of intestine

1358

6861

1.24

11.91

2.0

1.8

41.01

42.00

nmol/l

0.85

1309

6716

Cardiac arrhythmias

1475

7748

1.23

11.91

2.1

1.8

39.04

41.77

nmol/l

4.16

1437

7643

Ischaemic Stroke, excluding all haemorrhages

573

5721

0.73

11.81

1.8

43.43

43.67

nmol/l

0.09

549

5549

Infections of the skin and subcutaneous tissue

1580

12918

1.21

11.79

2.1

1.8

38.21

40.48

nmol/l

3.43

1540

12675

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

109

2139

0.50

11.72

2.1

1.9

46.25

44.38

nmol/l

0.20

104

2056

Hypertension, essential

1895

8995

1.20

11.60

2.1

1.9

35.52

41.29

nmol/l

19.55

1847

8837

Abnormal serum enzyme levels

747

5514

1.32

11.60

1.8

43.48

43.80

nmol/l

0.15

737

5321

Any dementia

164

1982

0.57

11.53

1.5

1.7

55.71

48.19

nmol/l

2.19

157

1882

Conjunctivitis (acute, non atopic), including avohilmo

2426

12570

1.17

11.53

2.0

1.8

39.40

40.90

nmol/l

2.05

2369

12332

Hallux rigidus

186

1078

1.75

11.50

2.0

1.7

46.08

45.19

nmol/l

0.19

179

1043

Vocal cord dysfunction

264

1473

1.60

11.32

1.9

1.7

43.08

44.38

nmol/l

0.28

257

1447

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

520

3787

1.39

11.31

1.9

1.8

38.79

39.98

nmol/l

0.50

507

3731

Pollen allergy

476

3367

1.41

11.30

2.0

1.8

39.31

39.66

nmol/l

0.10

465

3310

Nasal polyp

449

3191

1.43

11.29

1.9

41.36

41.47

nmol/l

0.04

437

3112

Other and unspecified disorders of vitreous body

528

3762

1.38

11.19

1.9

1.8

44.66

44.94

nmol/l

0.10

510

3620

Herpesviral [herpes simplex] infections, including avohilmo

461

3293

1.41

11.15

2.1

1.8

40.50

42.85

nmol/l

0.85

453

3229

Pain associated with micturition

194

1149

1.71

11.14

1.9

1.8

41.50

42.70

nmol/l

0.29

184

1120

Colonic or urogenital fistula

581

4315

1.36

11.12

2.0

1.9

41.04

41.05

nmol/l

0.00

563

4208

Inflammatory bowel disease treatment related agents

2724

13111

1.16

11.01

1.9

1.8

40.01

41.24

nmol/l

1.67

2676

12860

Diseases of middle ear and mastoid

1485

10073

1.21

10.91

1.9

1.8

39.20

40.33

nmol/l

0.90

1459

9891

Gingivitis and periodontal diseases

2249

9936

1.17

10.87

1.9

1.8

40.48

41.45

nmol/l

1.02

2175

9776

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

842

6609

1.29

10.86

2.1

1.9

37.82

39.11

nmol/l

0.98

828

6478

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1058

8347

1.25

10.75

2.0

1.8

42.59

43.30

nmol/l

0.33

1031

8146

Hernia of abdominal wall, postoperative

406

2838

1.44

10.73

2.1

1.8

38.98

41.53

nmol/l

1.12

392

2785

Osteopathies and chondropathies

1036

7606

1.25

10.63

2.0

1.8

42.35

41.24

nmol/l

0.75

1002

7449

Falls/tendency to fall

2593

11252

1.16

10.59

1.9

1.8

41.50

41.01

nmol/l

0.42

2525

11058

Any event in hilmo or specialist outpatient

5.54

10.59

1.7

1.4

34.31

41.93

nmol/l

0.84

Dislocation, sprain and strain of joints and ligaments at neck level

387

2714

1.45

10.55

2.1

1.9

40.73

39.71

nmol/l

0.31

377

2656

Other viral diseases, not elsewhere classified, including avohilmo

663

5028

1.32

10.55

2.0

1.8

38.65

40.63

nmol/l

1.15

653

4940

Heart failure and bmi 25plus

385

3642

0.70

10.52

1.8

1.9

39.76

39.90

nmol/l

0.04

362

3524

Migraine, single triptan purchase ok & required. ICD-code if available is included

1776

10163

1.19

10.49

2.0

1.8

39.51

39.72

nmol/l

0.12

1754

9994

Triptan medication for migraine, single purchase ok

1776

10163

1.19

10.49

2.0

1.8

39.51

39.72

nmol/l

0.12

1754

9994

Obsessive-compulsive disorder

202

1234

1.68

10.49

2.1

1.7

39.04

39.94

nmol/l

0.15

202

1218

Skin changes due to chronic exposure to nonionizing radiation

417

2669

1.42

10.48

1.8

48.98

47.53

nmol/l

0.60

402

2549

Diseases of salivary glands

596

4482

1.34

10.46

1.9

1.8

41.23

41.61

nmol/l

0.13

579

4384

Benign neoplasm: Rectum

308

2073

1.50

10.32

1.9

42.03

43.26

nmol/l

0.46

300

2003

Other disorders of eyelid

528

3676

1.36

10.31

1.9

1.8

42.85

45.54

nmol/l

1.91

514

3540

Actinic keratosis

403

2586

1.43

10.27

1.8

1.7

48.91

47.68

nmol/l

0.47

388

2469

Other symptoms and signs involving the urinary system

237

1513

1.60

10.23

2.0

1.9

40.85

41.90

nmol/l

0.28

231

1467

Persons with potential health hazards related to communicable diseases

955

7598

1.26

10.11

1.8

40.63

40.58

nmol/l

0.02

946

7466

Excessive attrition of teeth

1384

11414

1.21

10.07

1.9

1.8

41.93

41.23

nmol/l

0.47

1348

11190

Benign neoplasm: Rectum, anus and anal canal

334

2298

1.47

10.02

1.9

42.54

43.45

nmol/l

0.32

325

2220

Other follicular disorders

203

1258

1.65

10.00

1.9

37.79

39.68

nmol/l

0.62

195

1233

Heart failure and coronary heart disease

428

4140

0.72

9.99

1.7

1.8

42.13

44.66

nmol/l

1.62

410

4004

Functional dyspepsia

429

3093

1.40

9.87

1.7

1.8

40.26

42.47

nmol/l

1.30

420

3021

Infections, IBD-co-morbidities

309

1461

1.50

9.83

1.9

1.6

39.38

43.70

nmol/l

2.38

300

1441

Persons encountering health services in circumstances related to reproduction

1755

10004

1.19

9.76

2.0

1.9

37.06

37.61

nmol/l

0.49

1738

9841

Any dementia, excluding more controls

156

1808

0.59

9.70

1.5

1.7

55.16

48.59

nmol/l

1.68

149

1719

Other and unspecified follicular disorders

127

699

1.88

9.70

2.0

1.9

38.51

39.31

nmol/l

0.15

119

678

Hernia of abdominal wall

1013

8233

1.24

9.61

2.1

1.8

38.25

42.10

nmol/l

5.57

978

8036

Persons encountering health services in other circumstances

869

6866

1.26

9.60

1.9

1.8

40.80

41.75

nmol/l

0.50

855

6701

Myocardial infarction

655

5911

0.77

9.59

1.9

1.8

41.16

42.66

nmol/l

1.07

628

5760

Hypothyroidism, strict autoimmune

1246

6740

1.22

9.56

1.8

1.6

44.79

44.27

nmol/l

0.23

1222

6584

Organic, including symptomatic, mental disorders

434

4179

0.73

9.54

1.7

1.8

48.49

44.29

nmol/l

2.15

418

4016

Contact with and exposure to communicable diseases

763

5987

1.28

9.51

1.8

40.69

40.87

nmol/l

0.05

757

5886

Myocardial infarction, strict

609

5609

0.76

9.48

1.8

41.49

42.92

nmol/l

0.93

588

5460

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

960

7740

1.24

9.48

2.0

1.8

42.22

43.50

nmol/l

0.68

936

7537

Conjunctivitis

1616

11026

1.19

9.44

2.0

1.8

41.10

40.49

nmol/l

0.37

1581

10837

Pure hypercholesterolaemia

1638

8803

1.19

9.43

2.0

1.9

38.66

41.23

nmol/l

4.50

1593

8620

Other benign neoplasms of skin

562

4259

1.33

9.37

2.0

1.8

42.08

43.22

nmol/l

0.51

535

4144

Adhesive capsulitis of shoulder

265

1767

1.52

9.32

1.9

1.8

42.42

42.71

nmol/l

0.07

256

1724

Hypertension

1914

9251

1.17

9.31

2.1

1.9

35.46

41.25

nmol/l

20.40

1870

9091

Mental and behavioural disorders due to sedatives or hypnotics

220

1419

1.59

9.29

2.4

2.0

41.24

36.76

nmol/l

1.50

210

1388

Finngen Rheumatological endpoints

2342

11569

1.15

9.25

2.0

1.8

39.22

41.32

nmol/l

3.54

2286

11359

Hypertensive diseases

1914

9258

1.17

9.24

2.1

1.9

35.46

41.24

nmol/l

20.34

1870

9098

Presbyopia

178

1089

1.67

9.23

1.9

2.0

40.05

39.35

nmol/l

0.15

172

1058

Complications of medical and surgical care

1329

9991

1.20

9.14

2.0

1.8

42.91

42.85

nmol/l

0.02

1291

9770

Solid cancers

1378

9614

0.84

9.12

1.9

41.98

40.95

nmol/l

0.73

1353

9420

Gonarthrosis,primary

1615

8250

1.19

9.10

2.0

1.8

41.19

42.59

nmol/l

1.73

1562

8060

Ganglion

359

2549

1.42

9.10

1.9

1.7

41.24

41.96

nmol/l

0.24

352

2502

Benign paroxysmal vertigo

366

2607

1.41

9.06

2.0

1.8

44.10

43.82

nmol/l

0.06

356

2523

Malignant neoplasm

1449

10049

0.84

9.05

1.9

41.67

40.78

nmol/l

0.63

1421

9852

Benign neoplasm: Ascending colon

227

1476

1.56

9.03

2.0

1.9

43.18

43.64

nmol/l

0.12

218

1423

Acute appendicitis, no complications

1399

11730

1.19

9.00

1.9

39.93

40.48

nmol/l

0.30

1381

11510

Malignant neoplasm

1452

10061

0.84

8.97

1.9

41.77

40.73

nmol/l

0.78

1424

9864

Other sexually transmitted chlamydial diseases, including avohilmo

346

2461

1.43

8.92

1.9

1.8

42.97

39.07

nmol/l

1.15

334

2431

Retinal breaks without detachment

279

1903

1.48

8.84

1.9

49.53

42.24

nmol/l

3.18

274

1836

Other and unspecified dermatitis

935

7605

1.24

8.77

2.0

1.8

42.01

42.52

nmol/l

0.23

910

7435

COPD/asthma/ILD related infections

2105

9130

1.16

8.74

1.9

1.8

40.31

42.63

nmol/l

3.92

2062

8943

COPD/asthma related infections

2105

9130

1.16

8.74

1.9

1.8

40.31

42.63

nmol/l

3.92

2062

8943

Implicit viral Sepsis, including avohilmo

543

4131

1.32

8.73

2.1

1.8

40.65

42.62

nmol/l

1.19

527

4017

Disorders of synovium and tendon

1094

7658

1.22

8.71

2.0

1.8

40.91

42.10

nmol/l

0.83

1067

7524

Disorders of vestibular function (Vertigo)

644

4888

1.29

8.69

2.0

1.8

43.55

43.50

nmol/l

0.02

626

4747

Schizophrenia or delusion

565

7284

0.77

8.55

1.9

38.88

38.45

nmol/l

0.13

552

7164

Schizophrenia, schizotypal and delusional disorders

565

7283

0.77

8.54

1.9

38.88

38.46

nmol/l

0.13

552

7160

Any event in cancer register

1594

10880

0.85

8.51

1.9

41.81

41.53

nmol/l

0.16

1564

10675

Nontoxic multinodular goitre

124

700

1.78

8.47

1.8

1.7

43.80

45.77

nmol/l

0.42

119

671

Emergency coronary revascularization (for ACS)

1765

9152

1.17

8.47

2.0

1.9

38.98

40.77

nmol/l

2.96

1720

8951

Other diseases of lip and oral mucosa

752

6012

1.26

8.33

2.0

1.8

41.64

41.60

nmol/l

0.02

728

5876

Presence of other devices

302

2078

1.44

8.31

1.7

1.8

44.75

46.92

nmol/l

1.02

284

2007

Dementia

242

2440

0.67

8.23

1.6

1.8

51.27

47.61

nmol/l

1.14

232

2320

Emotionally unstable personality disorder

280

1942

1.46

8.22

2.0

1.8

44.34

41.44

nmol/l

0.86

273

1912

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1538

11994

1.17

8.20

2.0

1.8

39.96

40.33

nmol/l

0.23

1508

11781

Mixed and other personality disorders

224

1491

1.54

8.19

2.2

1.9

37.45

38.34

nmol/l

0.19

216

1464

External causes of morbidity and mortality

1385

5851

1.19

8.12

1.9

1.8

40.32

42.19

nmol/l

1.94

1344

5767

Carpal tunnel syndrome

1062

7632

1.21

8.07

2.1

1.8

38.71

42.92

nmol/l

7.46

1031

7475

Mycoses

541

4174

1.31

8.06

1.9

1.8

44.41

41.75

nmol/l

1.22

530

4066

443

2978

1.34

8.05

1.8

48.52

47.07

nmol/l

0.61

426

2850

Other disorders of ear

1880

10542

1.16

7.95

1.9

1.8

42.12

41.41

nmol/l

0.65

1821

10342

Heartburn

220

1466

1.52

7.89

2.0

1.9

38.71

41.27

nmol/l

1.10

211

1428

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

765

6176

1.25

7.88

1.8

1.9

40.17

39.70

nmol/l

0.20

751

6066

Lesion of ulnar nerve

331

2389

1.41

7.82

2.1

1.9

37.56

40.89

nmol/l

1.99

323

2334

Other spirochaetal diseases, including avohilmo

601

4719

1.28

7.80

1.9

44.80

41.67

nmol/l

2.55

585

4595

Early onset COPD

259

3698

0.69

7.77

2.0

1.9

39.12

42.47

nmol/l

1.58

248

3587

Malignant neoplasm of prostate

542

4125

0.77

7.76

1.8

1.9

45.65

43.83

nmol/l

1.04

529

3998

Coronary revascularization (ANGIO or CABG)

1685

8827

1.16

7.74

2.0

1.9

38.57

40.70

nmol/l

3.90

1645

8636

Other inflammation of eyelid

227

1529

1.50

7.71

1.9

41.32

41.92

nmol/l

0.12

219

1484

Disorders of vitreous body

683

5177

1.26

7.71

1.9

1.8

45.56

43.91

nmol/l

1.01

660

5013

Sulfonylureas

245

2817

0.69

7.70

2.0

1.8

40.79

49.38

nmol/l

7.60

229

2702

Percutaneous Coronary Intervention

1681

8819

1.16

7.69

2.0

1.9

38.61

40.70

nmol/l

3.78

1641

8628

Seborrhoeic dermatitis

232

1576

1.50

7.65

2.1

1.9

40.97

40.58

nmol/l

0.08

225

1532

Disorders of vitreous body and globe

705

5340

1.25

7.60

1.9

1.8

45.56

43.86

nmol/l

1.08

682

5173

Other spirochaetal diseases

589

4633

1.28

7.55

1.9

44.88

41.67

nmol/l

2.61

573

4509

Other and unspecified disorders of skin and subcutaneous tissue

102

566

1.83

7.55

2.0

1.8

46.18

41.66

nmol/l

0.77

546

Other symptoms and signs involving the nervous and musculoskeletal systems

744

6010

1.25

7.54

2.1

1.8

41.15

42.43

nmol/l

0.61

733

5861

Later onset COPD

131

1729

0.60

7.54

1.7

53.00

51.12

nmol/l

0.27

123

1628

Other predominantly sexually transmitted diseases, not elsewhere classified

375

2777

1.37

7.53

1.9

1.8

40.38

40.23

nmol/l

0.04

365

2734

Benign lipomatous neoplasm

517

4003

1.30

7.53

2.0

1.9

41.01

41.76

nmol/l

0.22

509

3897

Disorders of sclera, cornea, iris and ciliary body

1202

10177

1.19

7.52

2.0

1.9

41.28

40.57

nmol/l

0.41

1175

9963

Injuries to the neck

559

4380

1.29

7.48

2.0

1.8

41.52

40.46

nmol/l

0.42

545

4291

Lyme disease

582

4580

1.28

7.45

1.9

44.83

41.72

nmol/l

2.45

567

4458

Lyme disease, including avohilmo

582

4580

1.28

7.45

1.9

44.83

41.72

nmol/l

2.45

567

4458

Asthma, hospital admissions , main diagnosis only

1724

13037

1.15

7.44

2.0

1.8

38.41

41.59

nmol/l

6.56

1694

12780

Other symptoms and signs involving the circulatory and respiratory systems

135

816

1.68

7.40

2.1

1.8

39.39

42.02

nmol/l

0.74

129

795

Anaemias

533

2640

1.30

7.39

2.1

1.6

43.85

44.10

nmol/l

0.06

524

2618

Non-ischemic cardiomyopathy

283

3141

0.71

7.39

1.7

1.9

43.05

44.43

nmol/l

0.43

272

3027

Injury of muscle and tendon at hip and thigh level

254

1771

1.46

7.36

2.2

1.9

39.00

39.70

nmol/l

0.20

243

1724

Hypothyroidism, drug reimbursement

247

1180

1.47

7.34

1.8

1.6

43.30

47.11

nmol/l

1.37

235

1165

Anogenital herpesviral [herpes simplex] infection

143

881

1.66

7.32

2.0

1.8

42.73

41.88

nmol/l

0.13

136

862

Injuries to the abdomen, lower back, lumbar spine and pelvis

820

6621

1.23

7.29

1.9

1.8

42.17

41.11

nmol/l

0.59

800

6475

Spirochaetal infections, other/unspecified, including avohilmo

585

4624

1.27

7.23

1.9

44.76

41.70

nmol/l

2.40

570

4502

COPD (mode)

306

3285

0.72

7.22

1.9

1.8

43.94

44.78

nmol/l

0.22

290

3187

Thyrotoxicosis, other and/or unspecified

241

1665

1.46

7.18

1.7

1.8

51.14

43.50

nmol/l

2.31

235

1620

Dementia, including avohilmo

282

2683

0.71

7.09

1.7

50.38

47.27

nmol/l

1.03

269

2557

Urticaria and erythema

628

5015

1.26

7.09

1.9

1.8

43.15

42.23

nmol/l

0.24

611

4917

Hypertrophic disorders of skin

108

623

1.77

7.06

2.0

1.7

45.05

40.81

nmol/l

0.84

108

607

Chromosomal abnormalities, not elsewhere classified

312

2.13

7.05

2.5

1.9

36.53

37.23

nmol/l

0.08

304

Other disorders of bone

440

3370

1.32

7.04

1.9

40.04

39.84

nmol/l

0.06

426

3299

Any reimbursement code in KELA

1651

7169

1.16

7.02

2.0

1.7

37.13

41.77

nmol/l

11.67

1614

7083

Solid cancers, including Hilmo

1497

10083

0.86

7.01

1.9

41.70

40.80

nmol/l

0.65

1473

9885

Dermatitis

1166

9681

1.18

7.01

2.0

1.8

41.64

42.32

nmol/l

0.40

1138

9472

Calculus of kidney and ureter

633

5075

1.26

6.99

1.9

40.17

42.11

nmol/l

1.35

617

4927

Urolithiasis

674

5443

1.25

6.97

1.8

1.9

41.08

42.31

nmol/l

0.68

657

5275

Other symptoms and signs involving cognitive functions and awareness

770

5575

1.23

6.95

1.9

1.8

43.09

42.54

nmol/l

0.24

740

5427

Myocardial infarction, unclassifiable

130

1868

0.62

6.94

1.7

1.8

42.79

45.64

nmol/l

0.81

124

1791

Constipation

1643

9672

1.15

6.94

2.0

1.8

43.61

42.22

nmol/l

1.28

1583

9471

Nontoxic goitre/thyroid nodule

205

1382

1.49

6.90

1.8

43.91

46.25

nmol/l

0.70

200

1338

Thyrotoxicosis

279

1997

1.41

6.85

1.7

1.8

50.40

43.99

nmol/l

2.07

273

1939

Other diseases of anus and rectum

476

3679

1.30

6.83

1.9

1.8

41.99

42.74

nmol/l

0.31

460

3576

Macular pucker

192

1285

1.51

6.77

1.9

1.8

46.94

46.65

nmol/l

0.06

186

1219

Other disorders of skin and subcutaneous tissue, not elsewhere classified

233

1624

1.45

6.71

2.0

1.8

42.72

42.26

nmol/l

0.10

219

1570

Other sexually transmitted chlamydial diseases

218

1509

1.48

6.70

1.9

42.21

38.31

nmol/l

1.08

209

1488

Malignant neoplasm of prostate, including Hilmo

577

4264

0.79

6.68

1.8

1.9

45.33

43.61

nmol/l

1.02

564

4134

Major coronary heart disease event excluding revascularizations

867

6876

0.83

6.68

1.9

41.20

41.92

nmol/l

0.44

841

6709

Other and unspecified mood [affective] disorders

179

1190

1.53

6.64

2.1

1.8

36.20

39.87

nmol/l

1.53

174

1171

Sequelae of external causes of morbidity and mortality

438

3379

1.31

6.62

2.1

1.8

42.07

41.96

nmol/l

0.03

424

3279

Acute alcohol intoxication

462

5899

0.78

6.61

1.8

1.9

40.97

40.10

nmol/l

0.36

452

5764

Erosion of teeth , including avohilmo

631

5094

1.25

6.59

2.0

1.8

43.03

40.61

nmol/l

1.26

614

5001

Acute alcohol intoxication, ICD10

386

5035

0.76

6.59

1.9

39.45

39.44

nmol/l

0.00

378

4927

Procedures for purposes other than remedying health state

146

2.59

6.59

1.6

1.8

59.95

42.38

nmol/l

1.49

141

Keratitis

792

6544

1.22

6.58

2.0

1.8

39.98

40.32

nmol/l

0.15

772

6404

Otitis externa

454

3524

1.30

6.58

2.0

1.8

42.83

41.14

nmol/l

0.35

434

3448

Malignant neoplasm, wide definition

1565

10445

0.87

6.57

1.9

41.60

40.57

nmol/l

0.81

1537

10244

Other heart diseases, wide

2189

11772

1.13

6.51

2.1

1.8

39.45

40.29

nmol/l

0.89

2133

11583

Superficial injury of lower leg

505

3981

1.28

6.46

1.9

1.8

39.23

41.22

nmol/l

1.08

493

3903

Undetermined asthma

212

1462

1.46

6.44

2.1

1.8

37.24

42.94

nmol/l

3.22

204

1424

Ethmoidectomy

294

2155

1.38

6.42

2.0

1.9

39.82

40.38

nmol/l

0.17

288

2100

Disorders of tooth development and eruption

381

2352

1.33

6.38

1.9

1.8

39.60

40.16

nmol/l

0.17

373

2324

Chronic lower respiratory diseases

2786

13217

1.11

6.36

2.0

1.8

38.63

41.48

nmol/l

7.87

2731

12965

Hydrocele

312

2315

1.37

6.33

1.8

41.63

40.31

nmol/l

0.52

302

2246

Undetermined asthma, excluding more controls

212

1468

1.46

6.31

2.1

1.8

37.24

43.12

nmol/l

3.38

204

1428

Malignant neoplasm, including Hilmo

1568

10438

0.87

6.31

1.9

41.51

40.57

nmol/l

0.71

1540

10237

Superficial injury of abdomen, lower back and pelvis

344

2589

1.34

6.29

1.7

1.9

40.28

40.06

nmol/l

0.06

334

2531

Trigger finger

220

1540

1.44

6.22

2.0

1.8

43.44

42.82

nmol/l

0.12

213

1502

Benign thyroid growths and nodules

240

1583

1.41

6.14

1.9

1.7

43.66

45.44

nmol/l

0.52

235

1531

Hypermetropia

138

882

1.59

6.10

2.0

1.9

41.63

40.60

nmol/l

0.13

138

854

Conjunctivitis (acute, non atopic)

571

4579

1.25

6.09

1.9

1.8

40.45

41.17

nmol/l

0.23

553

4493

Nonalcoholic fatty liver disease

233

1659

1.43

6.09

2.0

33.68

38.78

nmol/l

2.72

228

1614

Influenza and pneumonia

2421

13408

1.12

6.08

1.9

1.8

39.12

41.33

nmol/l

4.29

2372

13162

Ischemic heart diseases

1745

9147

1.14

6.06

2.0

1.9

38.30

40.72

nmol/l

5.22

1708

8954

Chronic gastritis

311

2317

1.35

6.02

2.1

1.8

44.45

44.71

nmol/l

0.06

298

2235

Open wound of wrist and hand

1344

11303

1.16

6.01

1.8

1.9

39.61

39.73

nmol/l

0.07

1315

11097

FESS (DNB20)

282

2080

1.37

5.96

2.0

1.9

39.95

40.45

nmol/l

0.15

276

2025

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

201

1402

1.46

5.91

2.1

1.9

37.27

38.47

nmol/l

0.33

196

1377

Bruxism

155

2.46

5.88

2.7

1.7

44.14

39.48

nmol/l

0.29

150

Appendectomy

1439

11985

1.15

5.87

1.9

40.02

40.56

nmol/l

0.35

1419

11758

Inguinal hernia

1816

10699

1.13

5.86

1.9

42.15

38.86

nmol/l

7.54

1772

10496

Hypertrophic scar

575

1.72

5.83

2.1

1.7

42.07

41.20

nmol/l

0.13

559

Injury, poisoning and certain other consequences of external causes

1088

4646

1.18

5.81

1.9

1.7

40.54

42.71

nmol/l

2.05

1055

4583

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

536

1.74

5.68

2.3

1.9

40.11

38.34

nmol/l

0.31

521

Other viral diseases

730

6059

1.21

5.67

2.0

1.8

38.27

40.00

nmol/l

0.96

717

5955

Provisional assignment of new diseases of uncertain etiology

1024

8698

1.17

5.64

1.7

1.8

41.25

42.30

nmol/l

0.64

1009

8485

Sacrococcygeal disorders, not elsewhere classified

229

2.14

5.60

2.5

1.7

37.85

40.57

nmol/l

0.40

222

Codes for special purposes

1024

8704

1.17

5.59

1.7

1.8

41.25

42.31

nmol/l

0.65

1009

8490

Disorders of conjunctiva

1756

12076

1.13

5.58

2.0

1.8

41.96

40.75

nmol/l

0.99

1718

11856

Retinal detachments and breaks

552

4478

1.24

5.54

1.8

1.9

46.71

43.36

nmol/l

1.96

535

4329

Viral and other specified intestinal infections, including avohilmo

784

6338

1.20

5.54

2.0

1.8

39.52

39.00

nmol/l

0.15

775

6244

Diseases of inner ear

805

6474

1.19

5.52

1.9

1.8

43.11

42.84

nmol/l

0.10

782

6295

Sensorineural hearing loss

1294

7504

1.15

5.49

1.8

1.9

42.94

42.30

nmol/l

0.47

1241

7335

Oedema, not elsewhere classified

501

3931

1.25

5.47

1.9

1.8

43.15

43.28

nmol/l

0.04

487

3816

Other disorders of veins

529

4207

1.24

5.46

1.9

1.8

44.60

43.28

nmol/l

0.58

507

4090

Childhood asthma (age<16), excluding more controls

422

2595

1.28

5.44

1.8

1.7

36.38

39.83

nmol/l

1.61

416

2573

Unspecific neurodegenerative disorder

216

2056

0.72

5.44

1.6

1.7

53.27

48.95

nmol/l

1.42

208

1944

Childhood asthma (age<16)

422

2596

1.28

5.43

1.8

1.7

36.38

39.79

nmol/l

1.59

416

2574

Any prescribed medicine buy

6.86

5.43

1.8

1.2

37.36

37.25

nmol/l

0.01

Bacterial infection, other or unspecified

714

7198

0.83

5.39

1.9

1.8

43.95

42.57

nmol/l

0.77

689

7013

Status post-ami

272

2754

0.74

5.38

1.8

42.81

46.01

nmol/l

1.61

254

2647

Benign neoplasm: Colon, unspecified

376

2929

1.29

5.37

1.9

1.8

43.16

44.48

nmol/l

0.51

360

2820

Localized swelling, mass and lump of skin and subcutaneous tissue

553

4505

1.24

5.37

1.9

1.8

43.36

41.59

nmol/l

0.77

533

4396

Alcohol dependence

528

6469

0.81

5.34

2.0

1.9

41.06

39.88

nmol/l

0.60

514

6324

Vasomotor rhinitis (mode)

117

746

1.59

5.30

2.1

1.8

40.41

40.86

nmol/l

0.09

111

725

Ovarian dysfunction: estrogen excess

+∞

5.29

1.2

0.0

39.40

—

nmol/l

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1241

7255

1.15

5.26

1.8

1.7

45.00

44.54

nmol/l

0.19

1217

7076

Implicit viral Sepsis

358

2781

1.30

5.25

2.0

1.8

41.48

42.32

nmol/l

0.26

349

2699

Substance use, excluding alcohol

587

4834

1.23

5.25

2.2

1.9

41.19

37.79

nmol/l

2.47

565

4753

Diplopia

221

1603

1.39

5.20

1.9

1.8

42.61

42.11

nmol/l

0.12

215

1552

Adverse effects, not elsewhere classified

329

2531

1.31

5.20

1.8

38.77

41.75

nmol/l

1.15

323

2474

Acute bronchitis

767

6340

1.19

5.20

1.9

1.8

37.29

41.41

nmol/l

5.91

748

6192

Disorders of continuity of bone

190

1345

1.43

5.17

2.0

1.9

39.53

39.43

nmol/l

0.02

184

1311

Viral Sepsis

358

2787

1.29

5.17

2.0

1.8

41.48

42.33

nmol/l

0.27

349

2705

1755

9130

1.13

5.16

2.0

1.8

40.31

42.63

nmol/l

3.21

1715

8943

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1755

9130

1.13

5.16

2.0

1.8

40.31

42.63

nmol/l

3.21

1715

8943

Viral infections characterized by skin and mucous membrane lesions

912

7803

1.17

5.15

2.1

1.9

40.62

40.92

nmol/l

0.13

899

7644

Complications of procedures, not elsewhere classified

1598

11427

1.13

5.14

1.9

1.8

41.96

41.98

nmol/l

0.01

1547

11199

Coxarthrosis

849

4640

1.19

5.13

1.9

1.8

41.80

43.08

nmol/l

0.96

828

4527

Diabetic nephropathy, excluding more controls

186

2120

0.71

5.11

1.7

1.9

46.68

35.38

nmol/l

3.27

180

2064

Noninfective enteritis and colitis

994

8563

1.17

5.10

1.9

40.45

40.51

nmol/l

0.03

973

8387

Disorders of puberty

186

2.23

5.08

1.9

1.5

38.12

37.24

nmol/l

0.06

180

Myocardial infarction, with ST-elevation

165

2351

0.70

5.06

1.7

1.9

42.77

43.73

nmol/l

0.23

156

2265

Other diseases of liver

353

2755

1.29

5.04

2.0

1.9

37.93

40.27

nmol/l

0.91

342

2685

Diastasis of muscle

2.78

5.02

2.2

1.6

38.40

41.11

nmol/l

0.25

Certain disorders involving the immune mechanism

373

2934

1.28

5.01

2.1

1.9

39.47

40.02

nmol/l

0.14

367

2860

Peripheral artery operations in Hilmo

1483

0.62

5.00

1.9

41.87

43.88

nmol/l

0.46

1424

Dyspnoea

1738

11206

1.12

4.96

2.0

1.8

39.89

42.45

nmol/l

4.66

1695

10966

Lichen ruber planus, wide definition including periferal and oral lichen planus

301

2303

1.32

4.96

1.8

1.9

43.00

41.47

nmol/l

0.48

296

2233

Malignant neoplasm of breast, including Hilmo

435

0.44

4.95

1.1

1.3

69.80

60.70

nmol/l

0.65

430

Malignant neoplasm of breast, HER2-negative, including Hilmo

435

0.44

4.94

1.1

1.3

69.80

60.70

nmol/l

0.65

430

Abrasion of teeth

551

4529

1.22

4.93

1.9

1.8

44.91

42.08

nmol/l

1.82

541

4418

Recurrent dislocation and subluxation of joint

178

1260

1.44

4.92

2.2

1.9

35.54

37.94

nmol/l

0.85

173

1240

Cramp and spasm

105

667

1.61

4.92

2.1

1.9

46.58

39.46

nmol/l

1.53

105

645

Fever of other and unknown origin

1156

8744

1.15

4.89

2.1

1.8

40.65

41.67

nmol/l

0.71

1135

8564

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

574

4684

1.22

4.88

1.9

1.7

42.51

41.56

nmol/l

0.30

553

4622

Radiculopathy

215

1570

1.38

4.86

2.0

1.8

38.84

43.21

nmol/l

2.39

206

1524

Coronary artery bypass grafting

277

2692

0.76

4.85

1.7

1.8

45.57

46.72

nmol/l

0.32

265

2584

Polyarthrosis

163

1018

1.45

4.83

2.0

1.7

42.76

45.57

nmol/l

0.73

158

983

Urticaria

502

4101

1.23

4.79

1.9

1.8

43.48

42.34

nmol/l

0.25

487

4022

Benign neoplasm of bone and articular cartilage

168

1183

1.44

4.77

1.7

1.9

39.35

39.26

nmol/l

0.02

160

1155

Recurrent aphthous stomatitis , including avohilmo

233

1731

1.36

4.75

2.0

1.9

42.14

40.72

nmol/l

0.33

227

1688

Bacterial Sepsis

628

6198

0.83

4.75

2.0

1.8

42.39

42.87

nmol/l

0.19

604

6030

Other/unspecified enthesopathies, not elsewhere classified

132

888

1.50

4.72

2.1

1.8

43.73

41.70

nmol/l

0.38

127

863

Carbimazole or st.post thyroidectomy, condition for graves disease

241

1800

1.35

4.71

1.6

1.8

44.64

43.81

nmol/l

0.17

232

1750

Other bacterial intestinal infections, including avohilmo

392

3125

1.26

4.70

2.0

1.8

39.93

41.57

nmol/l

0.67

380

3045

Conductive and sensorineural hearing loss

1402

8234

1.13

4.70

1.8

42.87

41.95

nmol/l

0.80

1348

8059

Peripheral arterial reconstruction

110

1668

0.65

4.70

1.7

1.8

43.64

46.05

nmol/l

0.64

101

1593

Olecranon bursitis

171

1216

1.43

4.67

2.2

1.8

38.66

41.15

nmol/l

0.83

163

1180

Assault

478

3913

1.24

4.65

2.0

1.9

37.63

36.84

nmol/l

0.36

461

3849

Congenital malformations, deformations and chromosomal abnormalities

1366

11483

1.13

4.65

2.0

1.8

40.16

40.22

nmol/l

0.03

1343

11285

Testicular hyperfunction

13.53

4.64

3.8

1.3

21.56

39.81

nmol/l

—

Poisoning by drugs, medicaments and biological substances

569

4735

1.21

4.58

2.0

1.8

40.71

39.64

nmol/l

0.43

548

4651

Other and unspecified effects of external causes

578

4817

1.21

4.56

1.9

1.8

37.02

40.80

nmol/l

3.14

566

4725

Cushing syndrome

2.67

4.55

2.2

1.5

36.83

44.29

nmol/l

0.60

Dermatitis and eczema

2501

13527

1.10

4.53

1.9

1.8

41.48

40.91

nmol/l

0.52

2444

13272

Other heart diseases

1226

7014

1.14

4.52

2.1

1.8

37.79

40.27

nmol/l

3.63

1195

6914

Insulin, combination of fast acting with intermediate-acting or long-acting

1082

11180

0.87

4.52

1.8

1.9

41.92

41.04

nmol/l

0.47

1051

10933

Candidiasis

205

1505

1.37

4.52

2.0

1.8

47.09

42.71

nmol/l

1.16

198

1463

Benign neoplasm of other and ill-defined parts of digestive system

220

1639

1.35

4.42

1.9

1.8

41.42

43.58

nmol/l

0.45

215

1581

Nonsuppurative otitis media, including avohilmo

746

5503

1.18

4.41

1.9

1.8

39.58

40.60

nmol/l

0.41

735

5409

Other disorders of bladder

215

1599

1.36

4.41

2.0

1.9

44.55

43.19

nmol/l

0.38

210

1537

Trochanteric bursitis

109

714

1.53

4.39

1.9

1.7

45.98

44.63

nmol/l

0.20

103

694

Diabetic retinopathy, excluding more controls

352

2478

0.79

4.38

1.9

43.26

35.11

nmol/l

6.90

343

2418

Other disorders of prostate

491

1.67

4.36

2.1

1.9

42.59

42.46

nmol/l

0.02

473

Bacterial infection, other or unspecified, including avohilmo

837

7939

0.86

4.36

1.9

1.8

43.33

42.25

nmol/l

0.61

806

7751

Other skin changes

273

2102

1.31

4.36

1.8

45.83

43.31

nmol/l

0.67

266

2035

Major coronary heart disease event

1703

9155

1.12

4.34

2.0

1.9

38.59

40.67

nmol/l

3.81

1661

8956

Visual field defects

128

872

1.48

4.34

2.4

1.8

46.80

42.24

nmol/l

0.89

123

843

Otalgia

117

783

1.51

4.31

2.1

1.8

46.02

41.47

nmol/l

1.02

112

766

Disorders of iron metabolism

270

1.92

4.31

2.2

1.9

35.84

39.98

nmol/l

1.03

263

Unspecified dementia

458

0.41

4.30

1.3

1.6

69.76

48.56

nmol/l

1.32

435

Pituitary-dependent Cushing's disease

4.74

4.28

2.4

1.6

39.54

38.07

nmol/l

0.05

Septicaemia

527

5758

0.83

4.25

2.0

1.8

41.78

42.82

nmol/l

0.34

510

5599

Other diseases of blood and blood-forming organs, wide

355

2836

1.26

4.24

2.2

1.9

39.64

41.60

nmol/l

0.75

343

2756

Viral hepatitis

222

1676

1.35

4.23

2.3

2.0

47.67

36.44

nmol/l

7.65

211

1642

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

193

2593

0.74

4.23

1.8

1.9

50.62

41.30

nmol/l

4.02

186

2512

Mental retardation, wide definition

671

0.49

4.21

2.0

1.9

37.35

37.86

nmol/l

0.04

652

Other otitis externa (chronic)

119

806

1.50

4.19

1.9

48.87

40.96

nmol/l

0.64

110

785

Excessive earwax

1217

9777

1.13

4.18

1.9

1.8

40.93

41.61

nmol/l

0.43

1176

9566

Panniculitis affecting regions of neck and back

359

1.76

4.17

2.3

1.7

37.55

39.44

nmol/l

0.32

348

Injury of muscle and tendon at lower leg level

402

3270

1.24

4.16

1.9

38.55

39.66

nmol/l

0.58

395

3196

Benign neoplasm: Skin of eyelid, including canthus

181

1322

1.38

4.15

1.8

1.9

40.10

43.39

nmol/l

1.24

167

1276

Striking against or struck by other objects

998

8749

1.15

4.15

2.0

1.9

38.80

38.88

nmol/l

0.04

969

8587

Fracture at wrist and hand level

973

8500

1.15

4.14

2.0

1.9

39.17

38.55

nmol/l

0.41

957

8351

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1021

11485

0.88

4.13

2.0

1.9

40.77

39.97

nmol/l

0.52

990

11243

Disorders of puberty, all

252

1.93

4.13

2.1

1.6

38.02

38.10

nmol/l

0.01

246

COPD-related respiratory insufficiency

1222

0.62

4.13

1.8

36.29

44.83

nmol/l

3.33

1175

Bacterial, viral and other infectious agents, including avohilmo

272

2119

1.30

4.12

1.9

2.0

38.95

37.66

nmol/l

0.41

267

2071

Nontraumatic intracranial haemmorrhage

153

2126

0.72

4.12

1.7

1.9

44.46

43.51

nmol/l

0.17

148

2051

Early syphilis, including avohilmo

343

1.81

4.10

2.0

40.41

36.61

nmol/l

0.52

333

Insulin medication

1082

10158

0.88

4.09

1.8

1.9

41.92

42.01

nmol/l

0.04

1051

9966

Zoster [herpes zoster], including avohilmo

748

6202

1.17

4.09

1.9

1.8

42.95

43.30

nmol/l

0.15

728

6032

Mental retardation

648

0.49

4.05

2.0

1.9

36.97

37.37

nmol/l

0.03

631

Ill-defined and unknown causes of mortality

1053

0.60

4.02

2.1

1.9

48.80

42.67

nmol/l

0.86

1017

Superficial injury of wrist and hand

483

4014

1.21

4.01

1.9

1.8

38.37

39.62

nmol/l

0.65

473

3944

Fibroblastic disorders

341

2730

1.26

4.01

1.8

43.80

44.28

nmol/l

0.15

334

2655

Wide developmental disorders, excluding more controls

599

1.57

3.99

1.8

1.7

33.13

37.73

nmol/l

1.29

594

Malignant neoplasm of stomach

518

0.44

3.99

1.8

1.9

60.04

43.86

nmol/l

1.00

493

Viral hepatitis, including avohilmo

232

1779

1.33

3.99

2.3

2.0

48.35

36.33

nmol/l

8.63

221

1744

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

941

8143

1.15

3.97

1.9

1.8

39.06

39.88

nmol/l

0.41

923

8016

Other disorders of skin and subcutaneous tissue

1204

9033

1.13

3.93

1.9

1.8

43.53

42.72

nmol/l

0.50

1176

8812

Thoracic aortic aneurysm

327

2618

1.26

3.93

1.8

1.9

42.10

42.75

nmol/l

0.21

313

2523

Diseases of arteries, arterioles and capillaries

945

7892

0.87

3.90

1.8

1.9

42.79

42.47

nmol/l

0.16

911

7697

Diabetic retinopathy

418

3156

0.82

3.88

1.9

44.12

35.78

nmol/l

8.58

400

3070

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

261

2045

1.30

3.86

2.4

2.0

42.24

36.18

nmol/l

3.37

254

2015

Symptoms and signs involving cognition, perception, emotional state and behaviour

2011

12268

1.10

3.84

2.0

1.8

42.57

41.31

nmol/l

1.30

1950

12036

Covid-19 confirmed case

628

5354

1.18

3.80

1.8

40.86

42.79

nmol/l

1.21

615

5201

Open wound of lower leg

306

2439

1.27

3.80

1.8

1.9

41.24

39.96

nmol/l

0.42

295

2382

Other viral hepatitis

205

1558

1.34

3.80

2.4

2.0

47.43

36.21

nmol/l

7.74

194

1530

Superficial injury of thorax

321

2574

1.26

3.79

1.9

40.76

39.81

nmol/l

0.28

310

2513

Otitis externa, unspecified

217

1657

1.32

3.78

2.1

1.9

41.79

40.57

nmol/l

0.18

210

1620

Gout

500

3590

1.20

3.78

1.9

1.8

36.66

44.16

nmol/l

11.67

482

3487

Inguinal hernia, bilateral

252

1967

1.30

3.76

1.8

1.9

43.33

41.71

nmol/l

0.57

247

1895

Car occupant injured in other and unspecified transport accidents

421

3478

1.22

3.75

2.0

1.8

39.57

39.72

nmol/l

0.04

411

3409

Atopic dermatitis

1326

9468

1.12

3.75

1.8

40.89

40.17

nmol/l

0.47

1299

9317

Early onset COPD, excluding more controls

259

3285

0.78

3.73

2.0

1.8

39.12

43.69

nmol/l

2.58

248

3196

Assault by bodily force

271

2142

1.29

3.73

2.1

2.0

36.82

36.63

nmol/l

0.05

261

2105

Early syphilis

316

1.80

3.72

2.0

39.72

36.72

nmol/l

0.40

308

Heterophoria

135

960

1.42

3.71

1.6

1.8

41.08

40.95

nmol/l

0.02

129

936

Undefined dementia

453

0.45

3.69

1.3

1.6

68.23

49.29

nmol/l

1.19

430

Other specified disorders of external ear

554

1.57

3.68

1.8

1.9

42.25

40.78

nmol/l

0.23

537

Asthma-related pneumonia

555

4688

1.18

3.67

2.0

1.8

36.59

42.38

nmol/l

8.58

547

4568

Impacted cerumen

165

1215

1.37

3.67

2.0

1.9

39.80

42.27

nmol/l

0.71

149

1177

Gluteal tendinitis

239

1.86

3.67

1.3

1.7

46.26

42.18

nmol/l

0.42

228

Alcohol use disorder, ICD-based

945

10686

0.88

3.66

2.0

1.9

40.71

39.96

nmol/l

0.44

914

10460

malignant neoplasm of male genital organs

655

4586

0.85

3.66

1.9

42.74

42.78

nmol/l

0.01

641

4449

Peritonsillar abscess

497

4181

1.20

3.66

1.8

37.57

40.41

nmol/l

2.12

491

4109

Inguinal or femoral hernia, bilateral

252

1976

1.29

3.64

1.8

1.9

43.33

41.75

nmol/l

0.55

247

1904

Other viral diseases, not elsewhere classified

393

3224

1.22

3.64

2.0

1.9

38.80

39.58

nmol/l

0.21

385

3159

Abnormal findings on diagnostic imaging of central nervous system

619

1.53

3.63

2.1

1.8

41.27

41.07

nmol/l

0.03

598

Asthma, hospital admissions 3, pneumonia

555

4697

1.18

3.60

2.0

1.8

36.59

42.36

nmol/l

8.52

547

4577

Asthma-related pneumonia or sepsis

555

4697

1.18

3.60

2.0

1.8

36.59

42.36

nmol/l

8.52

547

4577

Explicit Sepsis, including avohilmo

567

6024

0.85

3.59

2.0

1.8

42.30

43.50

nmol/l

0.43

550

5865

Other viral hepatitis, including avohilmo

215

1659

1.32

3.59

2.4

2.0

48.10

35.96

nmol/l

8.86

204

1630

Explicit Sepsis

548

5862

0.85

3.57

2.0

1.8

42.44

43.54

nmol/l

0.37

531

5704

Malignant neoplasm of stomach, including Hilmo

588

0.50

3.55

2.1

1.9

55.70

43.63

nmol/l

0.92

561

Mental and behavioural disorders due to use of other stimulants, including caffeine

122

867

1.45

3.55

2.6

2.0

43.53

34.71

nmol/l

2.99

116

859

Drug-induced adrenocortical insufficiency

172

2.03

3.54

3.0

1.8

60.79

41.82

nmol/l

0.88

166

Other superficial mycoses, including avohilmo

257

2029

1.28

3.52

1.9

41.87

38.64

nmol/l

0.94

248

1983

Spontaneous rupture of synovium and tendon

123

869

1.43

3.52

2.0

1.8

38.36

42.53

nmol/l

1.32

115

847

Dizziness and giddiness

1277

8917

1.12

3.51

2.0

1.8

43.27

42.67

nmol/l

0.32

1234

8731

Amputation

1172

0.65

3.49

2.0

1.9

41.44

42.97

nmol/l

0.26

1128

Special screening examination for neoplasms

116

813

1.44

3.48

1.6

1.8

46.93

42.97

nmol/l

0.78

107

796

Other bursopathies

209

1607

1.31

3.48

2.0

1.8

40.83

42.07

nmol/l

0.29

203

1564

Other arrhythmias

1252

8392

1.12

3.46

2.0

1.8

42.73

41.72

nmol/l

0.72

1217

8235

Poisoning by medicine

498

4216

1.19

3.44

2.0

1.9

41.29

39.75

nmol/l

0.63

481

4142

Bacterial, viral and other infectious agents

254

2015

1.28

3.41

2.0

39.07

37.60

nmol/l

0.47

249

1969

Localized hypertrichosis

9.96

3.40

1.3

1.4

42.33

38.00

nmol/l

—

Cholecystectomy

945

7101

1.13

3.39

1.8

40.76

44.62

nmol/l

4.74

919

6910

Helminthiases, including avohilmo

494

1.56

3.33

1.9

1.7

41.41

42.14

nmol/l

0.10

480

Valvular heart disease excluding rheumatic fever

665

5470

0.86

3.32

1.9

44.86

41.89

nmol/l

2.55

637

5345

Chronic viral hepatitis

182

1392

1.33

3.30

2.4

2.0

49.15

35.89

nmol/l

8.97

171

1368

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1228

0.67

3.29

1.5

1.9

42.22

43.92

nmol/l

0.36

1182

Oral corticosteroids

2301

12471

1.08

3.29

1.9

1.8

40.09

41.38

nmol/l

1.58

2258

12229

Bacterial pneumoniae

597

6072

0.86

3.29

2.0

1.8

40.56

42.22

nmol/l

0.81

588

5910

Benign neoplasm: Pancreas

227

1.84

3.28

1.7

1.8

49.12

42.43

nmol/l

0.29

214

Other systemic involvement of connective tissue (FG)

243

1882

1.27

3.28

1.9

1.7

42.76

46.85

nmol/l

1.01

235

1823

Other septicaemia, including avohilmo

471

5211

0.84

3.26

2.0

1.8

42.13

43.08

nmol/l

0.27

456

5061

Superficial injury of shoulder and upper arm

240

1899

1.28

3.24

2.1

1.9

39.92

40.05

nmol/l

0.03

235

1857

Non-rheumatic valve diseases

661

5423

0.87

3.23

1.9

1.8

44.94

41.97

nmol/l

2.55

633

5300

Poisoning by narcotics and psychodysleptics [hallucinogens]

399

1.64

3.21

2.1

1.9

42.62

36.42

nmol/l

0.90

391

N06DA Anticholinesterases

161

1647

0.75

3.20

1.7

55.07

49.63

nmol/l

1.39

155

1556

Use of anticholinesterases

161

1647

0.75

3.20

1.7

55.07

49.63

nmol/l

1.39

155

1556

Autoimmune diseases related-to ILD

1812

13897

1.09

3.20

1.8

41.72

40.91

nmol/l

0.63

1772

13631

Coxarthrosis, primary, with hip surgery

561

4465

1.17

3.20

1.9

1.8

42.49

45.18

nmol/l

2.35

549

4307

Disorders of optic nerve and visual pathways

146

1082

1.36

3.18

1.9

45.21

41.41

nmol/l

0.89

141

1052

False labour

238

1159

1.28

3.16

1.2

56.97

54.88

nmol/l

0.24

233

1150

Neuromuscular dysfunction of bladder

151

1127

1.35

3.15

1.7

1.9

46.16

41.59

nmol/l

1.33

145

1086

Other noninfective gastroenteritis and colitis

402

3363

1.20

3.15

1.9

1.8

41.51

40.51

nmol/l

0.34

389

3285

Malignant neoplasm of oesophagus, including Hilmo

522

0.51

3.15

2.6

1.9

46.85

42.18

nmol/l

0.26

499

Algoneurodystrophy

352

1.65

3.12

2.3

1.8

44.68

40.74

nmol/l

0.57

343

Acute and transient psychotic disorders

172

2235

0.76

3.10

2.0

39.32

37.68

nmol/l

0.30

167

2190

Budesonide

276

2233

1.25

3.09

1.8

39.40

40.46

nmol/l

0.33

268

2181

Hypersomnia

182

1.93

3.08

2.2

1.8

42.71

40.10

nmol/l

0.22

174

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

3.23

3.08

1.2

1.1

73.31

52.54

nmol/l

0.62

Enlarged lymph nodes

293

2386

1.24

3.07

2.0

1.8

43.59

41.26

nmol/l

0.61

288

2324

Fall on same level involving ice and snow

1073

9640

1.12

3.07

1.9

1.8

40.70

41.20

nmol/l

0.29

1050

9436

Disorders of gallbladder, biliary tract and pancreas

1587

10782

0.91

3.06

1.8

41.34

42.36

nmol/l

0.91

1535

10557

Maternal care for other known or suspected fetal problems

226

1111

1.28

3.06

1.2

50.19

54.70

nmol/l

1.13

221

1102

Cutaneous abscess, furuncle and carbuncle

627

5462

1.15

3.04

2.1

1.8

39.42

40.13

nmol/l

0.29

611

5353

Mandibular retrognathia AND surgery (BSSO)

332

1.66

3.04

1.7

1.8

36.06

39.93

nmol/l

0.74

323

Bacterial pneumonia, not elsewhere classified

547

5562

0.86

3.04

1.9

1.8

40.51

42.43

nmol/l

0.91

538

5411

Other bacterial diseases

1765

12692

0.92

3.03

2.0

1.9

40.60

40.43

nmol/l

0.10

1722

12447

Cardiomyopathy (excluding other)

165

2150

0.76

3.03

1.6

1.9

39.08

42.29

nmol/l

1.13

160

2083

Malignant neoplasm of rectum

1194

0.68

3.03

1.4

1.9

40.97

43.71

nmol/l

0.71

1150

Renal failure

608

5952

0.87

3.03

1.8

42.39

43.18

nmol/l

0.33

587

5764

Sequelae of cerebrovascular disease

372

3798

0.83

3.03

1.8

45.50

44.68

nmol/l

0.26

351

3662

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1093

8554

1.11

3.02

1.9

1.8

44.04

42.33

nmol/l

1.24

1062

8341

Other septicaemia

458

5066

0.85

3.02

2.0

1.8

42.22

43.16

nmol/l

0.26

443

4917

Calcific aortic valvular stenosis, including rheumatic fever

234

2814

0.80

3.02

1.7

1.8

44.93

46.11

nmol/l

0.34

220

2693

Sequelae with surgical and medical care as external cause

295

2409

1.23

3.01

2.1

1.8

41.52

42.63

nmol/l

0.35

285

2334

Noninfectious colitis NAS

230

1828

1.27

3.01

1.9

39.10

39.67

nmol/l

0.13

222

1782

Spirochaetal infections, other/unspecified

132

975

1.37

2.97

2.0

1.8

44.76

40.73

nmol/l

1.16

127

938

Delayed puberty

122

2.14

2.96

2.2

1.4

38.08

33.45

nmol/l

0.25

117

malignant neoplasm of male genital organs, including Hilmo

700

4782

0.87

2.95

1.9

42.51

42.55

nmol/l

0.02

686

4643

Asthma (diagnoses ohter than nonallergic)

1728

12846

1.09

2.93

2.0

1.8

38.34

42.10

nmol/l

9.37

1697

12583

Other specified/unspecified spondylopathies

163

1.93

2.92

1.7

43.84

42.27

nmol/l

0.15

155

Mild mental retardation

428

0.48

2.92

2.2

1.9

38.29

38.05

nmol/l

0.01

415

Diabetic retinopathy, strict definition

219

2435

0.79

2.92

1.9

50.28

35.61

nmol/l

6.05

210

2364

Labour and delivery complicated by fetal stress [distress]

217

1109

1.28

2.91

1.2

60.87

54.57

nmol/l

1.06

217

1099

Other ill-defined and unspecified causes of mortality

934

0.65

2.91

2.1

1.9

47.02

42.94

nmol/l

0.58

901

Calcific aortic valvular stenosis, diagnosis (helper)

234

2803

0.80

2.90

1.7

1.8

44.93

46.14

nmol/l

0.35

220

2684

Operations 2 for CAVS

234

2803

0.80

2.90

1.7

1.8

44.93

46.14

nmol/l

0.35

220

2684

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

448

3771

1.18

2.90

1.8

1.7

42.56

44.18

nmol/l

0.45

442

3703

Hard cardiovascular diseases

1721

9348

1.09

2.90

2.0

1.9

38.61

40.47

nmol/l

3.09

1682

9155

Lactose intolerance, other/unspecified

305

1.67

2.90

1.6

1.8

41.24

40.33

nmol/l

0.10

296

Disorders of eyelid, lacrimal system and orbit

1520

10195

1.09

2.89

1.9

1.8

43.19

42.64

nmol/l

0.34

1481

9969

Nausea and vomiting

377

3085

1.20

2.89

1.7

44.50

42.68

nmol/l

0.49

371

3016

Other congenital malformations of peripheral vascular system

172

1.91

2.88

2.0

1.8

40.41

37.66

nmol/l

0.23

167

Adenocarcinoma and papilloma adenocarcinoma of rectum

1181

0.69

2.87

1.5

1.9

42.34

44.03

nmol/l

0.36

1137

Brain glioblastoma

221

0.35

2.85

1.6

1.9

36.75

39.66

nmol/l

—

214

Calcific aortic valvular stenosis, operated

235

2807

0.80

2.85

1.7

1.8

44.93

46.19

nmol/l

0.36

221

2688

Calcific aortic valvular stenosis

235

2807

0.80

2.85

1.7

1.8

44.93

46.19

nmol/l

0.36

221

2688

Atopic dermatitis, strict definition with reimbursement

629

5288

1.15

2.84

1.9

1.7

39.78

41.28

nmol/l

0.75

615

5200

Artificial joint re-operation

481

1.51

2.82

2.5

1.8

40.42

43.98

nmol/l

0.77

457

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

216

1.77

2.80

1.7

1.8

51.95

43.91

nmol/l

0.67

205

All pneumoniae

2238

13529

1.08

2.80

1.9

1.8

39.27

41.14

nmol/l

3.07

2190

13281

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

623

1.45

2.78

2.5

1.8

37.55

40.43

nmol/l

0.70

612

Renal tubulo-interstitial diseases

1316

10552

0.91

2.77

1.8

42.33

43.14

nmol/l

0.49

1277

10322

Cellulitis

489

4217

1.17

2.77

2.2

1.9

38.68

40.19

nmol/l

0.73

471

4126

Cardiomyopathies, Primary/intrinsic

158

2042

0.77

2.76

1.5

1.9

39.10

42.22

nmol/l

1.03

153

1979

Degeneration of nervous system due to alcohol

365

0.45

2.76

1.2

1.9

61.32

40.48

nmol/l

1.25

348

Chondropathies

310

2574

1.21

2.75

1.9

39.60

39.52

nmol/l

0.02

297

2516

Specific development disorders of scholastic skills

122

887

1.37

2.74

2.1

1.8

35.92

37.45

nmol/l

0.18

122

875

Later onset COPD, excluding more controls

123

1258

0.74

2.73

1.7

1.6

52.63

51.73

nmol/l

0.12

115

1193

Brain glioblastoma, helper endpoint

216

0.36

2.72

1.6

1.9

36.75

39.48

nmol/l

—

208

Degeneration of the brain due to alcohol

363

0.46

2.72

1.2

1.9

61.32

40.70

nmol/l

1.23

346

Misadventures to patients during surgical and medical care

198

1567

1.27

2.72

2.1

1.8

42.50

42.78

nmol/l

0.06

190

1517

All chronic kidney diseases

807

7208

0.89

2.72

1.8

42.90

42.49

nmol/l

0.15

786

7023

Other systemic involvement of connective tissue

254

2066

1.23

2.71

1.9

1.7

42.52

45.47

nmol/l

0.68

246

2006

Cardiodefibrillation

579

5046

1.15

2.70

1.8

44.02

43.90

nmol/l

0.05

565

4875

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

374

3167

1.19

2.68

1.9

41.23

39.06

nmol/l

0.82

358

3116

Biological medicines for asthma

353

1.59

2.66

2.5

1.9

38.46

38.94

nmol/l

0.05

343

Other diseases of pleura

538

5361

0.87

2.65

1.9

1.8

44.19

43.77

nmol/l

0.16

520

5181

Impacted maxillary molar

145

1110

1.32

2.63

1.6

44.63

41.17

nmol/l

0.43

145

1097

Benign neoplasm: Descending colon

104

757

1.39

2.61

1.9

45.06

43.09

nmol/l

0.32

724

Sequelae of injuries of head

138

1052

1.33

2.61

2.0

40.22

38.21

nmol/l

0.41

129

1025

Mental retardation, excluding more controls

546

0.57

2.61

2.0

1.8

36.97

37.79

nmol/l

0.06

536

143

1017

1.32

2.59

1.6

1.7

51.60

48.66

nmol/l

0.70

134

964

Phlebitis and thrombophlebitis (not including DVT)

342

2884

1.19

2.56

2.0

1.9

40.87

41.91

nmol/l

0.37

330

2805

Colorectal cancer

230

2707

0.81

2.56

1.5

1.9

41.47

44.74

nmol/l

1.74

219

2602

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1717

12477

0.92

2.55

2.0

1.8

42.83

41.49

nmol/l

1.15

1674

12226

Other and unspecified coagulation defects

576

1.44

2.54

2.0

1.8

41.26

40.91

nmol/l

0.04

561

Other hearing loss

311

2517

1.20

2.54

1.9

1.8

42.91

44.54

nmol/l

0.68

298

2432

Sudden idiopathic hearing loss

151

1167

1.30

2.54

2.0

1.9

41.22

41.80

nmol/l

0.13

142

1129

Dental caries

550

4541

1.15

2.54

2.1

1.9

41.41

41.00

nmol/l

0.15

535

4478

Meningitis, viral

3.10

2.54

1.6

1.9

44.36

40.51

nmol/l

0.12

Other and unspecified acne

248

1.70

2.54

2.4

1.9

47.95

38.82

nmol/l

0.94

242

Separation of retinal layers (serosa)

112

833

1.37

2.53

2.0

36.53

38.37

nmol/l

0.60

112

808

Diseases of pulp and periapical tissues, including avohilmo

2231

10771

1.07

2.52

1.8

40.23

41.77

nmol/l

2.08

2162

10606

Other gastritis (incl. Duodenitis)

326

2742

1.19

2.52

1.9

1.8

41.72

42.86

nmol/l

0.42

319

2665

Hypertensive heart and/or renal disease

298

2604

0.83

2.50

1.7

1.8

39.74

47.34

nmol/l

7.48

287

2515

Other specified/unspecified arthritis

418

3591

1.17

2.50

1.8

1.7

40.95

42.80

nmol/l

0.94

409

3509

Colorectal adenocarcinoma

188

2319

0.80

2.50

1.5

1.9

42.70

45.14

nmol/l

0.95

179

2232

Other keratitis

236

1929

1.23

2.49

2.1

1.9

40.99

39.55

nmol/l

0.41

231

1884

Suppurative and unspecified otitis media

929

7436

1.11

2.48

1.8

37.69

39.53

nmol/l

1.60

913

7313

Alcohol abuse, main dg

312

3698

0.84

2.47

1.9

40.01

39.20

nmol/l

0.28

307

3615

Care involving use of rehabilitation procedures

1253

10327

1.09

2.46

2.0

1.8

40.65

41.50

nmol/l

0.51

1236

10119

Unspecified haematuria

780

5684

1.12

2.46

1.9

1.8

43.94

42.78

nmol/l

0.67

759

5526

Mental and behavioural disorders due to alcohol

1204

12495

0.91

2.44

2.0

1.9

40.52

40.00

nmol/l

0.33

1170

12252

Urethritis and urethral syndrome

250

1.67

2.44

2.2

1.8

43.39

39.07

nmol/l

0.70

242

Bacterial pneumonia (organism specified)

631

6438

0.88

2.42

1.9

1.8

40.73

42.04

nmol/l

0.60

622

6254

Stomatitis and related lesions

348

2957

1.18

2.41

2.0

1.8

43.17

40.54

nmol/l

1.00

338

2890

Diabetic nephropathy

187

2296

0.80

2.41

1.7

1.9

46.57

37.02

nmol/l

2.51

181

2223

Injuries to the thorax

998

9066

1.10

2.41

1.9

42.02

40.70

nmol/l

0.86

957

8867

Parkinson's disease, strict definition, excluding more controls

131

932

1.32

2.40

1.5

1.7

49.21

49.18

nmol/l

0.01

126

904

Pneumonias (Asthma/COPD co-morbidities)

2212

13523

1.07

2.40

1.9

1.8

39.35

41.10

nmol/l

2.72

2164

13275

Injury of unspecified body region

126

959

1.33

2.40

1.8

1.9

41.17

40.71

nmol/l

0.07

121

928

Acute suppurative otitis media

723

6029

1.12

2.38

1.7

1.8

37.11

38.83

nmol/l

1.25

708

5935

Open bite

669

1.39

2.37

2.0

1.7

45.73

41.65

nmol/l

0.44

655

Primary gonarthrosis, bilateral

636

4720

1.13

2.36

2.0

1.8

42.01

45.08

nmol/l

3.10

613

4575

Fracture of skull and facial bones

572

5054

1.14

2.36

1.9

40.14

38.25

nmol/l

1.15

554

4957

Other neurological diseases

1180

8376

1.09

2.35

1.9

1.8

42.33

42.61

nmol/l

0.14

1148

8163

Primary coxarthrosis, bilateral

318

2687

1.19

2.35

2.1

1.8

39.73

44.80

nmol/l

4.74

310

2586

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

147

1146

1.29

2.35

2.0

1.9

43.64

42.19

nmol/l

0.24

142

1109

Other acute lower respiratory infections

1113

9694

1.10

2.34

1.9

1.8

37.89

40.88

nmol/l

4.37

1089

9496

Other diseases of intestine

243

2005

1.22

2.34

2.0

1.8

42.50

43.17

nmol/l

0.18

236

1944

Complications of internal orthopaedic prosthetic devices, implants and grafts

247

2040

1.22

2.34

2.3

1.8

42.86

43.95

nmol/l

0.37

237

1965

Brain glioblastoma and astrocytoma

300

0.46

2.31

1.4

2.1

43.36

38.61

nmol/l

0.48

290

Bilateral sagittal split ramus osteotomy operation

455

1.47

2.31

1.9

1.8

36.42

40.64

nmol/l

1.04

445

Fracture of femur

209

2305

0.81

2.28

1.7

1.8

47.02

42.66

nmol/l

1.53

202

2230

Cauda equina syndrome

164

1.81

2.28

1.6

1.8

42.00

38.65

nmol/l

0.33

157

Other and unspecified urticaria

295

2486

1.19

2.27

1.9

1.8

45.98

41.69

nmol/l

0.82

286

2429

Presence of cardiac and vascular implants and grafts

614

5077

0.89

2.26

1.7

1.9

44.62

43.43

nmol/l

0.57

571

4953

Abnormalities of gait and mobility

154

1214

1.28

2.25

1.8

1.9

43.01

43.91

nmol/l

0.18

147

1165

Supernumerary ureter

5.89

2.25

1.4

1.1

52.40

36.33

nmol/l

—

Injuries to unspecified part of trunk, limb or body region

180

1447

1.25

2.25

1.9

40.94

40.13

nmol/l

0.16

175

1404

Polymyalgia rheumatica

113

855

1.33

2.24

1.8

1.9

39.75

45.57

nmol/l

2.02

106

819

Other and unspecified nonorganic psychotic disorders

409

4698

0.87

2.20

1.9

38.20

37.30

nmol/l

0.25

402

4619

Implicit bacterial Sepsis

542

5248

0.88

2.19

1.9

1.8

43.00

43.47

nmol/l

0.16

519

5094

Superficial injury of ankle and foot

276

2324

1.20

2.19

1.8

1.9

38.73

38.85

nmol/l

0.03

271

2274

Melanocytic naevi of scalp and neck

314

1.56

2.18

2.7

1.9

48.04

40.10

nmol/l

0.85

299

Other peripheral vertigo

101

756

1.34

2.17

1.9

45.53

42.89

nmol/l

0.44

725

Barrett oesophagus

100

750

1.35

2.16

2.1

1.9

39.73

40.78

nmol/l

0.21

100

727

Other and unspecified mental retardation

235

0.41

2.16

1.1

2.0

38.90

35.92

nmol/l

—

226

Other disorders of binocular movement

267

1.60

2.15

1.9

1.8

37.48

40.97

nmol/l

0.46

260

Hypertensive Heart Disease

265

2386

0.84

2.11

1.7

1.8

39.47

47.69

nmol/l

7.87

254

2301

Adult-onset Still disease

0.00

2.11

0.0

1.6

—

38.95

—

Corneal ulcer

392

3407

1.16

2.10

2.1

1.9

39.76

39.40

nmol/l

0.12

382

3331

Malignant neoplasm of oesophagus

368

0.53

2.10

3.0

1.9

40.00

42.84

nmol/l

0.32

350

Sub-endpoint used in defining T1D endpoints

531

5881

0.88

2.09

1.8

1.9

49.07

38.78

nmol/l

10.98

523

5756

Other strabismus

386

3337

1.16

2.09

1.7

1.8

42.76

40.74

nmol/l

0.87

375

3270

Anoxic brain damage

193

0.41

2.09

2.3

1.8

42.63

40.32

nmol/l

—

184

Peroneal tendinitis

161

1.77

2.08

2.5

1.8

39.61

39.87

nmol/l

0.02

156

Colorectal cancer, including Hilmo

269

2964

0.84

2.08

1.6

1.8

41.81

44.53

nmol/l

1.36

257

2854

Hidradenitis suppurativa

525

1.41

2.06

1.8

35.74

41.09

nmol/l

1.48

516

Diseases of pulp and periapical tissues and dental caries

1259

5954

1.09

2.06

1.9

1.8

40.52

42.22

nmol/l

1.69

1220

5861

Scissor bite

347

1.51

2.06

1.7

38.04

39.27

nmol/l

0.17

340

Implicit bacterial Sepsis, including avohilmo

630

5839

0.89

2.04

1.9

1.8

42.55

43.11

nmol/l

0.23

600

5678

Coxarthrosis, primary

789

5933

1.11

2.04

1.9

1.8

42.09

44.27

nmol/l

2.19

768

5742

Suggestive for eosinophilic asthma

159

1278

1.25

2.03

2.1

1.9

41.49

41.98

nmol/l

0.11

152

1239

Pedal cyclist injured in collision with motor vehicle

502

1.42

2.03

1.6

1.9

44.20

38.31

nmol/l

1.25

488

Vestibular neuronitis

131

1029

1.28

2.02

2.1

1.9

42.70

40.41

nmol/l

0.52

125

992

Viral meningitis, including avohilmo

579

1.38

2.01

2.2

1.9

38.04

39.15

nmol/l

0.17

566

Other disorders of Eustachian tube

320

1.52

2.01

2.6

1.7

36.94

42.12

nmol/l

0.48

308

Benign neoplasm of male genital organs

404

1.47

2.00

2.0

37.15

39.26

nmol/l

0.30

388

Viral meningitis

554

1.39

2.00

2.2

1.9

38.45

39.23

nmol/l

0.11

541

Conotruncal defects

203

0.43

2.00

1.6

1.8

39.11

36.76

nmol/l

—

196

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

2.18

2.00

2.0

1.8

54.93

48.66

nmol/l

0.42

Aortic aneurysm

417

3582

1.15

1.99

1.8

43.06

44.18

nmol/l

0.45

399

3450

Inflammatory bowel disease

710

6424

1.11

1.98

1.8

1.9

39.70

39.77

nmol/l

0.02

696

6292

Heart failure and antihypertensive medication

365

2730

0.86

1.98

1.9

1.8

38.71

44.13

nmol/l

4.89

353

2687

Schizophrenia or delusion, excluding more controls

565

6233

0.89

1.98

1.9

1.8

38.88

38.96

nmol/l

0.02

552

6147

Other congenital malformations, including avohilmo

212

1760

1.21

1.97

1.9

1.8

40.50

40.45

nmol/l

0.01

207

1722

Other infective otitis externa

753

1.33

1.96

1.8

1.9

43.10

40.78

nmol/l

0.40

731

Gonococcal infection

497

1.41

1.96

2.1

2.0

37.87

37.37

nmol/l

0.07

488

Acquired clawhand, clubhand, clawfoot and clubfoot

2.32

1.95

1.7

1.9

37.69

39.17

nmol/l

0.08

Collagenous colitis

115

893

1.30

1.95

1.9

44.45

41.48

nmol/l

0.65

109

863

Atopic dermatitis, strict definition

585

5125

1.12

1.94

1.8

1.7

39.46

41.58

nmol/l

1.20

573

5044

Other disorders of cornea

156

1258

1.25

1.94

2.0

1.9

38.97

nmol/l

0.00

150

1220

Wide developmental disorders

710

1.34

1.93

1.8

33.13

37.05

nmol/l

1.03

700

Amblyopia ex anopsia

498

1.40

1.92

1.8

42.52

40.41

nmol/l

0.28

482

Other bacterial intestinal infections

256

2168

1.19

1.92

2.0

1.9

40.86

42.14

nmol/l

0.34

248

2104

Caries of dentine, including avohilmo

1544

7359

1.07

1.92

1.9

1.8

40.78

42.15

nmol/l

1.38

1492

7244

Hypertrophy of breast

488

1.40

1.92

1.4

1.2

58.26

55.52

nmol/l

0.18

483

Acanthosis nigricans

2.52

1.91

2.0

1.9

35.09

40.33

nmol/l

0.19

Orthopaedic devices associated with adverse incidents

121

1.85

1.90

2.0

1.7

47.94

43.48

nmol/l

0.46

111

Dental caries, including avohilmo

1410

6712

1.08

1.90

1.9

1.8

40.68

42.11

nmol/l

1.38

1363

6605

Caries of dentine

491

4207

1.13

1.89

2.1

1.9

41.53

40.65

nmol/l

0.34

476

4152

5-aminosalicylic acid

496

4414

1.13

1.89

1.8

1.9

38.65

39.50

nmol/l

0.39

487

4328

Impacted teeth

534

4092

1.13

1.89

1.6

1.7

40.39

40.02

nmol/l

0.10

526

4035

Pediculosis, acariasis and other infestations, including avohilmo

390

3419

1.15

1.88

2.0

1.8

38.41

39.51

nmol/l

0.41

382

3350

Nonsuppurative otitis media

540

4186

1.12

1.88

1.9

1.7

38.96

40.38

nmol/l

0.51

529

4120

Other diseases of urinary system

1692

10122

0.94

1.87

1.8

45.62

42.60

nmol/l

4.53

1648

9901

Insulin, intermediate and long-acting

1023

10684

0.92

1.86

1.8

1.9

42.25

40.97

nmol/l

0.75

995

10444

Bell's palsy

188

1554

1.22

1.86

1.8

1.9

41.81

41.31

nmol/l

0.09

181

1516

Exposure to excessive natural cold

181

0.43

1.86

2.4

2.0

45.50

38.55

nmol/l

—

172

Systemic connective tissue disorders

344

2991

1.15

1.84

1.9

1.8

43.45

44.71

nmol/l

0.30

332

2901

Glucosamine medication

377

2627

1.15

1.84

2.0

1.8

44.86

46.22

nmol/l

0.55

355

2524

Malignant neoplasm of oral cavity

452

0.61

1.84

1.6

1.9

42.11

41.47

nmol/l

0.05

432

Contact with machinery

325

2825

1.16

1.83

1.8

2.0

41.79

39.15

nmol/l

1.24

317

2746

Strabismus

456

4034

1.13

1.83

1.7

1.8

42.87

41.00

nmol/l

0.85

444

3948

Kela-code for severe mental illness

725

7958

0.91

1.83

2.0

1.9

37.83

39.21

nmol/l

0.74

706

7819

Periapical abscess

890

9681

0.92

1.82

2.0

1.9

39.79

40.26

nmol/l

0.23

865

9486

Fracture of rib(s), sternum and thoracic spine

605

5457

1.11

1.82

1.9

42.99

41.13

nmol/l

0.94

577

5316

Other congenital malformations of circulatory system

312

1.50

1.81

2.4

1.8

44.54

39.37

nmol/l

0.49

298

Cardiac murmurs and other cardiac sounds

129

1015

1.26

1.81

1.7

1.6

41.46

42.15

nmol/l

0.12

124

992

Malignant neoplasm of rectum, including Hilmo

113

1432

0.78

1.81

1.4

1.9

40.12

44.05

nmol/l

1.55

106

1381

Primary open-angle glaucoma

279

2301

1.17

1.80

1.7

1.8

48.35

45.41

nmol/l

1.27

270

2204

Adenocarcinoma and papillary adenocarcinoma of stomach

286

0.52

1.79

1.7

1.9

60.73

42.77

nmol/l

0.70

270

Failure and rejection of transplanted organs and tissues

241

1.58

1.79

1.8

1.9

44.43

38.06

nmol/l

0.60

229

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

413

1.42

1.77

2.0

1.8

41.29

40.42

nmol/l

0.09

397

Allergic contact dermatitis

158

1290

1.23

1.77

1.7

43.60

42.15

nmol/l

0.27

152

1260

Glaucoma suspect

398

3505

1.14

1.77

1.8

45.62

43.44

nmol/l

0.67

393

3390

Asthma, unspecified (mode), excluding more controls

965

6359

1.09

1.76

2.0

1.7

38.57

42.69

nmol/l

6.34

945

6237

Other specified disorders of muscle

414

1.42

1.76

1.9

34.90

38.70

nmol/l

0.83

407

Unspecified jaundice

567

0.66

1.74

1.6

1.9

50.54

41.47

nmol/l

1.00

542

Gonarthrosis, primary, with knee surgery

705

4988

1.10

1.74

2.0

1.8

40.65

45.34

nmol/l

7.53

677

4835

In situ neoplasms

355

3110

1.14

1.73

1.5

1.7

46.62

49.02

nmol/l

1.01

346

3004

Accidental poisoning by and exposure to alcohol

369

0.58

1.73

1.9

1.8

33.95

39.60

nmol/l

0.76

354

Pedal cyclist injured in transport accident

499

4472

1.12

1.72

1.9

42.10

39.20

nmol/l

2.03

488

4386

Pervasive developmental disorders excl. Autism + Asperger

185

1.63

1.71

1.5

2.0

31.90

35.03

nmol/l

0.26

179

Bacterial intestinal infections, IBD co-morbidities

254

2177

1.17

1.69

2.0

1.9

40.38

42.12

nmol/l

0.52

246

2111

Hypertrophy of bone

2.56

1.69

1.7

1.8

36.60

40.29

nmol/l

—

Need for immunization against single bacterial diseases

2.93

1.68

2.0

1.5

34.86

40.36

nmol/l

—

Erysipelas

1042

9672

0.93

1.68

2.0

1.9

40.02

40.82

nmol/l

0.54

1009

9460

Embedded and impacted teeth

701

5194

1.10

1.65

1.6

1.8

40.44

39.91

nmol/l

0.16

691

5121

Other disorders of conjunctiva

176

1467

1.21

1.63

2.0

1.9

50.54

42.93

nmol/l

2.77

170

1417

Atrial fibrillation and flutter

759

4484

1.10

1.63

2.0

1.8

39.05

40.65

nmol/l

1.21

738

4411

Other disorders of fluid, electrolyte and acid-base balance

329

3526

0.88

1.61

2.0

1.8

47.54

43.90

nmol/l

1.56

319

3415

Asthma, unspecified (mode)

969

6472

1.08

1.60

2.0

1.7

38.61

42.87

nmol/l

6.79

948

6346

Abscess of anal and rectal regions

221

1888

1.18

1.59

1.9

37.23

38.24

nmol/l

0.26

213

1844

Other specified and unspecified disorders of eye and adnexa

388

1.41

1.59

1.7

1.9

45.39

40.29

nmol/l

0.80

372

Epiphora

144

1.69

1.59

2.1

1.7

43.29

43.43

nmol/l

0.01

134

Abnormal spermatozoa

273

2371

1.16

1.59

2.2

1.8

41.47

44.21

nmol/l

1.09

251

2279

Fracture of lumbar spine and pelvis

272

2351

1.16

1.59

1.9

46.07

41.95

nmol/l

1.94

263

2280

Circumscribed brain atrophy

175

0.45

1.58

1.9

39.38

43.32

nmol/l

—

164

Other and unspecified injuries of lower leg

136

1111

1.23

1.57

1.8

1.9

39.66

40.02

nmol/l

0.06

131

1089

Campylobacter enteritis

407

1.40

1.57

2.3

1.9

38.98

38.71

nmol/l

0.03

392

Dengue fever [classical dengue]

2.78

1.56

3.3

1.3

39.00

41.44

nmol/l

—

Non-small cell lung cancer, adenocarcinoma

494

0.66

1.56

1.5

1.9

47.30

45.85

nmol/l

0.12

468

Other osteochondropathies

154

1277

1.22

1.56

1.9

2.0

39.59

38.85

nmol/l

0.15

148

1244

Cholelithiasis, broad definition with cholecystitis

1154

8220

0.93

1.55

1.8

41.17

44.22

nmol/l

4.02

1116

8025

Cerebrovascular diseases (FINNGEN)

546

4222

0.90

1.54

2.0

1.8

40.67

41.48

nmol/l

0.34

535

4149

Ulcerative colitis

535

4848

1.11

1.54

1.8

1.9

39.46

39.20

nmol/l

0.09

524

4750

Insulin, fast-acting (human)

270

3097

0.87

1.54

1.8

2.0

51.68

37.78

nmol/l

12.58

265

3038

Scabies, including avohilmo

335

2957

1.14

1.53

2.0

1.8

37.22

39.22

nmol/l

0.89

328

2902

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1902

12167

1.06

1.52

1.9

1.8

41.42

41.01

nmol/l

0.31

1849

11936

Parkinson's disease, excluding more controls

134

1008

1.23

1.51

1.5

1.7

49.14

49.33

nmol/l

0.03

129

980

Myocardial infarction, without ST-elevation

483

4827

0.90

1.51

1.8

42.59

44.74

nmol/l

1.32

463

4659

Open wound of ankle and foot

234

2018

1.17

1.51

1.9

41.34

39.07

nmol/l

0.66

228

1965

Benign neoplasm: Stomach

722

1.28

1.50

1.8

39.48

44.16

nmol/l

1.54

692

L01XE Protein kinase inhibitors

453

0.66

1.50

2.2

1.8

42.70

42.21

nmol/l

0.04

431

Coxarthrosis [arthrosis of hip](FG)

865

5502

1.08

1.49

1.9

1.8

42.07

43.33

nmol/l

0.95

844

5360

Non-small cell lung cancer, adenocarcinoma, helper endpoint

489

0.67

1.49

1.5

1.8

47.30

45.67

nmol/l

0.14

466

Other benign neoplasms of connective and other soft tissue

139

1145

1.22

1.49

1.8

1.9

42.03

40.88

nmol/l

0.18

139

1111

Drug-induced osteoporosis

124

1.72

1.49

1.8

1.9

42.00

38.82

nmol/l

0.32

119

Autism spe

568

1.32

1.48

1.9

1.8

33.46

36.68

nmol/l

0.65

559

Cardiomyopathy

248

2852

0.86

1.48

1.7

1.9

39.81

42.20

nmol/l

0.98

242

2768

Use of bromocriptine

3.31

1.47

3.4

1.9

40.20

46.87

nmol/l

—

Other CVD

215

1844

1.17

1.46

1.8

46.89

44.64

nmol/l

0.62

206

1770

Degeneration of macula and posterior pole

482

3354

1.11

1.45

1.9

1.8

47.64

45.75

nmol/l

0.68

466

3215

Focal epilepsy

292

3317

0.88

1.45

1.9

47.74

40.66

nmol/l

2.86

286

3229

Benign neoplasm: Spinal meninges

2.00

1.45

1.8

2.0

42.92

44.61

nmol/l

0.08

Lesion of lateral popliteal nerve

728

1.28

1.44

1.8

1.9

43.53

39.97

nmol/l

0.68

707

All influenza

545

4960

1.10

1.44

1.8

1.9

39.73

40.46

nmol/l

0.32

534

4845

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

149

1.65

1.44

1.7

1.8

35.83

38.67

nmol/l

0.36

144

Autism

579

1.31

1.44

1.9

1.8

33.55

36.69

nmol/l

0.64

570

Chronic periodontitis, complicated

930

9724

0.93

1.43

1.8

1.9

41.10

41.62

nmol/l

0.27

885

9509

Malignant neoplasm of penis, including Hilmo

123

0.39

1.41

3.4

2.0

39.40

41.58

nmol/l

—

116

Fracture of foot, except ankle

512

4655

1.10

1.40

1.8

1.9

42.77

39.80

nmol/l

1.64

505

4566

Dipeptidyl peptidase 4 (DPP-4) inhibitors

773

6548

0.92

1.40

1.9

1.8

33.91

44.89

nmol/l

33.76

738

6396

Enterobiasis, including avohilmo

280

1.45

1.40

2.3

1.7

37.63

42.73

nmol/l

1.00

274

Primary open-angle glaucoma, strict

221

1902

1.16

1.40

1.8

48.18

45.51

nmol/l

1.03

215

1823

Helminthiases

190

1.55

1.39

1.7

2.0

42.31

41.39

nmol/l

0.07

182

Other arthritis (FG)

490

4446

1.11

1.39

1.8

41.30

42.42

nmol/l

0.51

480

4339

Traumatic spondylopathy

2.72

1.39

1.7

1.4

55.17

41.87

nmol/l

—

Mental and behavioural disorders due to cannabinoids

119

979

1.24

1.38

2.2

2.0

38.50

34.41

nmol/l

1.13

113

969

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1960

11060

1.05

1.38

1.9

35.60

41.78

nmol/l

21.87

1895

10867

Shoulder region

191

1.55

1.37

1.3

1.8

47.00

39.60

nmol/l

0.52

183

Type 1 diabetes, strict definition, subgroup 2

0.00

1.37

0.0

1.4

—

33.88

—

Left bundle-branch block

724

1.26

1.36

1.8

1.9

46.08

43.02

nmol/l

0.39

706

Gout, FINNGEN

500

4517

1.10

1.36

1.9

1.8

36.66

44.27

nmol/l

12.35

482

4360

Fracture of lower leg, including ankle

1051

9665

1.07

1.35

1.9

39.52

40.40

nmol/l

0.61

1033

9476

Other congenital malformations of skin

470

1.33

1.35

1.7

1.8

41.84

40.48

nmol/l

0.14

454

Personal history of other diseases and conditions

134

1107

1.21

1.35

1.5

1.6

42.08

44.50

nmol/l

0.44

129

1091

Malignant neoplasm of oral cavity, including Hilmo

581

0.72

1.35

2.1

2.0

40.24

41.84

nmol/l

0.21

556

Personal history of malignant neoplasm

349

1.38

1.34

1.8

1.7

43.56

44.79

nmol/l

0.10

338

Cytomegaloviral disease, including avohilmo

368

1.38

1.34

1.7

1.9

35.62

39.39

nmol/l

0.48

354

Retinal haemorrhage

192

1.53

1.33

1.9

1.8

49.31

41.31

nmol/l

0.89

183

Open wound of head

1156

11528

0.94

1.32

1.9

40.70

39.73

nmol/l

0.78

1118

11310

Other and unspecified mononeuropathies of lower limb

225

1.48

1.32

2.1

1.8

46.73

41.47

nmol/l

0.50

216

Vascular dementia (subcortical)

147

0.47

1.32

1.1

1.8

65.86

48.24

nmol/l

—

137

Melanocytic naevi of upper limb, including shoulder

242

1.46

1.31

1.6

1.8

35.51

42.21

nmol/l

1.51

228

therapeutic use

234

1.47

1.30

1.9

1.8

48.04

43.62

nmol/l

0.62

222

Acute myeloid leukaemia, helper endpoint

131

0.45

1.30

2.5

2.0

74.83

41.93

nmol/l

—

123

Acute myeloid leukaemia

131

0.45

1.30

2.5

2.0

74.83

41.93

nmol/l

—

123

Acute myeloid leukaemia, including Hilmo

131

0.45

1.30

2.5

2.0

74.83

41.93

nmol/l

—

123

Unequal limb length (acquired)

138

1.63

1.29

2.0

1.6

39.59

37.32

nmol/l

0.17

132

Valvular operations

197

2275

0.86

1.28

1.8

42.93

42.39

nmol/l

0.12

191

2203

Carcinoma in situ of prostate

1.84

1.28

3.0

1.9

41.73

42.84

nmol/l

0.08

L02BX Other hormone antagonists and related agents

746

0.76

1.28

1.9

1.8

46.40

46.17

nmol/l

0.03

705

Malignant neoplasm of eye and adnexa, including Hilmo

157

0.50

1.26

1.3

2.0

40.25

42.29

nmol/l

—

149

Injury of eye and orbit

403

3648

1.11

1.26

2.0

1.9

39.18

38.38

nmol/l

0.33

394

3579

Other disorders of white blood cells

608

1.28

1.26

2.2

1.9

35.70

40.51

nmol/l

1.01

587

Rheumatoid arthritis

282

2815

0.88

1.26

1.7

45.23

44.64

nmol/l

0.14

277

2735

Non-allergic asthma

116

958

1.22

1.25

1.7

1.8

39.95

40.92

nmol/l

0.21

116

932

Infection of intervertebral disc (pyogenic)

163

1.56

1.25

2.4

1.8

48.12

38.76

nmol/l

1.67

157

Pedal cyclist injured in noncollision transport accidents

249

2193

1.14

1.25

2.0

1.9

41.37

38.64

nmol/l

1.12

243

2142

Syncope and collapse

776

6023

1.08

1.24

1.9

1.8

42.72

42.64

nmol/l

0.03

748

5876

Open wound of hip and thigh

700

1.26

1.24

2.2

1.9

36.55

37.77

nmol/l

0.22

683

Rheumatoid arthritis, including avohilmo

334

3724

0.90

1.24

1.7

1.8

45.15

43.40

nmol/l

0.56

328

3622

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1715

11372

0.95

1.24

1.9

42.96

41.38

nmol/l

1.77

1663

11140

Dengue, including avohilmo

2.74

1.23

1.2

2.0

47.80

34.11

nmol/l

—

Liquid cancers, including Hilmo

459

4437

0.91

1.23

1.9

42.55

42.79

nmol/l

0.08

442

4309

1377

12954

0.95

1.23

2.0

1.9

40.56

40.08

nmol/l

0.33

1341

12695

Dialysis

661

0.75

1.22

1.4

2.0

40.96

38.97

nmol/l

0.28

643

ILD medications: azathioprine

295

2629

1.13

1.22

1.8

1.9

40.49

39.70

nmol/l

0.20

290

2574

Osteonecrosis due to drugs

144

0.48

1.22

2.1

2.0

41.29

42.20

nmol/l

—

133

Dyshidrosis [pompholyx]

197

1.49

1.21

2.6

1.6

31.45

40.47

nmol/l

2.35

188

Type 1 diabetes

522

5671

0.92

1.20

1.8

1.9

49.08

40.25

nmol/l

8.19

514

5569

Varicose veins

555

4555

0.92

1.20

1.7

1.8

45.43

44.76

nmol/l

0.24

541

4412

Maternal care for known or suspected malpresentation of fetus

151

912

1.18

1.20

1.2

64.47

56.50

nmol/l

1.46

151

906

Other specified and unspecified disorders of eyelid

165

1.54

1.19

2.0

1.9

36.56

40.89

nmol/l

0.51

157

Mixed disorders of conduct and emotions

446

1.32

1.19

1.9

1.7

35.50

37.87

nmol/l

0.28

439

Outcome of delivery

594

0.79

1.19

1.2

59.05

52.08

nmol/l

0.57

585

Benign neoplasm: Oesophagus

128

0.46

1.18

3.0

1.8

34.50

40.87

nmol/l

—

121

Carcinoma in situ of skin of scalp and neck

198

1.48

1.18

1.5

1.9

56.31

47.76

nmol/l

0.82

182

Cytomegalovirus infection, IBD co-morbidity

334

1.37

1.17

1.7

1.9

37.11

39.08

nmol/l

0.20

320

Cholecystitis

167

1435

1.17

1.9

40.86

43.49

nmol/l

0.73

162

1382

Malignant neoplasm of other and ill-defined sites, including Hilmo

129

0.46

1.17

3.0

1.9

39.67

40.89

nmol/l

—

122

STROKE

950

6800

0.94

1.14

1.9

40.99

41.37

nmol/l

0.20

926

6659

Pedestrian injured in collision with pedal cycle

449

1.31

1.14

2.1

1.9

48.12

38.42

nmol/l

2.16

433

Dengue fever [classical dengue], including avohilmo

2.38

1.13

3.3

1.3

39.00

42.52

nmol/l

—

Chronic apical periodontitis

2381

12825

1.04

1.13

1.9

1.8

40.66

41.22

nmol/l

0.46

2299

12617

Conductive hearing loss, unspecified

120

1008

1.20

1.13

1.8

1.9

42.90

40.14

nmol/l

0.56

115

981

Abnormal findings on diagnostic imaging of lung

684

6028

1.08

1.12

1.8

44.09

43.36

nmol/l

0.35

664

5847

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2110

13471

1.04

1.12

1.9

1.8

39.48

41.03

nmol/l

2.12

2061

13223

Fitting and adjustment of other devices

435

3497

1.10

1.12

1.8

43.72

45.65

nmol/l

0.99

405

3368

Benign neoplasm: Nasopharynx

1.70

1.12

1.4

1.7

40.25

40.36

nmol/l

0.01

Non-Hodgkin lymphoma, all

412

0.70

1.12

2.1

1.9

48.62

44.01

nmol/l

0.32

392

Lesion of plantar nerve

310

1.36

1.12

1.9

1.8

41.48

42.61

nmol/l

0.14

300

Dermatitis due to ingested food

422

1.30

1.11

1.4

1.6

39.95

37.24

nmol/l

0.41

414

Other specific arthropathies

2.48

1.11

2.0

1.2

28.40

39.95

nmol/l

—

Haemorrhage, not elsewhere classified

337

1.34

1.10

1.8

1.9

42.82

41.42

nmol/l

0.17

322

Lipomatosis, not elsewhere classified

2.27

1.10

1.4

2.1

30.14

42.84

nmol/l

—

Other degenerative diseases of the nervous system

242

1989

0.89

1.09

1.6

1.7

49.87

47.61

nmol/l

0.55

237

1938

Other abnormal findings of blood chemistry

558

1.26

1.09

2.0

1.8

40.36

41.49

nmol/l

0.13

537

Acute pancreatitis

363

3298

1.10

1.08

1.8

1.9

39.38

41.20

nmol/l

0.85

354

3212

Intracranial injury

1199

10596

1.06

1.08

1.9

1.8

40.41

40.97

nmol/l

0.35

1172

10384

Azathioprine

295

2654

1.12

1.07

1.8

1.9

40.49

39.42

nmol/l

0.29

290

2595

Viral pneumonia

238

2115

1.13

1.07

1.8

1.9

38.93

40.39

nmol/l

0.45

233

2055

Cholelithiasis

1085

7823

0.94

1.07

1.8

41.14

44.39

nmol/l

4.28

1048

7632

384

1.32

1.06

2.4

1.9

39.12

38.23

nmol/l

0.06

376

Chronic hepatitis, not elsewhere classified

375

1.32

1.06

1.5

1.9

50.97

39.60

nmol/l

1.15

360

Malignant neoplasm of heart, mediastinum and pleura

125

0.47

1.05

1.8

36.67

44.90

nmol/l

—

116

Polyarteritis nodosa and related conditions

147

0.54

1.05

3.1

1.9

36.00

39.76

nmol/l

—

141

Papulosquamous disorders

669

6245

1.07

1.05

1.9

43.11

41.17

nmol/l

0.88

650

6088

Chalazion

187

1639

1.15

1.05

1.9

42.41

40.76

nmol/l

0.42

179

1597

Brain meningioma, including Hilmo

297

1.35

1.04

2.0

1.9

46.60

45.04

nmol/l

0.16

281

Erythema nodosum

229

1.41

1.04

1.8

1.7

47.84

43.04

nmol/l

0.20

220

Superficial injury of head

428

3923

1.09

1.04

1.9

39.34

39.58

nmol/l

0.08

418

3843

Benign neoplasm: Skin of other and unspecified parts of face

111

934

1.19

1.04

2.0

1.9

40.44

43.02

nmol/l

0.48

105

907

Type of accident

573

5323

1.08

1.03

1.8

1.9

40.81

40.36

nmol/l

0.16

556

5210

Other necrotizing vasculopathies (FG)

482

1.27

1.03

1.8

1.7

51.43

43.36

nmol/l

1.31

465

Asthma/COPD (KELA code 203)

1896

13189

0.96

1.03

2.0

1.8

38.41

41.50

nmol/l

7.35

1857

12937

Missing teeth due to accident, extraction or parodontitis

989

8346

1.06

1.03

1.8

1.9

42.14

42.62

nmol/l

0.21

930

8162

Noninfective disorders of pinna

2.08

1.02

3.3

2.0

24.00

43.11

nmol/l

—

Somnolence

147

1.52

1.02

1.5

1.8

41.14

38.95

nmol/l

0.16

140

Mesothelioma, including Hilmo

108

0.46

1.02

1.2

1.8

46.00

44.94

nmol/l

—

100

Open wound of forearm

206

1823

1.14

1.01

1.9

40.18

38.56

nmol/l

0.46

197

1779

Transient ischemic attack

685

5097

1.07

1.01

1.9

1.8

43.12

44.05

nmol/l

0.46

665

4939

Focal epilepsy, strict definition

271

3009

0.90

1.01

1.8

1.9

46.66

40.57

nmol/l

2.37

265

2930

Diseases of the digestive system

715

6648

1.07

1.01

1.8

42.39

42.72

nmol/l

0.13

690

6469

Leisure time condition

319

2894

1.11

1.00

1.8

1.9

43.32

40.05

nmol/l

1.20

311

2825

LSIL lesion of the cervix uteri, vagina or vulva

609

1.23

1.00

1.1

1.2

64.41

57.18

nmol/l

0.54

602

Acute renal failure

278

3083

0.90

1.00

1.8

1.9

40.11

43.17

nmol/l

1.47

263

2971

Mental and behavioural disorders due to psychoactive substance use

1526

13372

1.05

0.99

2.0

1.9

40.41

40.01

nmol/l

0.26

1478

13120

Infective bursitis

495

1.27

0.99

2.0

1.9

39.39

39.26

nmol/l

0.01

483

Cytomegaloviral disease

362

1.31

0.99

1.7

1.9

36.23

39.51

nmol/l

0.38

348

Speech disturbances, not elsewhere classified

111

939

1.19

0.99

1.6

1.9

43.37

42.24

nmol/l

0.15

104

904

Viral and other specified intestinal infections

543

4924

1.08

0.99

1.9

1.8

40.96

38.27

nmol/l

0.79

537

4849

Oral lichen planus

181

1.45

0.99

1.7

1.9

54.69

42.49

nmol/l

0.69

173

Pneumonia derived septicemia

435

0.73

0.98

2.2

1.8

34.47

40.71

nmol/l

1.48

418

Other sideroblastic anaemias

0.00

0.98

0.0

1.5

—

41.10

—

Retrobulbar neuritis in diseases classified elsewhere

1.99

0.98

1.3

1.7

69.86

34.25

nmol/l

—

Paralytic ileus and intestinal obstruction

326

2961

1.10

0.98

2.1

1.8

43.31

43.12

nmol/l

0.05

316

2872

Drug-induced hypoglycaemia without coma

247

0.64

0.98

1.6

1.9

36.31

40.44

nmol/l

0.43

236

Other/unspecified cytomegaloviral diseases

302

1.34

0.97

1.6

1.9

38.15

38.82

nmol/l

0.05

288

Dislocation, sprain and strain of joints and ligaments of head

586

1.24

0.97

1.7

1.9

43.46

39.28

nmol/l

0.91

572

Palmar fascial fibromatosis [Dupuytren]

211

1876

1.13

0.96

1.7

1.8

46.60

45.25

nmol/l

0.39

205

1818

Glaucoma secondary to other eye disorders

422

0.73

0.96

1.6

1.9

46.45

39.80

nmol/l

0.81

404

Papillary adenocarcinoma of thyroid gland

425

1.28

0.96

1.9

41.91

41.50

nmol/l

0.05

411

Myositis ossificans

2.29

0.95

1.8

1.3

38.00

42.78

nmol/l

—

Tracheo-bronchomalasia

1.92

0.95

1.0

1.6

46.00

41.89

nmol/l

—

Unspecified fall

934

8680

1.06

0.94

1.8

41.63

40.88

nmol/l

0.40

903

8494

Complications of surgical and medical care, not elsewhere classified

1942

12460

1.04

0.94

1.9

1.8

42.31

41.55

nmol/l

0.49

1884

12225

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

129

1112

1.17

0.94

2.0

1.9

41.66

40.76

nmol/l

0.16

124

1081

Monosomies and deletions from the autosomes, not elsewhere classified

2.21

0.93

1.8

42.00

34.96

nmol/l

—

Toxic effect of ethanol

808

0.81

0.93

1.7

1.9

43.29

38.85

nmol/l

0.69

789

Disorder of external ear, unspecified

437

1.27

0.92

2.3

1.9

40.78

39.58

nmol/l

0.09

425

Other disorders of urethra and urinary system

773

5706

0.94

0.92

1.7

47.43

46.26

nmol/l

0.47

753

5546

Neovascular glaucoma

418

0.74

0.92

1.6

1.8

46.45

41.13

nmol/l

0.59

399

Lung transplant status

152

0.58

0.91

3.4

1.9

44.11

39.08

nmol/l

—

146

Lung transplantation

153

0.57

0.91

3.4

1.9

44.11

39.08

nmol/l

—

146

Surgical ablation of atrial fibrillation

105

0.46

0.91

1.0

1.8

34.80

42.08

nmol/l

—

Other or unspecified ileus, impaction or obstruction

237

2129

1.12

0.91

2.1

1.8

43.15

42.98

nmol/l

0.04

231

2061

Hypotension

177

1563

1.13

0.91

1.8

46.65

44.79

nmol/l

0.48

169

1499

Lesion of radial nerve

510

1.25

0.91

2.7

1.9

40.61

39.48

nmol/l

0.11

495

Malignant neoplasm of gum, including Hilmo

101

0.49

0.91

3.6

2.0

38.80

41.95

nmol/l

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

531

1.25

0.90

2.0

48.02

36.82

nmol/l

2.16

520

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

531

1.25

0.90

2.0

48.02

36.82

nmol/l

2.16

520

Other retinal disorders

939

7517

0.95

0.90

1.9

46.22

41.80

nmol/l

5.04

915

7322

Benign neoplasm: Lower jaw bone

1.95

0.90

1.0

1.6

27.50

36.00

nmol/l

—

Acidosis

277

0.68

0.89

1.9

1.8

35.63

42.38

nmol/l

0.76

269

Human immunodeficiency virus [HIV] disease

559

1.24

0.89

2.0

47.84

36.93

nmol/l

2.18

546

Disorders in reading

316

1.32

0.89

2.3

1.9

30.10

36.49

nmol/l

1.36

310

Other congenital musculoskeletal deformities, including avohilmo

1.91

0.89

1.4

1.8

44.50

37.26

nmol/l

—

Portal vein thrombosis

203

1.40

0.89

2.0

44.50

39.96

nmol/l

0.36

195

Kyphosis

111

1.55

0.88

1.5

1.8

39.82

38.58

nmol/l

0.08

106

Congenital malformations of nose, including avohilmo

2.07

0.88

2.8

1.4

35.00

37.13

nmol/l

—

Other disorders of pigmentation

377

1.28

0.88

2.2

1.8

47.13

41.58

nmol/l

0.60

359

Gout, unspecified

343

3147

1.09

0.88

2.0

1.8

35.91

44.05

nmol/l

11.23

330

3028

Acute pancreatitis (for exclusion)

363

3340

1.09

0.88

1.8

1.9

39.38

40.88

nmol/l

0.65

354

3248

Use of memantine

115

1076

0.86

0.87

1.4

1.7

61.31

50.24

nmol/l

2.90

108

1018

Use of other anti-dementia drugs

115

1076

0.86

0.87

1.4

1.7

61.31

50.24

nmol/l

2.90

108

1018

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

574

5379

1.07

0.86

1.9

1.8

42.51

41.73

nmol/l

0.24

553

5287

Alcohol use disorder, Swedish definition

1321

12518

0.96

0.86

2.0

1.9

40.75

40.00

nmol/l

0.56

1282

12267

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

177

0.60

0.86

1.4

2.0

35.82

38.36

nmol/l

0.20

171

Benign neoplasm: Connective and other soft tissue of head, face and neck

196

1.39

0.85

1.6

1.8

46.30

40.10

nmol/l

0.27

186

Alcohol induced polyneuropathy

166

0.59

0.85

1.3

1.8

37.30

41.28

nmol/l

—

156

Implicit Sepsis

1343

10314

0.96

0.85

1.9

1.8

41.53

41.70

nmol/l

0.09

1295

10099

Dependence on enabling machines and devices, not elsewhere classified

137

0.57

0.84

1.4

1.9

37.75

37.54

nmol/l

—

132

Human immunodeficiency virus [HIV] disease, including avohilmo

563

1.23

0.84

2.0

47.84

36.93

nmol/l

2.18

550

Disorder of lipoprotein metabolism, unspecified

176

1565

1.13

0.84

2.1

1.8

39.19

44.22

nmol/l

2.25

168

1508

Secondary right heart disease

308

0.71

0.83

1.7

1.8

59.05

42.22

nmol/l

1.74

288

Other helminthiases, including avohilmo

1.93

0.83

1.8

2.0

29.67

37.78

nmol/l

—

415

1.25

0.83

1.7

38.92

42.22

nmol/l

0.44

401

Persistent delusional disorders

1122

0.85

0.83

2.0

37.65

37.59

nmol/l

0.01

1092

Malignant neoplasm of colon, including Hilmo

174

1945

0.89

0.83

1.6

1.8

42.81

44.78

nmol/l

0.57

167

1865

Behavioural disorders

465

0.77

0.83

2.5

1.9

42.06

36.72

nmol/l

0.53

456

Discharge of firework

0.00

0.82

0.0

1.7

—

35.44

—

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

215

1.37

0.82

2.4

2.0

37.07

39.10

nmol/l

0.29

210

Brain meningioma

284

1.31

0.82

2.0

1.9

46.32

45.24

nmol/l

0.11

268

Other infiltrative disorders of skin and subcutaneous tissue

1.73

0.82

2.0

1.7

31.13

38.36

nmol/l

—

Corneal scars and opacities

329

1.29

0.81

2.1

1.9

39.05

39.19

nmol/l

0.01

316

Malignant neoplasm of eye, brain and central nervous system

686

0.81

1.8

2.0

41.88

39.56

nmol/l

0.30

663

Complications following infusion, transfusion and therapeutic injection

147

1.44

0.81

2.0

46.38

39.71

nmol/l

0.42

139

Aplastic and other anaemias

509

4975

0.93

0.81

1.8

48.04

44.40

nmol/l

1.76

491

4810

Epilepsy

488

4545

1.07

0.81

1.9

1.7

45.73

43.30

nmol/l

0.88

477

4448

Malignant neoplasm of base of tongue, including Hilmo

163

0.60

0.81

1.6

1.9

41.30

40.21

nmol/l

—

154

Flatulence and related conditions

114

1.51

0.80

2.1

1.7

39.88

37.61

nmol/l

0.17

108

Sequelae of inflammatory diseases of the central nervous system

1.71

0.80

1.8

2.2

39.63

35.60

nmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

352

0.74

0.80

1.6

1.2

60.12

55.84

nmol/l

0.29

347

Malignant neoplasm of tonsil and base of tongue, including Hilmo

418

0.76

0.80

1.8

2.0

46.72

41.06

nmol/l

0.49

399

Malignant neoplasm of base of tongue

125

0.55

0.80

1.6

1.9

44.00

40.97

nmol/l

—

118

Lung diseases due to external agents

141

1599

0.88

0.80

1.9

41.59

42.80

nmol/l

0.26

133

1544

Erythema intertrigo

268

1.32

0.80

2.1

1.8

36.97

39.28

nmol/l

0.41

255

Gout due to impairment of renal function

131

1.47

0.80

1.7

1.9

43.37

44.20

nmol/l

0.05

123

Habit and impulse disorders

412

1.26

0.79

1.8

1.9

36.45

37.61

nmol/l

0.14

402

Hypoglycaemia, other or unspecified

115

1000

1.16

0.78

2.1

1.9

50.71

38.78

nmol/l

3.31

110

970

Macular cyst

225

1.34

0.78

1.7

1.8

41.53

42.12

nmol/l

0.06

213

Pneumococcal septicemia

417

0.76

0.78

2.2

1.8

34.47

40.74

nmol/l

1.49

398

Intrahepatic Cholestasis of Pregnancy (ICP)

350

0.74

0.78

1.6

1.2

60.12

55.77

nmol/l

0.29

345

Other disorders of glucose regulation and pancreatic internal secretion

142

1254

1.14

0.78

2.1

1.9

49.68

39.27

nmol/l

3.58

137

1220

Unspecified mental disorder

824

8658

0.95

0.77

2.0

1.9

38.11

39.42

nmol/l

0.74

803

8511

Immunodeficiency associated with other major defects

2.24

0.77

1.8

25.40

34.22

nmol/l

—

Obstructed labour due to malposition and malpresentation of fetus

121

978

1.15

0.76

1.3

1.2

58.88

55.80

nmol/l

0.34

121

972

Alcohol abuse, main dg, excluding more controls

312

3380

0.92

0.76

1.9

1.8

40.01

39.63

nmol/l

0.11

307

3321

LSIL lesion of the cervix uteri

558

1.20

0.76

1.1

1.2

66.34

56.09

nmol/l

0.78

551

Otorrhoea

2.14

0.75

2.2

1.6

48.20

37.88

nmol/l

—

Other melanin hyperpigmentation

124

1.46

0.75

1.8

1.9

52.72

43.09

nmol/l

0.47

116

Bleeding

1510

10974

0.96

0.74

1.9

41.94

40.67

nmol/l

1.28

1464

10742

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

404

3767

1.08

0.74

1.7

1.9

38.27

38.96

nmol/l

0.25

394

3689

Peripheral retinal degeneration

298

1.28

0.74

1.9

1.8

51.82

40.93

nmol/l

0.98

287

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

299

1.29

0.74

1.8

38.13

37.51

nmol/l

0.07

288

Cerebral palsy

288

0.72

0.74

2.1

2.0

40.86

38.00

nmol/l

0.14

283

Alopecia areata

254

1.31

0.74

1.7

47.73

42.60

nmol/l

0.47

245

Malignant neoplasm of floor of mouth, including Hilmo

106

0.56

0.74

1.8

2.0

47.50

42.91

nmol/l

—

101

ILD medications: pirfenidone

108

0.55

0.73

1.7

1.9

51.50

47.41

nmol/l

—

Folate deficiency anaemia

108

0.55

0.73

2.0

1.7

29.83

41.91

nmol/l

—

100

Wegener granulomatosis

183

0.65

0.73

2.3

1.9

57.83

40.47

nmol/l

1.59

177

Malignant neoplasm of parotid gland, including Hilmo

110

0.54

0.73

2.2

2.0

45.67

41.10

nmol/l

—

102

Malignant neoplasm of rectosigmoid junction, including Hilmo

265

0.71

0.73

1.8

1.9

41.74

43.79

nmol/l

0.19

250

Rheumatic valve diseases

171

0.64

0.72

1.2

2.0

39.64

41.36

nmol/l

0.12

162

Thyrotoxicosis with toxic multinodular goitre

237

1.31

0.72

1.7

1.8

45.81

44.54

nmol/l

0.08

224

Diseases of arteries, arterioles and capillaries (FINNGEN)

467

3434

0.94

0.72

1.9

1.8

39.53

41.81

nmol/l

1.59

457

3369

Suicide or other Intentional self-harm

512

4819

1.07

0.72

1.9

41.34

39.85

nmol/l

0.58

492

4733

Familial benign pemphigus (Hailey-Hailey disease)

1.98

0.72

1.2

1.7

80.40

44.92

nmol/l

—

Congenital malformations of the respiratory system, including avohilmo

194

1.35

0.72

2.7

1.9

38.04

37.51

nmol/l

0.05

186

Other leukaemias of specified cell type

1.97

0.72

3.4

1.5

59.00

38.15

nmol/l

—

AV-block

224

1741

1.10

0.71

1.9

1.8

46.55

45.37

nmol/l

0.28

211

1671

Other complications of labour and delivery, not elsewhere classified

118

917

1.14

0.71

1.1

1.2

60.92

54.05

nmol/l

0.92

118

910

IBD patients in KELA-register

531

5008

1.06

0.70

1.7

1.9

38.62

38.94

nmol/l

0.12

518

4910

Tobacco use

911

0.85

0.70

2.2

1.9

45.18

40.25

nmol/l

0.60

885

Gout, idiopatic and unspecified

422

3950

1.07

0.70

2.0

1.9

36.14

43.99

nmol/l

12.46

407

3801

Dermatopolymyositis

144

0.62

0.70

1.7

2.0

36.67

40.81

nmol/l

—

139

Monoarthritis, not elsewhere classified

500

1.21

0.70

1.9

1.8

41.95

40.97

nmol/l

0.11

484

Benign neoplasm: Bronchus and lung

157

0.63

0.70

2.4

1.7

39.70

41.15

nmol/l

—

150

Other and unspecified spinal muscular atrophies

1.55

0.70

1.8

38.31

43.55

nmol/l

0.49

Burn and corrosion of shoulder and upper limb, except wrist and hand

375

0.77

0.70

1.4

1.9

35.66

38.12

nmol/l

0.24

362

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

368

3431

1.08

0.70

1.7

1.9

38.03

38.72

nmol/l

0.24

359

3355

Malignant neoplasm of oropharynx, including Hilmo

330

0.75

0.70

2.0

49.44

40.92

nmol/l

0.68

316

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

169

0.65

0.69

1.7

1.9

39.73

44.31

nmol/l

0.45

156

Sequelae of injuries involving multiple and unspecified body regions

1.90

0.69

1.6

1.5

39.40

35.63

nmol/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

262

2845

0.92

0.69

1.9

48.10

40.84

nmol/l

2.56

257

2771

Idiopathic hypoparathyroidism

1.89

0.69

2.2

1.4

60.80

35.44

nmol/l

—

Allergic bronchopulmonary aspergillosis (ABPA)

1.88

0.69

1.8

1.9

29.00

41.48

nmol/l

—

Paroxysmal tachycardia

399

3096

1.07

0.69

2.1

1.7

41.81

43.33

nmol/l

0.64

387

3035

Contusion of ankle

705

1.17

0.68

1.8

37.09

38.64

nmol/l

0.28

687

Other fall from one level to another

483

4545

1.06

0.68

1.7

1.9

41.97

40.25

nmol/l

0.76

476

4445

Ulcerative colitis (strict definition, require KELA)

377

3522

1.07

0.68

1.7

1.9

37.89

38.82

nmol/l

0.36

368

3445

Myeloproliferative diseases

807

1.16

0.68

2.2

1.9

41.27

42.53

nmol/l

0.22

775

Other nutritional anaemias

0.54

0.68

3.6

1.8

62.00

41.98

nmol/l

—

Ectopic pregnancy

520

1.19

0.67

1.1

1.2

53.06

59.24

nmol/l

0.91

515

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

314

1.27

0.67

1.9

2.1

49.28

37.08

nmol/l

1.39

308

Insulin, fast-acting or short human

703

7375

0.95

0.66

1.8

1.9

46.56

39.87

nmol/l

7.15

691

7201

Other diseases of gallbladder

348

1.24

0.66

2.0

1.9

38.51

41.47

nmol/l

0.47

335

Chronic periodontitis, including avohilmo

2034

12594

1.03

0.66

1.9

40.37

40.82

nmol/l

0.35

1970

12373

Other demyelinating diseases of the central nervous system

483

0.80

0.66

1.3

1.8

37.69

40.10

nmol/l

0.38

470

Malignant neoplasm of brain

581

0.82

0.66

1.6

2.0

43.06

39.00

nmol/l

0.53

561

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

902

5437

1.05

0.66

1.9

1.8

41.01

42.13

nmol/l

0.65

885

5351

Other and unspecified iron deficiency

374

3488

1.07

0.66

1.9

1.7

45.04

44.93

nmol/l

0.02

364

3374

Other and unspecified hydrocephalus

178

0.67

0.65

1.8

1.9

37.58

41.51

nmol/l

0.23

169

Localized skin eruption due to drugs and medicaments

120

1.43

0.65

1.7

1.9

45.24

40.13

nmol/l

0.34

115

Traction detachment of retina

130

0.61

0.65

1.1

2.0

44.00

38.46

nmol/l

—

125

Schizoid personality disorder

359

0.77

0.65

2.3

1.9

39.68

38.26

nmol/l

0.09

349

Contusion of toe(s) without damage to nail

377

1.23

0.65

1.6

1.8

43.11

39.34

nmol/l

0.43

366

Charcot foot

258

0.73

0.64

1.5

1.9

33.21

40.49

nmol/l

1.41

249

Use of donepezil

924

0.87

0.64

1.7

55.03

49.82

nmol/l

0.87

875

Secondary and unspecified malignant neoplasm of lymph nodes

122

1084

1.13

0.64

1.8

1.9

44.07

42.04

nmol/l

0.45

122

1043

Abscess of lung

246

0.72

0.64

1.7

1.9

44.89

39.55

nmol/l

0.64

237

Complications of genitourinary prosthetic devices, implants and grafts

172

1.34

0.64

2.0

1.9

52.39

42.66

nmol/l

0.74

160

Burns and corrosions confined to eye and internal organs

562

1.19

0.64

1.7

2.0

39.26

37.02

nmol/l

0.42

547

Allergic contact dermatitis due to drugs in contact with skin

177

0.67

0.64

1.8

44.08

41.20

nmol/l

0.16

166

Congenital musculoskeletal deformities of head, face, spine and chest

199

1.32

0.64

1.7

2.0

38.27

35.86

nmol/l

0.26

193

Ulcer of lower limb, not elsewhere classified

163

1800

0.90

0.63

1.8

43.01

42.92

nmol/l

0.02

155

1732

Loose body in joint

342

1.24

0.63

2.1

1.8

38.67

40.06

nmol/l

0.18

333

Thrombocytopenia, unspecified

880

0.86

0.63

1.9

49.41

41.91

nmol/l

1.51

847

Enteropathic arthropathies

288

1.26

0.63

1.7

34.58

39.00

nmol/l

1.02

282

Leukaemia of unspecified cell type

102

0.58

0.63

1.8

1.9

22.17

40.08

nmol/l

—

Exposure to vibration

0.00

0.63

0.0

1.8

—

33.50

—

Sequelae of intentional self-harm, assault and events of undetermined intent

139

1.40

0.62

1.8

1.9

39.21

37.31

nmol/l

0.14

134

Osteolysis

0.00

0.62

0.0

1.6

—

39.47

—

Type 1 diabetes, wide definition

465

4916

0.94

0.62

1.8

1.9

50.52

39.87

nmol/l

9.89

459

4827

Moyamoya

0.00

0.62

0.0

1.6

—

44.40

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

631

0.84

0.61

2.5

1.9

36.96

42.41

nmol/l

1.57

606

Chlamydial lymphogranuloma (venereum)

1.84

0.61

2.3

1.7

33.50

38.36

nmol/l

—

Cystic fibrosis with intestinal manifestations

0.00

0.61

0.0

1.3

—

36.16

—

Polyp of middle ear

0.00

0.61

0.0

1.5

—

37.00

—

Malignant neoplasm of pyriform sinus

0.00

0.61

0.0

1.5

—

44.57

—

Congenital malformations of heart and great arteries

212

2237

0.92

0.61

2.0

1.9

39.48

39.03

nmol/l

0.10

207

2183

Anisometropia and aniseikonia

307

1.24

0.61

1.8

48.68

41.03

nmol/l

1.09

295

Chlamydial lymphogranuloma (venereum), including avohilmo

1.83

0.61

2.3

1.7

33.50

38.36

nmol/l

—

Discitis, unspecified

165

1.34

0.61

1.8

45.09

40.97

nmol/l

0.46

156

Endometriosis ASRM stages 3,4

693

1.16

0.61

1.2

63.12

58.78

nmol/l

0.45

686

Adhesive middle ear disease

227

1.29

0.61

1.7

1.8

32.03

39.61

nmol/l

2.17

218

Use of galantamine

301

0.76

0.61

1.5

1.7

53.30

51.07

nmol/l

0.13

281

Deficiency of other B group vitamins

139

1.38

0.60

1.8

1.9

53.58

42.13

nmol/l

0.59

133

Substance abuse

1478

13300

1.03

0.60

2.0

1.9

40.44

39.98

nmol/l

0.31

1431

13049

Cystic fibrosis, other manifestations/unspecified

0.00

0.60

0.0

1.2

—

42.73

—

Conduction disorders

422

3182

1.06

0.60

1.9

1.8

45.24

43.38

nmol/l

0.72

405

3082

Pemphigus vulgaris

0.00

0.60

0.0

1.5

—

41.68

—

Postprocedural disorders of digestive system, not elsewhere classified

317

1.24

0.60

1.5

1.8

43.15

41.22

nmol/l

0.22

300

Venous thromboembolism

747

6879

1.05

0.60

2.0

1.8

40.34

43.15

nmol/l

3.20

734

6684

Alcoholic cardiomyopathy

114

0.60

3.0

1.8

37.14

41.79

nmol/l

—

108

Non-follicular lymphoma

116

1034

1.13

0.59

2.0

1.9

46.91

42.70

nmol/l

1.01

116

993

Other and unspecified types of non-Hodgkin lymphoma, hilmo

372

1.22

0.59

2.1

1.8

46.44

42.38

nmol/l

0.54

354

Insulin, fast-acting

703

7346

0.95

0.59

1.8

1.9

46.56

40.08

nmol/l

6.75

691

7176

Mucosal proctocolitis

289

2693

1.08

0.59

1.8

1.9

37.61

38.40

nmol/l

0.26

283

2635

Haemophilus septicemia

0.00

0.59

0.0

1.5

—

32.78

—

Small kidney of unknown cause

0.00

0.59

0.0

1.7

—

36.78

—

Upper arm

1.77

0.59

1.2

2.0

41.50

38.23

nmol/l

—

Chronic tubulo-interstitial nephritis

254

0.74

0.59

1.5

1.9

43.16

41.87

nmol/l

0.08

242

Malignant neoplasm of colon

138

1529

0.90

0.58

1.6

1.9

41.35

44.64

nmol/l

1.14

133

1471

Burn and corrosion confined to eye and adnexa

484

1.19

0.58

1.8

2.0

38.15

37.00

nmol/l

0.18

471

Congenital malformations of the respiratory system

175

1.32

0.58

2.8

1.8

39.13

37.40

nmol/l

0.16

167

Convulsions, not elsewhere classified

469

4890

0.95

0.58

2.0

1.8

44.23

40.47

nmol/l

1.72

460

4793

Glomerular disorders in diseases classified elsewhere

177

1935

0.91

0.58

1.7

1.9

45.05

40.82

nmol/l

0.70

172

1876

Malignant neoplasm of tonsil and base of tongue

364

0.79

0.58

1.9

2.0

47.93

40.81

nmol/l

0.60

349

Effects of foreign body entering through natural orifice

643

6141

1.05

0.58

1.9

39.92

38.73

nmol/l

0.74

626

6014

Autoimmune diseases excluding thyroid diseases

2336

12341

1.03

0.58

1.8

42.74

40.34

nmol/l

3.98

2287

12104

Acute and subacute iridocyclitis

316

2956

1.07

0.58

2.0

1.9

43.67

40.23

nmol/l

1.09

311

2884

Other protozoal intestinal diseases

158

1.34

0.58

2.1

1.8

46.24

40.67

nmol/l

0.38

153

Lordosis

1.71

0.58

1.7

1.4

26.00

39.11

nmol/l

—

Rheumatic fever incl heart disease

253

0.75

0.58

1.6

1.9

43.53

40.71

nmol/l

0.14

238

Whooping cough, including avohilmo

238

1.27

0.57

1.4

2.0

41.10

40.06

nmol/l

0.10

233

Endometriosis ASRM stages 1,2

669

1.15

0.57

1.2

64.19

56.39

nmol/l

0.84

662

Late syphilis

218

0.73

0.57

1.5

2.0

37.69

39.20

nmol/l

0.15

210

Inflammatory bowel disease, strict (require KELA)

531

5049

1.05

0.57

1.7

1.9

38.62

39.05

nmol/l

0.16

518

4952

Enduring personality changes

1.58

0.57

2.9

1.9

39.00

37.15

nmol/l

—

Atrial fibrillation and flutter with reimbursement

523

3127

1.06

0.57

1.9

1.8

39.60

42.53

nmol/l

2.25

503

3068

Other specified/unspecified systemic involvement of connective tissue

374

1.21

0.56

2.2

1.8

50.91

43.14

nmol/l

0.75

361

Nonspecific lymphadenitis

793

1.14

0.56

1.8

1.9

43.33

39.48

nmol/l

0.63

778

Pneumonia, organism unspecified

1898

12660

1.03

0.56

1.9

1.8

39.31

41.08

nmol/l

2.57

1851

12423

Malignant neoplasm of parotid gland

0.55

0.56

2.0

1.9

43.60

41.08

nmol/l

—

Other and unspecified injuries of abdomen, lower back and pelvis

221

1.28

0.56

2.4

2.0

44.71

39.51

nmol/l

0.47

213

Occlusion and stenosis of arteries, not leading to stroke

0.56

1.6

42.20

44.09

nmol/l

—

Other misadventures during surgical and medical care

257

1.25

0.56

2.3

1.8

43.03

41.47

nmol/l

0.15

244

Ulcerative colitis (strict definition, all Crohn cases excluded)

318

2982

1.07

0.56

1.7

1.9

38.48

38.76

nmol/l

0.08

310

2916

Postzoster neuralgia

107

1.41

0.55

2.9

1.8

36.73

43.10

nmol/l

0.55

100

Contact with lifting and transmission devices, not elsewhere classified

404

1.20

0.55

2.4

2.0

38.29

37.95

nmol/l

0.04

387

Contusion of toe(s) with damage to nail

195

1.30

0.55

2.0

1.9

36.60

38.09

nmol/l

0.12

188

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

515

0.83

0.55

1.7

1.9

58.32

43.83

nmol/l

2.23

491

Diseases of liver

615

5877

1.05

0.54

1.9

41.49

41.28

nmol/l

0.07

595

5730

Other surgical follow-up care

450

1.18

0.54

1.8

43.28

39.50

nmol/l

0.59

437

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

697

0.86

0.54

1.7

1.9

56.61

43.60

nmol/l

2.90

669

Contusion of other and unspecified parts of foot

103

919

1.13

0.54

1.9

1.8

38.77

38.76

nmol/l

0.00

898

Other disorders of central nervous system

125

1.37

0.54

2.4

1.8

35.35

42.05

nmol/l

0.83

119

Diabetic neuropathy

172

1569

1.09

0.54

1.8

1.9

43.41

36.97

nmol/l

2.89

165

1511

Malignant neoplasm of rectosigmoid junction

170

0.70

0.54

2.1

2.0

44.08

40.63

nmol/l

0.22

161

Psoriasis vulgaris

349

3287

1.06

0.54

1.9

42.29

40.18

nmol/l

0.57

336

3209

Scar conditions and fibrosis of skin

386

1.20

0.53

1.7

1.8

43.28

40.91

nmol/l

0.21

372

Carcinoma in situ of other and unspecified sites

414

1.19

0.53

1.6

1.8

43.94

45.84

nmol/l

0.29

389

Papilloedema, unspecified

286

1.23

0.53

1.7

1.8

38.71

41.99

nmol/l

0.48

274

Pneumonitis due to solids and liquids

972

0.88

0.53

1.9

44.69

41.32

nmol/l

0.66

938

Toxic effect of other gases, fumes and vapours

126

1.38

0.53

2.2

2.0

34.82

36.71

nmol/l

0.15

121

Malignant neoplasm of tonsil, including Hilmo

282

0.77

0.53

2.0

1.9

49.18

40.82

nmol/l

0.57

271

Unspecified visual impairment (binocular)

158

0.69

0.53

1.8

73.09

41.10

nmol/l

0.33

150

Hypo-osmolality and hyponatraemia

165

1786

0.91

0.53

2.0

1.8

52.77

43.28

nmol/l

3.31

158

1730

Emphysema

823

0.87

0.53

1.4

1.8

48.37

43.77

nmol/l

0.46

793

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

0.61

0.53

3.0

1.9

34.50

41.86

nmol/l

—

Aspergillosis, including avohilmo

135

0.66

0.52

1.6

1.7

42.67

39.58

nmol/l

—

127

Malignant neoplasm of tongue, including Hilmo

370

0.81

0.52

1.7

2.0

40.03

40.55

nmol/l

0.05

354

Hypercalcemia

341

1.21

0.52

2.2

1.9

39.63

41.71

nmol/l

0.30

324

Use of levodopa decarboxylase inhibitor

128

1158

1.11

0.52

1.4

1.8

47.93

45.36

nmol/l

0.72

123

1105

Malignant neoplasm of renal pelvis, including Hilmo

133

0.67

0.52

1.4

1.9

49.11

44.56

nmol/l

—

124

Pulmonary eosinophilia, not elsewhere classified

0.61

0.52

3.7

1.7

52.33

40.77

nmol/l

—

Diagnoses used for exclusion with ILD

379

3582

1.06

0.52

2.1

1.9

41.26

41.30

nmol/l

0.01

367

3481

Adult respiratory distress syndrome

136

0.66

0.52

2.4

1.9

25.67

41.68

nmol/l

—

127

Thiazolidinediones

156

1427

1.10

0.52

2.1

1.9

35.29

45.93

nmol/l

8.18

143

1379

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

224

1.26

0.52

1.8

1.9

37.71

36.53

nmol/l

0.12

217

Ventral hernia

304

2854

1.07

0.52

2.0

1.8

41.48

42.79

nmol/l

0.33

289

2766

Fibrosis and cirrhosis of liver

906

0.88

0.52

1.5

2.0

57.19

41.98

nmol/l

3.68

871

Other coagulation defects

799

1.13

0.52

2.1

1.8

40.63

41.67

nmol/l

0.15

775

Fracture of forearm

774

7225

0.96

0.51

1.8

42.61

40.74

nmol/l

1.07

758

7087

Oral lichen planus and hypothyroidism or thyroxine medication

1.41

0.51

1.4

1.8

68.00

44.02

nmol/l

—

202

0.73

0.51

1.8

28.00

39.88

nmol/l

1.76

195

Sulfasalazine

469

4462

1.05

0.51

1.8

43.97

41.50

nmol/l

1.10

463

4365

Other and unspecified epidermal thickening

315

1.21

0.51

1.5

1.9

41.13

39.88

nmol/l

0.11

299

Exposure to other and unspecified animate mechanical forces

500

1.17

0.51

2.0

1.8

39.66

40.09

nmol/l

0.06

488

Open wound of thorax

335

0.80

0.51

2.0

1.9

34.04

37.97

nmol/l

0.40

323

Overjet

277

1.23

0.51

1.6

1.7

50.21

39.06

nmol/l

0.60

271

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

542

0.85

0.51

1.7

1.9

59.76

43.97

nmol/l

2.96

517

Crohn disease

262

2452

1.07

0.50

1.9

39.36

38.90

nmol/l

0.11

257

2398

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1843

11932

0.97

0.50

1.7

1.8

42.32

41.80

nmol/l

0.36

1779

11731

Toxic effect of alcohol

400

0.82

0.50

1.8

2.0

41.33

37.02

nmol/l

0.43

386

Diabetes, insulin treatment (Kela reimbursement)

2050

11905

1.02

0.50

1.9

35.77

41.51

nmol/l

20.06

1981

11697

Condition for Implicit Sepsis (Organ dysfunction codes)

1638

11639

0.97

0.49

1.9

1.8

41.78

41.07

nmol/l

0.55

1584

11414

Pneumocystosis, including avohilmo

212

0.75

0.49

1.9

46.69

40.57

nmol/l

0.36

203

Pneumocystosis

212

0.75

0.49

1.9

46.69

40.57

nmol/l

0.36

203

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

965

0.89

0.49

1.8

2.0

40.19

40.24

nmol/l

0.01

933

Iridocyclitis

368

3484

1.06

0.49

2.0

1.9

43.10

40.53

nmol/l

0.85

362

3399

Benign neoplasm: Floor of mouth

1.55

0.49

2.3

2.0

39.29

41.11

nmol/l

—

Other blood glucose lowering drugs, excl. Insulins

187

1730

1.08

0.49

2.0

1.8

34.41

46.15

nmol/l

14.22

181

1673

Other juvenile arthritis

502

1.16

0.49

1.7

45.57

42.03

nmol/l

0.25

493

Supplementary factors related to causes of morbidity and mortality classified elsewhere

618

5928

1.04

0.49

1.8

1.9

40.58

40.30

nmol/l

0.10

598

5802

Respiratory tuberculosis, clinically confirmed

110

0.63

0.49

1.4

1.7

45.71

43.44

nmol/l

—

103

Other and unspecified paralytic syndromes

181

1.28

0.49

1.7

2.0

31.48

37.39

nmol/l

0.81

173

Benign neoplasm: Skin of lip

119

1.36

0.48

1.9

1.7

42.56

38.94

nmol/l

0.31

113

Aneurysms, operations, SAH

166

1801

0.92

0.48

2.1

1.9

44.22

42.47

nmol/l

0.32

160

1741

Intentional self-harm by jumping or lying before moving object

1.51

0.48

3.4

1.8

36.86

36.38

nmol/l

—

Aortic valve malfunction, age under 60 years

199

2141

0.93

0.48

2.0

38.16

39.16

nmol/l

0.30

193

2085

Short stature, not elsewhere classified

184

1.27

0.48

1.9

1.5

37.76

39.82

nmol/l

0.20

178

Hyperlipidaemia, other/unspecified

592

5096

1.04

0.48

1.9

1.8

40.85

43.78

nmol/l

2.34

567

4957

Iron deficiency anaemia secondary to blood loss (chronic)

133

1457

0.91

0.48

2.3

1.8

43.73

42.67

nmol/l

0.19

127

1410

Periodontitis

2027

12615

1.02

0.48

1.9

40.43

40.80

nmol/l

0.27

1963

12394

Unspecified human immunodeficiency virus [HIV] disease

301

1.22

0.47

1.9

2.1

49.81

36.79

nmol/l

1.40

296

Gout, strict definition

298

2808

1.06

0.47

2.0

1.8

35.66

44.18

nmol/l

11.04

286

2695

Paranoid personality disorder

255

0.78

0.47

1.7

1.8

36.10

39.57

nmol/l

0.33

244

Disorders of choroid and retina

1370

9853

0.97

0.47

1.9

46.20

40.99

nmol/l

9.31

1333

9630

Left ventricular outflow tract obstruction (LVOTO), broad definition

210

2252

0.93

0.47

2.0

38.30

38.92

nmol/l

0.17

204

2195

Chronic hepatitis NAS

120

1.34

0.46

1.3

1.9

54.25

39.61

nmol/l

0.80

114

Other specified and unspecified disorders of iris and ciliary body

1.45

0.46

2.1

1.4

44.00

34.08

nmol/l

—

Ankylosing spondylitis, strict definition

109

989

1.11

0.46

1.7

2.0

36.13

36.78

nmol/l

0.15

109

967

DVT of lower extremities

246

2307

1.07

0.46

1.9

40.68

42.18

nmol/l

0.52

240

2238

Disorders of orbit

412

1.17

0.45

2.1

1.8

42.96

40.93

nmol/l

0.18

399

194

1548

1.08

0.45

1.7

50.52

48.79

nmol/l

0.44

182

1472

Third [oculomotor] nerve palsy

183

1.27

0.45

2.0

1.8

39.00

42.21

nmol/l

0.35

174

Other noninfective disorders of lymphatic vessels and lymph nodes

352

0.82

0.45

2.2

1.9

45.55

40.18

nmol/l

0.45

343

Unstable angina pectoris

482

3959

0.95

0.45

1.8

42.52

45.18

nmol/l

1.63

466

3827

Psoriasis

511

4894

1.05

0.45

1.9

42.49

40.82

nmol/l

0.56

495

4776

Chronic kidney disease

389

3932

0.95

0.45

1.7

1.9

43.01

43.82

nmol/l

0.27

378

3789

Oxycodone

538

4406

1.04

0.45

2.1

1.8

40.79

44.20

nmol/l

2.78

515

4296

Diffuse large B-cell lymphoma, including Hilmo

497

1.15

0.45

2.2

1.9

50.77

42.85

nmol/l

1.26

474

Diffuse large B-cell lymphoma, helper endpoint

497

1.15

0.45

2.2

1.9

50.77

42.85

nmol/l

1.26

474

Diffuse large B-cell lymphoma

497

1.15

0.45

2.2

1.9

50.77

42.85

nmol/l

1.26

474

Aspergillosis

131

0.68

0.44

1.6

1.8

42.67

39.66

nmol/l

—

124

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

257

1.21

0.43

1.7

2.0

42.90

38.81

nmol/l

0.40

243

Other and unspecified bullous disorders

104

1.36

0.43

1.5

1.7

44.36

39.79

nmol/l

0.20

Vitreous haemorrhage

147

1356

1.09

0.43

1.9

48.42

40.75

nmol/l

3.71

142

1314

Other specified/unspecified disorders of ear

1.64

0.43

1.6

1.3

50.06

37.13

nmol/l

—

Lagophthalmos

104

1.36

0.43

1.2

2.0

42.71

43.15

nmol/l

0.02

Tuberculosis of other organs, strict

128

0.70

0.43

1.2

1.8

46.00

43.26

nmol/l

—

120

Tuberculosis of other organs, strict, including avohilmo

129

0.69

0.43

1.2

1.8

46.00

43.21

nmol/l

—

121

Maternal care for known or suspected fetal abnormality and damage

115

887

1.10

0.43

1.2

58.63

56.39

nmol/l

0.22

115

882

Other diseases of the respiratory system

210

2244

0.93

0.43

2.0

1.8

43.24

43.18

nmol/l

0.01

205

2159

Other respiratory disorders and diseases

210

2244

0.93

0.43

2.0

1.8

43.24

43.18

nmol/l

0.01

205

2159

Crushing injuries involving multiple body regions

0.00

0.43

0.0

1.5

—

35.93

—

Protozoal diseases, including avohilmo

359

1.18

0.43

1.6

1.8

44.62

40.46

nmol/l

0.43

346

Malignant neoplasm of skin

645

4531

0.96

0.43

1.7

1.9

45.50

43.73

nmol/l

1.18

627

4400

Single delivery by forceps and vacuum extractor

118

771

0.91

0.42

1.2

59.26

53.15

nmol/l

1.03

118

765

Pityriasis alba

0.00

0.42

0.0

1.7

—

39.20

—

Induced delusional disorder

0.00

0.42

0.0

2.1

—

37.31

—

Hereditary retinal dystrophy

195

0.76

0.42

1.9

35.33

37.62

nmol/l

0.28

188

Carcinoma in situ, bladder

397

1.16

0.42

1.6

1.8

44.22

45.51

nmol/l

0.17

373

Encephalocele

0.00

0.42

0.0

1.2

—

32.20

—

Other and unspecified hereditary haemolytic anaemias

0.00

0.42

0.0

2.1

—

39.81

—

Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

0.00

0.42

0.0

1.3

—

35.88

—

Benign neoplasm: Urethra

0.00

0.42

0.0

1.6

—

42.94

—

Chronic mastoiditis

261

0.80

0.41

2.2

1.8

39.52

41.18

nmol/l

0.15

248

Superficial injuries involving multiple body regions

391

0.84

0.41

1.5

1.8

40.33

38.92

nmol/l

0.11

376

Radiodermatitis

0.00

0.41

0.0

1.9

—

49.12

—

Anterior Iridocyclitis

326

3097

1.05

0.41

2.0

1.9

43.44

40.26

nmol/l

1.01

321

3021

Other combined immunodeficiencies

0.00

0.41

0.0

1.9

—

41.94

—

Transepidermal elimination disorders

0.00

0.41

0.0

1.5

—

44.65

—

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

123

1.32

0.41

1.4

1.7

56.00

39.41

nmol/l

1.04

117

Injury of nerves at shoulder and upper arm level

168

1.26

0.41

1.6

2.0

39.38

38.45

nmol/l

0.07

163

Nocardiosis, including avohilmo

0.00

0.41

0.0

1.6

—

40.61

—

Nocardiosis

0.00

0.41

0.0

1.6

—

40.61

—

Disorders resulting from impaired renal tubular function

508

0.86

0.41

1.8

2.0

38.43

38.52

nmol/l

0.01

488

Severe combined immunodeficiency [SCID] with reticular dysgenesis

1.49

0.41

2.8

1.9

52.00

38.74

nmol/l

—

Duodenal ulcer - Chronic without haemorrhage or perforation, drug-induced

0.00

0.41

0.0

1.7

—

40.50

—

Graves ophthalmopathy, strict

138

0.72

0.40

2.4

1.8

50.90

44.69

nmol/l

—

132

Left hemicolectomy

205

0.78

0.40

1.7

1.8

38.00

41.09

nmol/l

0.31

193

Other injuries involving multiple body regions, not elsewhere classified

0.00

0.40

0.0

1.7

—

31.50

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

241

1.21

0.40

1.4

1.7

39.66

39.03

nmol/l

0.06

234

Diseases of the myoneural junction and muscle

175

1632

1.07

0.40

1.9

38.93

41.13

nmol/l

0.55

167

1583

Disorders of calcium metabolism

634

1.12

0.40

2.1

1.8

38.96

42.59

nmol/l

0.63

613

Retinal vascular disorders

109

996

1.10

0.40

1.6

1.8

45.73

44.28

nmol/l

0.26

103

952

Other renal tubulo-interstitial diseases

177

1.25

0.40

1.5

1.9

40.14

43.77

nmol/l

0.22

167

Lichenoid drug reaction

0.00

0.40

0.0

1.9

—

40.00

—

Exposure to excessive heat of man-made origin

101

0.69

0.40

2.7

1.7

41.57

40.35

nmol/l

—

Other and unspecified atrophic disorders of skin

0.00

0.40

0.0

1.6

—

40.11

—

Syndactyly

1.46

0.40

1.2

1.3

30.00

35.51

nmol/l

—

Other bacterial agents as the cause of diseases classified to other chapters

102

0.68

0.40

1.9

1.8

35.43

43.53

nmol/l

—

Crushing injury of wrist and hand

316

1.18

0.40

1.8

2.0

44.03

37.50

nmol/l

1.00

305

Malignant neoplasm of other connective and soft tissue, including Hilmo

432

0.85

0.39

2.2

1.9

37.51

41.27

nmol/l

0.64

414

Personal history of medical treatment

106

1.33

0.39

1.9

29.43

39.11

nmol/l

0.91

101

Other specified/unspecified disorders of middle ear and mastoid

0.00

0.39

0.0

1.3

—

31.63

—

Other injuries of lower limb, level unspecified

133

1.29

0.39

1.6

1.8

38.06

39.84

nmol/l

0.14

128

Congenital malformations of the circulatory system

267

2455

1.06

0.39

2.1

1.9

40.70

39.43

nmol/l

0.33

262

2397

Malignant neoplasm of tongue

291

0.82

0.39

1.5

2.0

42.00

40.49

nmol/l

0.12

278

Retinal vascular occlusion

108

989

1.09

0.39

1.6

1.8

45.84

44.22

nmol/l

0.29

102

946

Other/unspecified disorders of vestibular function

344

1.17

0.39

2.1

1.8

45.28

41.82

nmol/l

0.42

326

Respiratory tuberculosis, bacteriologically and histologically confirmed

181

0.77

0.38

1.3

1.9

48.00

42.61

nmol/l

0.38

173

Other disorders affecting eyelid function

1.34

0.38

1.7

1.9

49.62

41.24

nmol/l

0.57

Pedal cyclist injured in collision with pedestrian or animal

114

0.69

0.38

1.8

1.9

39.13

39.28

nmol/l

—

109

Smoking dependency

129

1393

0.92

0.38

2.0

1.9

44.62

40.43

nmol/l

0.89

117

1349

Mantle cell lymphoma

113

0.70

0.38

2.5

2.2

32.13

42.96

nmol/l

—

105

Injuries to the elbow and forearm

1272

11158

0.98

0.37

1.9

1.8

40.94

40.85

nmol/l

0.05

1244

10944

DVT of lower extremities and pulmonary embolism

544

5220

1.04

0.37

2.0

1.8

39.83

43.18

nmol/l

3.43

536

5054

Chronic myeloid leukaemia, including Hilmo

125

1.29

0.37

2.9

1.9

35.81

41.16

nmol/l

0.39

119

Ischaemic heart disease, wide definition

1413

8494

1.02

0.37

2.0

1.9

39.06

41.21

nmol/l

3.42

1376

8307

Gastrojejunal ulcer

134

1.28

0.37

1.8

1.7

44.94

40.30

nmol/l

0.53

129

Disorders of lacrimal system and orbit in diseases classified elsewhere

158

0.76

0.37

2.4

1.8

51.42

44.41

nmol/l

0.23

151

Other bullous disorders

281

1.18

0.37

1.7

1.8

47.55

41.35

nmol/l

0.62

270

Other infective (teno)synovitis

1.48

0.36

2.7

1.9

32.50

37.24

nmol/l

—

Seronegative juvenile rheumatoid arthritis

189

1.22

0.36

1.3

1.7

51.78

40.89

nmol/l

0.36

183

Marginal zone B-cell lymphoma, including Hilmo

146

0.75

0.36

2.0

44.64

43.12

nmol/l

0.08

139

Disseminated intravascular coagulation [defibrination syndrome]

1.45

0.36

2.0

1.7

47.17

41.17

nmol/l

—

Defect, injury or illness of lumbar spine

1.45

0.36

1.0

1.3

32.83

35.05

nmol/l

—

Chronic Coagulation defects

212

0.80

0.36

2.9

1.6

38.24

40.96

nmol/l

0.22

204

Protozoal diseases

338

1.16

0.35

1.7

1.8

46.36

40.12

nmol/l

0.69

326

Other congenital malformations of the digestive system

532

1.12

0.35

1.7

1.9

41.25

38.84

nmol/l

0.31

514

Other and unspecified aplastic anaemias

122

0.73

0.35

1.3

1.8

68.89

40.47

nmol/l

—

116

Internuclear ophthalmoplegia

1.41

0.35

1.0

1.9

60.50

42.16

nmol/l

—

Tuberculosis of other organs

122

0.73

0.35

1.2

1.8

46.00

42.30

nmol/l

—

115

Respiratory tuberculosis, confirmed

167

0.77

0.34

1.3

1.9

49.77

42.60

nmol/l

0.52

159

Malignant neoplasm of corpus uteri

1.36

0.34

1.0

1.4

43.00

72.98

nmol/l

—

Acute myringitis

100

1.31

0.34

2.5

1.6

42.54

42.28

nmol/l

0.01

100

Mental and behavioural disorders due to tobacco

129

1385

0.93

0.34

2.0

1.9

44.62

40.26

nmol/l

0.95

117

1344

Graves ophthalmopathy

155

0.77

0.33

2.4

1.8

51.42

44.79

nmol/l

0.21

149

Type 1 diabetes, wide definition, subgroup 1

461

4771

0.96

0.33

1.8

1.9

50.57

39.77

nmol/l

9.99

455

4686

Senile cataract

877

5472

0.97

0.33

1.8

1.9

45.83

43.23

nmol/l

1.97

839

5338

Crystalline deposits in vitreous body

1.36

0.32

2.3

1.9

33.90

43.64

nmol/l

—

Gastric ulcer

191

1805

1.06

0.32

1.9

1.8

46.00

43.95

nmol/l

0.47

186

1740

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

328

3053

1.04

0.32

1.8

1.9

40.47

39.48

nmol/l

0.29

321

2983

Acute appendicitis, with complications

330

3165

1.04

0.32

2.0

1.9

38.79

40.60

nmol/l

0.70

324

3090

Presence of other functional implants

767

5106

1.03

0.31

1.8

1.9

45.29

43.97

nmol/l

0.59

736

4982

Late syphilis, including avohilmo

251

0.83

0.31

1.5

1.9

38.90

39.28

nmol/l

0.03

241

Acute nephritic syndrome

315

0.85

0.31

1.7

1.9

38.93

40.54

nmol/l

0.14

304

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

523

1.11

0.31

1.7

1.9

41.38

38.97

nmol/l

0.31

506

Malignant neoplasm of mesothelium and soft tissue

379

0.87

0.31

2.5

1.8

37.33

42.77

nmol/l

0.91

362

Carrier of infectious disease

296

1.15

0.30

2.0

1.8

37.26

40.09

nmol/l

0.43

286

Migraine, unspecified, drug-induced

1.30

0.30

1.7

1.8

37.14

37.35

nmol/l

—

Fall on and from stairs and steps

397

3827

1.04

0.30

2.0

1.9

42.13

41.08

nmol/l

0.39

386

3735

Malignant neoplasm of skin, including Hilmo

717

4934

0.97

0.30

1.7

1.9

45.72

43.40

nmol/l

1.95

698

4798

Other and unspecified myopathies

124

1159

1.07

0.30

1.9

38.85

40.97

nmol/l

0.42

117

1122

Explicit fungal Sepsis

1.30

0.30

2.3

1.8

56.83

43.54

nmol/l

0.72

Hallux valgus (acquired)

233

1585

1.05

0.30

1.9

1.7

45.20

46.17

nmol/l

0.21

227

1538

Benign neoplasm of thyroid gland

212

1.18

0.30

1.8

46.84

44.51

nmol/l

0.16

202

Type 2 diabetes, wide definition

1453

8984

1.02

0.30

2.0

1.9

34.83

42.79

nmol/l

26.05

1398

8810

Communicating hydrocephalus

185

0.81

0.30

2.0

1.8

33.93

40.97

nmol/l

0.96

175

Respiratory tuberculosis, confirmed, including avohilmo

174

0.80

0.30

1.3

1.9

48.79

42.10

nmol/l

0.51

166

Infection due to other mycobacteria

141

0.78

0.29

1.7

1.9

48.45

41.09

nmol/l

0.57

134

Pleural plaque

871

1.08

0.29

1.6

1.8

47.83

48.87

nmol/l

0.19

817

ILD medications: immunosuppressive drugs

1251

11543

0.98

0.28

1.8

41.72

40.88

nmol/l

0.52

1228

11318

Colitis, primary sclerosing, strict definition

214

1.18

0.28

2.1

2.0

45.00

35.53

nmol/l

0.95

208

Primary_lymphoid and hematopoietic malignant neoplasms

313

3010

1.04

0.28

2.0

1.9

43.36

43.07

nmol/l

0.07

306

2903

All kidney diseases

1863

12669

0.98

0.28

1.9

1.8

40.70

41.79

nmol/l

1.03

1823

12422

Spinal enthesopathy

121

1.24

0.28

1.2

1.8

43.93

42.11

nmol/l

0.13

114

Benign neoplasm: Brain, unspecified

1.28

0.28

3.0

1.7

28.50

39.57

nmol/l

—

Coronary atherosclerosis

1160

7166

1.02

0.28

1.9

39.58

41.60

nmol/l

2.59

1128

6999

Other diseases of the digestive system

459

4446

1.03

0.28

1.8

1.9

42.20

43.04

nmol/l

0.30

440

4309

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

118

0.76

0.28

2.2

2.1

37.00

41.19

nmol/l

—

113

Injury of blood vessels at wrist and hand level

139

0.78

0.27

2.3

1.9

36.73

38.10

nmol/l

0.10

134

Pediculosis and phthiriasis

1.29

0.27

2.1

2.0

40.00

39.96

nmol/l

0.00

Poisoning by medicine, drug-induced

204

0.83

0.27

1.4

2.0

39.12

38.56

nmol/l

0.03

198

Maternal care for other conditions predominantly related to pregnancy

109

1135

0.94

0.27

1.3

1.2

62.97

58.37

nmol/l

0.41

109

1126

Infection due to other mycobacteria, including avohilmo

150

0.80

0.27

1.7

1.9

47.25

41.22

nmol/l

0.48

142

Other anaemias

479

4619

0.97

0.27

1.8

48.17

44.72

nmol/l

1.54

462

4460

Disorders of porphyrin and bilirubin metabolism

187

1.19

0.27

2.4

1.9

38.73

40.49

nmol/l

0.15

182

Use of amantadine

139

0.79

0.27

1.5

1.9

42.64

41.45

nmol/l

0.08

134

Explicit fungal Sepsis, including avohilmo

1.28

0.26

2.3

1.8

56.83

43.15

nmol/l

0.75

Toxic effect of other and unspecified substances

272

1.15

0.26

1.8

2.0

34.16

36.18

nmol/l

0.23

263

Retention of urine

530

4163

1.03

0.26

2.0

1.8

45.91

44.34

nmol/l

0.64

506

4023

Fibrosarcoma, including Hilmo

1.29

0.26

1.3

1.9

40.64

41.12

nmol/l

0.02

Malignant neoplasm of renal pelvis

0.68

0.26

1.2

2.1

48.20

42.49

nmol/l

—

Other specified congenital malformation syndromes affecting multiple systems

253

1.15

0.26

2.2

1.8

40.41

37.61

nmol/l

0.17

245

Adenocarcinoma and Papillary adenocarcinoma of kidney

197

1.18

0.26

1.6

2.0

39.30

42.15

nmol/l

0.25

186

Mature T/NK-cell lymphomas, hilmo

160

0.81

0.26

1.2

1.8

47.69

42.38

nmol/l

0.26

151

1477

13052

0.98

0.26

2.0

1.9

40.30

40.10

nmol/l

0.12

1435

12796

Primary angle-closure glaucoma

272

1.14

0.26

1.4

1.8

48.00

41.75

nmol/l

0.57

257

Other disorders of choroid

149

0.80

0.26

2.8

1.9

37.67

39.49

nmol/l

0.16

144

Hypocalcemia

235

0.85

0.26

2.0

1.9

39.20

39.99

nmol/l

0.06

222

Acquired haemolytic anaemia

235

0.85

0.26

1.6

1.8

50.25

41.52

nmol/l

0.71

225

Pacemaker

398

3818

0.97

0.26

1.7

1.8

46.30

44.95

nmol/l

0.52

381

3676

Mixed specific developmental disorders

305

0.87

0.25

1.9

1.8

32.79

35.65

nmol/l

0.31

297

Angina pectoris

921

5979

1.02

0.25

2.0

1.8

40.30

42.75

nmol/l

2.70

896

5829

Other condition

271

2607

1.04

0.25

1.9

37.57

39.79

nmol/l

1.09

263

2546

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

123

1.22

0.25

2.1

1.8

56.53

45.50

nmol/l

0.85

113

Burns and corrosions

291

3019

0.96

0.25

1.9

38.89

38.69

nmol/l

0.05

283

2954

Other bacterial diseases, including avohilmo

2100

12920

1.01

0.25

2.0

1.8

39.56

40.74

nmol/l

1.28

2047

12686

Other and unspecified anaemias

475

4587

0.97

0.25

1.8

48.05

44.66

nmol/l

1.49

458

4429

Nephrotic syndrome

445

0.90

0.25

1.8

1.9

50.48

39.05

nmol/l

0.46

429

Other necrotizing vasculopathies

608

1.09

0.25

1.8

50.38

41.97

nmol/l

1.56

584

Other congenital malformations of ear

170

1.18

0.25

1.4

1.5

40.75

42.07

nmol/l

0.08

165

Nondiabetic hypoglycaemic coma

0.73

0.25

1.5

1.8

46.83

33.88

nmol/l

—

Unspecified nephritic syndrome

302

1.13

0.25

2.1

1.9

34.59

40.30

nmol/l

1.12

289

Cardiomyopathy, Hypertrophic obstructive

217

1.16

0.24

1.4

1.8

41.52

38.97

nmol/l

0.24

208

Malignant neoplasm of brain, including Hilmo

725

0.92

0.24

1.7

1.9

40.87

39.51

nmol/l

0.18

699

Other injuries of upper limb, level unspecified

212

0.84

0.24

2.1

1.8

42.06

39.32

nmol/l

0.17

200

Persons encountering health services for specific procedures and health care

2281

13281

1.01

0.24

1.9

1.8

41.26

40.90

nmol/l

0.25

2230

13034

Inflammation of lacrimal passages (chronic)

1.27

0.24

2.1

1.9

49.36

40.79

nmol/l

0.26

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

0.72

0.24

2.3

2.0

32.83

44.78

nmol/l

—

Benign neoplasm: Bladder

0.73

0.24

1.0

1.8

39.00

45.47

nmol/l

—

Oher contracture of tendon (sheath)

1.33

0.23

1.0

1.8

44.60

38.92

nmol/l

—

Ankylosis of teeth

1.32

0.23

1.6

1.5

32.60

37.42

nmol/l

—

Torticollis

256

1.14

0.23

1.7

1.8

39.28

36.86

nmol/l

0.31

248

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

264

0.87

0.23

1.7

1.9

38.09

41.02

nmol/l

0.31

252

Arenaviral haemorrhagic fever, including avohilmo

0.00

0.23

0.0

1.3

—

46.70

—

Other and unspecified disorders of psychological development

173

0.83

0.23

2.1

1.9

32.27

35.83

nmol/l

0.24

167

Necrotizing fasciitis

0.76

0.23

1.6

1.7

46.14

39.42

nmol/l

—

Hypertrophic cardiomyopathy

563

1.09

0.23

1.6

2.0

37.64

39.24

nmol/l

0.26

543

Crushing injury of shoulder and upper arm

0.00

0.22

0.0

1.6

—

31.70

—

Carcinoma in situ of colon

314

1.12

0.22

1.4

1.8

43.69

41.73

nmol/l

0.25

298

Carcinoma in situ of other/unspecified male genital organs

0.00

0.22

0.0

1.4

—

46.36

—

Other specified and unspecified strabismus

144

1.19

0.22

2.1

1.9

43.88

39.19

nmol/l

0.19

139

Brucellosis

0.00

0.22

0.0

1.5

—

41.30

—

Myeloproliferative diseases (CML excluded)

719

1.07

0.22

2.0

1.9

42.49

42.81

nmol/l

0.05

688

Multiple sites

0.00

0.22

0.0

1.4

—

35.91

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

585

4039

0.98

0.22

1.7

1.8

46.82

44.37

nmol/l

1.71

566

3913

Vibratory urticaria

0.00

0.22

0.0

1.9

—

31.40

—

Progressive external ophthalmoplegia

0.00

0.22

0.0

2.1

—

41.00

—

Fetal alcohol syndrome (dysmorphic)

0.00

0.22

0.0

1.3

—

37.27

—

Other congenital malformations of posterior segment of eye (coloboma)

0.00

0.22

0.0

2.2

—

39.73

—

Chronic myeloproliferative disease

124

0.80

0.22

2.0

1.9

43.60

45.27

nmol/l

—

113

Diphyllobothriasis and sparganosis, including avohilmo

0.00

0.22

0.0

1.4

—

30.90

—

Anaemia due to enzyme disorders

0.00

0.22

0.0

1.4

—

32.73

—

Bacterial agents resistant to antibiotics

0.00

0.22

0.0

1.3

—

37.00

—

Acute tubulo-interstitial nephritis

770

6626

0.98

0.22

1.8

1.7

44.16

45.73

nmol/l

0.74

748

6438

Brucellosis, including avohilmo

0.00

0.22

0.0

1.7

—

41.50

—

Bartonellosis

0.00

0.22

0.0

2.0

—

37.08

—

Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]

0.00

0.22

0.0

1.6

—

45.92

—

Conditions involving the integument and temperature regulation of fetus and newborn

0.00

0.21

0.0

1.9

—

29.70

—

Disorder of amino-acid metabolism, other/unspecified

0.00

0.21

0.0

1.5

—

32.20

—

Carcinoma in situ of bronchus and lung

0.00

0.21

0.0

1.1

—

45.70

—

Scleritis and episcleritis in diseases classified elsewhere

0.00

0.21

0.0

1.7

—

37.50

—

Secondary lactase deficiency

0.00

0.21

0.0

1.4

—

44.27

—

Non-neuropathic heredofamilial amyloidosis

0.00

0.21

0.0

1.8

—

42.90

—

Iliac crest spur

0.00

0.21

0.0

1.6

—

42.58

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

0.21

0.0

1.3

—

46.45

—

Benign neoplasm: Renal pelvis

0.00

0.21

0.0

1.6

—

37.70

—

Other eccrine sweat disorders

0.00

0.21

0.0

1.3

—

40.75

—

Blindness (ICD-9)

0.00

0.21

0.0

1.3

—

39.83

—

Benign neoplasm: Trachea

0.00

0.21

0.0

1.2

—

40.50

—

Mucinosis of skin

0.00

0.21

0.0

1.7

—

42.17

—

Other hypersecretion of intestinal hormones

0.00

0.21

0.0

1.1

—

42.31

—

Alzheimer’s disease (undefined), excluding more controls

0.00

0.21

0.0

1.1

—

48.00

—

Complications of anaesthesia during the puerperium

0.00

0.21

0.0

1.1

—

40.09

—

Trichomoniasis

0.00

0.21

0.0

1.2

—

39.10

—

Superficial injury of neck

377

0.90

0.21

2.1

2.0

39.06

39.75

nmol/l

0.06

367

Atypical mycobacterium lung infection

102

0.78

0.21

1.5

1.7

49.50

40.85

nmol/l

—

Pneumonia due to Streptococcus pneumoniae

657

0.93

0.21

2.0

1.9

40.38

39.35

nmol/l

0.15

634

Congenital syphilis, including avohilmo

0.00

0.21

0.0

1.2

—

39.00

—

Contraceptive management

961

6832

0.98

0.21

1.9

38.42

37.95

nmol/l

0.25

944

6718

Superficial frostbite

145

1.18

0.21

1.4

2.0

53.88

37.41

nmol/l

0.75

140

Pemphigus foliaceus

0.00

0.21

0.0

1.5

—

46.31

—

Amputation of ankle

0.00

0.21

0.0

1.6

—

46.69

—

Follicular keratosis (Darier-White), including avohilmo

0.00

0.21

0.0

1.7

—

36.15

—

Autoimmune diseases excluding thyroid diseases, strict definition

2229

11979

1.01

0.21

1.8

42.90

40.38

nmol/l

4.11

2185

11750

Acquired coagulation factor deficiency

0.00

0.21

0.0

1.6

—

46.08

—

Viral encephalitis, not elsewhere classified/unspecified

249

1.13

0.21

1.8

2.0

43.46

38.43

nmol/l

0.47

235

Disorders of other digestive organs in diseases classified elsewhere

0.00

0.21

0.0

1.3

—

41.71

—

Congenital malformations of anterior segment of eye

1.26

0.20

1.6

41.20

40.56

nmol/l

—

Inflammation of lacrimal passages (acute and unspecified)

145

1.18

0.20

2.3

1.8

42.65

42.84

nmol/l

0.01

140

Rare circulating lymphoid malignancy, including Hilmo

335

1.11

0.20

2.4

2.0

43.54

42.27

nmol/l

0.10

317

Hodgkin lymphoma, hilmo

441

1.09

0.20

1.6

1.9

41.02

39.10

nmol/l

0.29

423

Exposure to uncontrolled fire in building or structure

155

0.83

0.20

1.8

38.00

39.64

nmol/l

0.10

148

Motor neuron disease ALS

166

0.84

0.20

1.8

1.6

55.50

43.59

nmol/l

0.74

159

Melanoma in situ of ear and external auricular canal

0.00

0.20

0.0

1.8

—

41.00

—

Ophthalmic devices associated with adverse incidents

0.00

0.20

0.0

1.3

—

51.50

—

Coarctation of the aorta

176

0.85

0.20

1.5

1.8

39.40

37.75

nmol/l

0.09

171

Malignant neoplasm of tonsil

250

0.88

0.20

2.0

49.18

40.79

nmol/l

0.57

240

Malignant neoplasm of corpus uteri, including Hilmo

1.25

0.20

1.0

1.5

43.00

72.65

nmol/l

—

Dislocation of lens

114

0.79

0.20

2.0

1.7

44.78

43.35

nmol/l

—

108

Benign neoplasm: Connective and other soft tissue of thorax

1.21

0.20

1.7

1.8

66.67

40.16

nmol/l

—

L04AC Interleukin inhibitors

132

1260

1.05

0.20

1.8

2.0

37.87

37.47

nmol/l

0.09

132

1228

Contact with other hot metals

260

0.88

0.20

2.4

2.0

33.00

38.89

nmol/l

0.97

250

Hepatomegaly and splenomegaly, not elsewhere classified

133

0.82

0.19

2.9

1.8

31.00

39.30

nmol/l

1.54

127

Injuries involving multiple body regions

582

0.93

0.19

1.9

40.30

38.00

nmol/l

0.29

563

Ankylosing hyperostosis [Forestier]

146

1.17

0.19

2.8

1.7

36.24

39.33

nmol/l

0.38

141

Combinations of oral blood glucose lowering drugs

512

5008

1.02

0.19

2.0

1.8

32.91

44.94

nmol/l

36.42

494

4876

Periodontal disease, other/unspecified

291

0.89

0.19

1.7

1.8

46.88

42.56

nmol/l

0.37

281

Hypothermia

280

0.89

0.19

1.6

1.9

42.52

40.52

nmol/l

0.19

265

251

1.12

0.19

1.6

1.5

37.25

41.41

nmol/l

0.33

244

Other and unspecified injuries of ankle and foot

686

1.07

0.19

1.6

1.8

40.96

39.73

nmol/l

0.17

667

Hypertensive Renal Disease

353

0.90

0.18

2.0

1.7

47.88

47.01

nmol/l

0.07

337

GI-bleeding

460

4495

1.02

0.18

1.8

1.9

42.23

42.96

nmol/l

0.26

441

4357

Liquid cancers

397

3664

1.03

0.18

2.0

1.9

42.92

43.08

nmol/l

0.04

384

3551

Erythrasma

1.20

0.18

1.1

1.6

42.00

40.19

nmol/l

—

Polyarthropathies

1251

7921

1.01

0.18

1.8

40.05

41.85

nmol/l

1.65

1221

7779

Aphakia

153

0.85

0.18

2.1

1.8

50.00

39.90

nmol/l

0.63

147

Monoplegia

174

0.86

0.18

1.6

1.9

35.20

40.16

nmol/l

0.47

166

Frostbite

214

1.13

0.18

1.8

2.0

48.25

37.63

nmol/l

0.60

208

Iron deficiency anaemia

470

4509

1.02

0.18

1.9

1.8

44.74

44.73

nmol/l

0.00

456

4362

Malignant neoplasm of oropharynx

268

0.89

0.17

2.0

50.42

40.86

nmol/l

0.76

255

Necrosis of pulp, including avohilmo

1272

12405

1.01

0.17

2.0

1.9

39.44

40.43

nmol/l

0.66

1238

12183

Ankyloglossia

252

1.11

0.17

1.8

1.7

35.29

36.74

nmol/l

0.11

246

Exclusion endpoint for clefts

310

1.10

0.17

2.1

1.8

46.56

38.06

nmol/l

0.63

301

Familial hypercholesterolemia, with ischemic heart disease

937

0.95

0.17

1.7

1.9

37.05

45.97

nmol/l

4.01

898

Artificial opening status

621

1.06

0.17

1.7

1.9

37.35

40.91

nmol/l

1.19

605

Right hemicolectomy

495

0.93

0.16

1.4

1.8

37.50

41.88

nmol/l

0.79

471

Sequelae of poliomyelitis, including avohilmo

1.15

0.16

2.0

1.6

44.25

48.17

nmol/l

—

Myeloid leukaemia

287

0.90

0.16

2.8

2.0

42.65

41.23

nmol/l

0.07

273

Pustular psoriasis

401

0.92

0.16

1.8

42.81

40.79

nmol/l

0.13

387

Benign neoplasm: Skin of lower limb, including hip

283

1.10

0.16

1.6

1.9

43.00

40.68

nmol/l

0.27

270

Vitamin B12 deficiency anaemia

760

0.95

0.15

1.9

1.8

57.71

44.88

nmol/l

2.82

730

ILD-related respiratory insufficiency

297

0.91

0.15

1.9

1.8

42.48

43.22

nmol/l

0.08

277

Other congenital malformations of upper alimentary tract

1.14

0.15

2.6

1.8

43.89

41.15

nmol/l

—

Benign neoplasm: Tonsil

140

0.85

0.15

1.8

39.00

39.72

nmol/l

0.06

133

129

0.85

0.15

2.5

1.8

36.00

39.20

nmol/l

0.29

122

Abscess of tendon sheath

1.09

0.15

1.2

1.6

41.78

43.57

nmol/l

—

Impacted maxillary canine

1.19

0.14

1.2

1.5

34.09

40.97

nmol/l

0.66

Other malignant neoplasms of skin (=non-melanoma skin cancer)

544

3755

0.98

0.14

1.7

1.8

46.77

44.48

nmol/l

1.49

525

3631

Fracture of shoulder and upper arm

574

5640

1.02

0.14

1.9

1.8

41.59

39.88

nmol/l

0.94

562

5523

Colitis due to radiation

1.20

0.14

1.9

1.7

50.50

44.43

nmol/l

—

Scleritis

141

1.14

0.14

1.4

1.8

56.50

39.33

nmol/l

0.77

135

Blindness, monocular

0.80

0.14

2.3

1.8

45.25

41.17

nmol/l

—

Chorioretinal inflammation

346

0.92

0.13

2.2

1.9

44.69

39.96

nmol/l

0.55

333

Extreme obesity with alveolar hypoventilation

459

0.94

0.13

2.1

1.9

32.70

40.74

nmol/l

2.34

444

Second line medication for Crohn's disease

989

9990

0.99

0.13

1.8

1.9

41.39

41.07

nmol/l

0.15

968

9776

Benign neoplasm: Pharynx, unspecified

1.18

0.13

3.0

1.9

31.73

39.42

nmol/l

0.56

Dissection of aorta

366

0.93

0.13

1.5

1.9

43.35

41.46

nmol/l

0.26

352

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

138

0.87

0.13

1.6

1.9

37.75

41.54

nmol/l

0.28

131

Shock, not elsewhere classified

106

0.85

0.13

1.3

1.9

41.78

42.13

nmol/l

—

100

Use of disulfiram, acamprosate or naltrexone

244

2384

1.03

0.13

2.1

2.0

36.86

37.31

nmol/l

0.15

233

2333

Background retinopathy and retinal vascular changes

252

0.91

0.13

1.7

1.9

38.48

39.93

nmol/l

0.14

242

Parkinson's disease

134

1384

0.97

0.12

1.5

1.8

49.14

45.24

nmol/l

1.30

129

1323

Parkinson's disease, strict definition

131

1268

1.03

0.12

1.5

1.8

49.21

45.37

nmol/l

1.30

126

1216

Radial styloid tenosynovitis [de Quervain]

482

1.06

0.12

2.0

1.7

39.69

42.42

nmol/l

0.41

475

Glomerular diseases

292

2980

0.98

0.12

1.8

1.9

42.71

40.84

nmol/l

0.41

286

2897

Need for immunization against other single viral diseases

346

1.07

0.12

1.7

1.9

51.46

37.20

nmol/l

1.41

337

Toxic liver disease

181

1.11

0.12

1.7

1.8

49.60

39.47

nmol/l

0.57

173

Basal cell carcinoma, including Hilmo

550

3778

0.98

0.12

1.7

1.8

46.98

44.45

nmol/l

1.77

531

3655

Benign neoplasm: Brain, supratentorial

191

1.10

0.12

2.1

1.9

37.62

39.56

nmol/l

0.16

183

Carcinoma in situ of other and unspecified digestive organs

493

1.06

0.11

1.5

1.9

39.15

41.39

nmol/l

0.36

469

Disorders of lens

1088

6811

0.99

0.11

1.8

1.9

45.13

41.85

nmol/l

3.49

1046

6659

Sixth [abducent] nerve palsy

337

1.07

0.11

2.1

1.8

41.50

41.29

nmol/l

0.01

322

Toxic effect of carbon monoxide

279

1.08

0.11

2.7

1.9

37.47

38.48

nmol/l

0.14

266

Disorders of oesophagus in diseases classified elsewhere

211

1.09

0.11

2.0

1.8

51.96

41.56

nmol/l

0.82

201

Cellulitis of external ear

157

0.89

0.11

1.9

2.0

45.50

40.44

nmol/l

0.22

152

Oesophageal obstruction

363

0.94

0.11

1.5

1.8

45.38

41.23

nmol/l

0.57

346

Benign neoplasm: Other and unspecified parts of small intestine

105

1.15

0.11

1.5

1.9

39.42

42.84

nmol/l

0.18

Parkinson's disease, including avohilmo

147

1430

1.03

0.11

1.5

1.8

48.76

45.26

nmol/l

1.10

142

1369

Follow-up examination after treatment for conditions other than malignant neoplasms

637

4293

0.99

0.11

1.7

44.34

41.56

nmol/l

1.75

617

4234

Inflammatory disorders of male genital organs, not elsewhere classified

319

1.07

0.10

1.9

41.50

37.72

nmol/l

0.44

306

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

154

1.11

0.10

2.0

1.8

37.94

37.48

nmol/l

0.04

149

Malignant neoplasm of other and unspecified parts of tongue

187

0.91

0.10

1.5

2.0

41.18

40.25

nmol/l

0.07

179

Secondary thrombocytopenia

154

1.11

0.10

2.0

1.9

41.59

41.16

nmol/l

0.03

147

Other cataract

597

4382

1.01

0.10

1.8

1.9

46.94

42.85

nmol/l

2.51

579

4264

Wet age-related macular degeneration

781

1.04

0.10

1.7

1.6

53.04

48.70

nmol/l

0.78

736

Syndactyly, including avohilmo

1.12

0.10

1.2

1.7

30.00

35.89

nmol/l

—

Iridocyclitis in diseases classified elsewhere

232

1.08

0.10

2.1

1.8

39.92

40.13

nmol/l

0.02

223

Adrenomedullary hyperfunction

1.09

0.10

2.8

1.4

34.60

47.33

nmol/l

—

Systemic sclerosis

135

1.11

0.09

1.9

1.8

46.60

41.81

nmol/l

0.45

130

Exposure to ignition or melting of other clothing and apparel

1.07

0.09

1.2

1.7

26.80

40.83

nmol/l

—

Other congenital malformations of tongue, mouth and pharynx

202

1.09

0.09

1.3

1.6

40.50

38.56

nmol/l

0.12

197

Other fibroblastic disorders

1.07

0.09

1.2

1.6

35.60

39.40

nmol/l

—

Hyperosmolality and hypernatraemia

116

1.12

0.09

1.5

1.9

49.08

41.95

nmol/l

0.43

111

Prolonged pregnancy

110

966

0.97

0.09

1.2

68.65

55.65

nmol/l

1.07

110

959

Cystitis

1102

6604

0.99

0.09

1.7

47.95

45.39

nmol/l

2.07

1076

6427

L04AX Other immunosuppressants

939

9461

0.99

0.09

1.8

1.9

41.52

41.16

nmol/l

0.16

921

9252

Lesion of medial popliteal nerve

1.12

0.09

1.7

2.0

42.33

36.98

nmol/l

—

Sicca syndrome [Sjögren]

370

1.05

0.09

2.2

1.7

38.97

44.45

nmol/l

0.65

358

Glaucoma

631

5303

1.01

0.08

1.7

1.8

46.30

44.06

nmol/l

1.12

619

5122

Benign neoplasm: Pelvic bones, sacrum and coccyx

0.80

0.08

3.2

1.6

46.60

34.92

nmol/l

—

Burns classified according to extent of body surface involved

185

1.09

0.08

1.6

2.0

38.15

nmol/l

0.00

180

Other and unspecified immunodeficiencies with predominantly antibody defects

146

1.10

0.08

2.3

1.8

46.94

38.84

nmol/l

0.41

140

Gastroduodenal ulcer

293

2964

0.98

0.08

1.9

1.8

46.31

44.08

nmol/l

0.75

286

2863

Other abnormalities of plasma proteins

156

1.09

0.08

1.8

2.0

56.71

40.64

nmol/l

0.81

147

Obstructive hydrocephalus

166

1.09

0.08

2.1

1.8

41.50

39.95

nmol/l

0.13

159

Panniculitis, unspecified

1.13

0.07

2.6

1.8

49.91

40.50

nmol/l

0.42

Previous suicide attempt

176

1.08

0.07

1.6

1.8

39.26

37.19

nmol/l

0.14

170

Colorectal neuroendocrine tumor and carcinoma

147

1.09

0.07

1.1

2.0

32.19

39.21

nmol/l

0.75

140

Injuries to the hip and thigh

761

6767

1.01

0.07

2.0

1.8

42.09

41.53

nmol/l

0.25

739

6598

Morphin

153

0.91

0.07

1.9

1.5

44.71

46.35

nmol/l

0.10

143

Cerebral atherosclerosis

1.07

0.07

1.7

1.8

43.11

44.50

nmol/l

—

Amyloidosis, other/unspecified

157

1.08

0.07

1.2

2.0

42.94

44.62

nmol/l

0.12

149

Complications of other internal prosthetic devices, implants and grafts

316

0.95

0.07

1.9

1.8

45.83

42.66

nmol/l

0.33

299

Other conjunctival vascular disorders and cysts

206

1.07

0.07

1.9

59.82

40.05

nmol/l

1.15

197

Spondylopathies in diseases classified elsewhere

1.02

0.07

2.9

1.8

31.11

41.91

nmol/l

—

Familial hypercholesterolemia

163

1658

0.98

0.06

2.0

1.8

37.15

45.08

nmol/l

6.12

150

1590

Mixed conductive and sensorineural hearing loss

111

1134

0.98

0.06

1.8

45.82

43.07

nmol/l

0.61

105

1100

Intestinal stricture

380

3839

0.99

0.06

2.0

1.8

43.03

42.93

nmol/l

0.03

369

3718

Postdysenteric arthropathy

152

0.92

0.06

1.2

1.9

51.64

38.43

nmol/l

1.21

146

Nutritional anaemias

536

5150

0.99

0.06

2.0

1.8

46.00

44.97

nmol/l

0.33

522

4986

Erythema multiforme

256

1.06

0.06

2.1

1.8

39.44

39.87

nmol/l

0.03

242

Basal cell carcinoma

514

3533

0.99

0.06

1.7

1.8

47.38

44.77

nmol/l

1.72

495

3417

Motor neuron disease (with DMD)

172

0.93

0.06

1.7

1.6

51.44

43.01

nmol/l

0.52

165

Alcohol abuse counselling and surveillance

395

0.96

0.05

2.2

2.0

40.47

37.48

nmol/l

0.53

383

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

247

1.05

0.05

2.1

1.9

37.35

39.35

nmol/l

0.24

236

Pulmonary heart disease, diseases of pulmonary circulation

369

3655

1.01

0.05

2.0

1.8

39.68

43.36

nmol/l

2.99

364

3532

Contact with venomous snakes and lizards

141

0.92

0.05

2.0

1.8

38.46

39.62

nmol/l

0.09

136

Erysipelas, including avohilmo

1513

11156

1.00

0.05

2.0

1.9

39.48

40.28

nmol/l

0.66

1469

10931

Reimbursement for rheumatic diseases

789

7879

0.99

0.04

1.8

43.98

41.98

nmol/l

1.26

776

7692

Congenital malformations of the nervous system

292

0.96

0.04

1.9

43.39

38.38

nmol/l

0.36

285

Haemolytic anaemias

387

1.03

0.04

1.8

41.90

40.58

nmol/l

0.12

370

Other abnormal immunological findings in serum

209

1.05

0.04

1.7

1.9

51.50

41.15

nmol/l

0.66

201

Other infestations, including avohilmo

221

0.95

0.04

2.2

1.9

46.76

40.42

nmol/l

0.45

211

Disorders of globe

219

1.05

0.04

2.1

1.9

45.04

40.53

nmol/l

0.38

208

Injury of muscle and tendon at wrist and hand level

311

3085

1.01

0.04

2.1

1.9

38.73

38.97

nmol/l

0.06

302

3022

Mantle cell lymphoma, including Hilmo

170

1.06

0.04

2.3

2.1

45.83

43.00

nmol/l

0.21

161

Vasculitis limited to skin, not elsewhere classified

269

1.04

0.04

2.1

1.9

33.86

38.34

nmol/l

0.74

255

Congenital malformations of great arteries

264

1.04

0.04

1.5

1.8

39.04

39.23

nmol/l

0.02

257

Implicit Sepsis, including avohilmo

1570

11241

1.00

0.04

1.9

1.8

41.86

41.31

nmol/l

0.38

1514

11020

Other congenital malformations of intestine

121

1.08

0.04

1.8

1.9

45.54

37.53

nmol/l

0.42

116

Other secondary coxarthrosis

349

1.03

0.03

1.8

1.9

41.03

40.41

nmol/l

0.06

336

Acute epiglottitis

250

0.96

0.03

1.7

1.8

34.54

39.84

nmol/l

0.87

238

Malignant neoplasm of other connective and soft tissue

250

0.96

0.03

2.2

1.9

37.67

41.74

nmol/l

0.45

239

Other and unspecified haemorrhagic conditions

151

1.06

0.03

1.1

1.8

49.87

41.58

nmol/l

0.47

145

Perforation of tympanic membrane

130

1285

1.01

0.03

2.0

1.9

40.40

40.27

nmol/l

0.02

121

1254

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

1.09

0.03

1.3

1.8

58.70

40.39

nmol/l

—

Other retinal artery occlusion

189

0.95

0.03

1.3

1.8

42.83

41.36

nmol/l

0.09

178

Tooth eruption problems

280

2721

0.99

0.03

1.7

41.48

41.32

nmol/l

0.03

275

2681

Tic and related disorders

231

1.04

0.03

1.5

2.0

34.33

36.28

nmol/l

0.19

225

Other CVD (FINNGEN)

154

1163

1.01

0.02

1.9

1.7

43.94

46.63

nmol/l

0.75

146

1125

severe traumatic brain injury, does not include concussion

327

3287

0.99

0.02

1.8

1.9

43.54

41.40

nmol/l

0.89

319

3185

Isolated proteinuria with specified morphological lesion

162

1.05

0.02

1.6

1.9

41.06

39.43

nmol/l

0.09

155

Lack of expected normal physiological development

272

1.03

0.02

1.4

37.47

40.51

nmol/l

0.37

266

Nystagmus and other irregular eye movements

178

0.95

0.02

2.1

2.0

47.41

37.62

nmol/l

0.79

169

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

172

1.05

0.02

2.7

1.5

47.89

41.63

nmol/l

0.37

164

Inhalation and ingestion of food causing obstruction of respiratory tract

107

0.93

0.02

2.5

1.8

34.20

40.46

nmol/l

—

101

Tetraplegia

117

0.94

0.02

1.5

1.8

45.36

40.16

nmol/l

0.24

112

Chronic pancreatitis

229

2301

1.00

0.01

1.7

2.0

44.39

40.67

nmol/l

1.31

223

2237

Amiodarone users

128

1289

0.99

0.01

1.5

1.9

51.75

42.63

nmol/l

3.58

121

1242

Other and unspecified vasculitis limited to skin

253

1.03

0.01

2.1

1.9

33.69

38.38

nmol/l

0.72

239

Liposarcoma

1.07

0.01

2.3

1.9

35.50

41.97

nmol/l

—

Other autoimmune haemolytic anaemias

116

0.95

0.00

1.5

1.8

59.55

42.25

nmol/l

0.91

110

Other meningitis

206

0.97

0.00

2.5

1.9

29.95

40.09

nmol/l

2.64

200

Other and unspecified degenerative diseases of nervous system

206

0.97

0.00

1.6

1.8

46.95

44.21

nmol/l

0.20

193

Diseases of spleen

224

1.03

0.00

1.7

2.0

41.70

39.55

nmol/l

0.15

215

Drug-induced cataract

294

1.02

0.00

1.9

36.77

39.76

nmol/l

0.38

283

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

551

4271

1.00

0.00

1.7

1.6

49.83

49.24

nmol/l

0.14

526

4156

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

298

2882

1.00

0.00

1.9

40.89

39.25

nmol/l

0.51

292

2814

Pneumothorax

105

1055

1.00

0.00

1.9

41.54

40.86

nmol/l

0.12

100

1020

Idiopathic gout

142

1415

1.00

0.00

2.1

1.9

36.11

43.13

nmol/l

3.72

136

1360

Hypersensitivity pneumonitis due to organic dust

185

0.97

0.00

2.1

1.8

40.17

41.70

nmol/l

0.12

175

Intussusception

136

1.03

0.00

3.1

1.8

42.14

40.98

nmol/l

0.06

131

Heart failure and hypertrophic cardiomyopathy

225

1.02

0.00

2.0

35.00

41.26

nmol/l

0.66

214

Cutaneous lupus erythematosus

164

0.98

0.00

1.8

43.62

43.12

nmol/l

0.02

155

Ventricular septal defect, a heart condition

257

1.01

0.00

2.2

1.7

43.65

38.84

nmol/l

0.35

248

Vitiligo

163

0.98

0.00

1.7

1.9

37.56

39.45

nmol/l

0.14

157

Pustulosis palmaris et plantaris

346

1.01

0.00

1.8

43.20

40.85

nmol/l

0.15

334

Congenital deformities of feet

394

0.99

0.00

2.8

1.9

39.90

38.39

nmol/l

0.14

385

Other nonthrombocytopenic purpura

1.02

0.00

2.2

1.7

42.00

41.87

nmol/l

—

Granuloma annulare

1.02

0.00

1.5

1.7

46.80

42.78

nmol/l

—

Liposarcoma, including Hilmo

122

0.98

0.00

2.2

1.9

36.00

40.92

nmol/l

0.47

117

Renal tubulo-interstitial disorders in diseases classified elsewhere

122

0.98

0.00

1.2

1.8

40.83

39.10

nmol/l

0.15

115

Retained placenta and membranes, without haemorrhage

303

0.99

0.00

1.3

1.2

61.60

56.03

nmol/l

0.28

298

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

467

1.01

0.00

2.0

37.36

37.34

nmol/l

0.00

454

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

212

0.99

0.00

1.9

38.71

36.74

nmol/l

0.21

205

Cholangitis (primary sclerosing, PSC), with reimbursement 202

278

1.01

0.00

2.3

1.9

54.86

37.17

nmol/l

1.91

266

Burn and corrosion of hip and lower limb, except ankle and foot

392

0.99

0.00

2.1

1.9

43.79

38.28

nmol/l

0.52

378

Other degenerative diseases of the basal ganglia

139

1.01

0.00

1.1

1.7

39.00

44.35

nmol/l

0.38

127

Chronic nephritic syndrome

548

1.00

0.00

1.9

38.37

39.22

nmol/l

0.09

526

Carcinoma in situ of rectum

161

0.99

0.00

1.7

1.8

30.37

41.79

nmol/l

1.50

150

Dermatitis herpetiformis

181

0.99

0.00

1.8

1.9

50.61

41.95

nmol/l

0.72

173

Burns and corrosions of multiple body regions

191

0.99

0.00

2.0

1.9

39.11

39.68

nmol/l

0.04

183

Laparoscopic left hemicolectomy

209

1.00

0.00

1.7

1.9

39.43

42.21

nmol/l

0.33

200

Parapsoriasis

229

1.00

0.00

1.7

1.8

48.43

40.28

nmol/l

0.44

218

Other diseases of arteries and capillaries

964

1.00

0.00

2.0

1.8

42.06

41.90

nmol/l

0.03

932

Use of rivastigmine

686

1.00

0.00

1.6

54.25

49.80

nmol/l

0.53

648

Benign neoplasm: Other parts of oropharynx

117

1.03

0.00

1.4

2.0

45.00

41.47

nmol/l

0.27

111

Idiopathic thrombocytopenic purpura

325

0.98

0.00

1.4

1.8

48.72

39.55

nmol/l

1.01

310

Juvenile arthritis (FINNGEN)

597

1.01

0.00

1.8

44.23

40.44

nmol/l

0.28

587

Effects of heat and light

106

1.04

0.00

1.3

1.7

38.27

38.44

nmol/l

0.01

101

Bullous disorders in diseases classified elsewhere

0.00

0.0

1.3

—

26.83

—

Lung transplantation

0.00

0.0

1.2

—

44.60

—

Perioral dermatitis, drug-induced

0.00

0.0

1.7

—

34.33

—

Other and unspecified disorders of skin and subcutaneous tissue related to radiation

0.00

0.0

2.1

—

37.14

—

Leukoderma, not elsewhere classified

0.00

0.0

1.8

—

37.40

—

Lethal midline granuloma

0.00

0.0

2.0

—

27.86

—

Intrauterine hypoxia

0.00

0.0

1.4

—

28.00

—

Scleritis and episcleritis (ICD-9) only

0.00

0.0

1.2

—

40.00

—

Toxic liver disease with cholestasis, drug-induced

0.00

0.0

1.9

—

43.13

—

Other early complications of trauma

0.00

0.0

1.9

—

42.57

—

GM2 gangliosidosis

0.00

0.0

1.4

—

57.00

—

Accident to nonpowered aircraft causing injury to occupant

0.00

0.0

2.0

—

40.50

—

Iodine-deficiency-related goitre

0.00

0.0

1.6

—

49.71

—

Occupant of streetcar injured in transport accident

0.00

0.0

1.3

—

35.78

—

Physical medicine devices associated with adverse incidents

0.00

0.0

1.0

—

35.40

—

Malignant neoplasm of other and unspecified female genital organs

0.00

0.0

1.0

—

47.00

—

Chagas' disease

0.00

0.0

1.2

—

54.40

—

Zygomycosis, including avohilmo

0.00

0.0

2.4

—

39.00

—

Plasmodium malariae malaria

0.00

0.0

1.3

—

56.83

—

Ischaemic infarction of muscle

0.00

0.0

1.1

—

31.22

—

Myiasis

0.00

0.0

1.3

—

48.50

—

Plasmodium malariae malaria, including avohilmo

0.00

0.0

1.3

—

56.83

—

Chagas' disease, including avohilmo

0.00

0.0

1.2

—

54.40

—

Q fever, including avohilmo

0.00

0.0

2.3

—

36.33

—

Arenaviral haemorrhagic fever

0.00

0.0

1.3

—

38.17

—

Coccidioidomycosis

0.00

0.0

2.0

—

36.37

—

Benign neoplasm: Liver/bile ducts (ICD-9)

0.00

-0.00

0.0

1.4

—

45.40

—

Delta-beta thalassaemia

0.00

-0.00

0.0

1.9

—

34.14

—

Phlebitis and thrombophlebitis of femoral vein, drug-induced

0.00

-0.00

0.0

2.4

—

41.20

—

Androgen resistance syndrome

0.00

-0.00

0.0

1.1

—

34.57

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

-0.00

0.0

1.0

—

32.60

—

Malignant immunoproliferative diseases

0.93

-0.00

2.1

1.9

33.11

44.12

nmol/l

—

Benign neoplasm: Prostate

0.97

-0.00

2.0

1.8

38.00

47.88

nmol/l

—

Carcinoma in situ of uteri, other/unspecified

0.00

-0.00

0.0

1.8

—

39.20

—

Hereditary factor XI deficiency

0.00

-0.00

0.0

1.3

—

52.29

—

Operations of war

0.00

-0.00

0.0

1.2

—

33.40

—

Chronic congestive splenomegaly

0.00

-0.00

0.0

1.6

—

32.00

—

Failure in dosage during surgical and medical care

0.00

-0.00

0.0

1.9

—

38.00

—

Tetanus, including avohilmo

0.00

-0.00

0.0

2.0

—

38.00

—

Tetanus

0.00

-0.00

0.0

2.0

—

38.00

—

Duodenal ulcer - Acute without haemorrhage or perforation, drug-induced

0.00

-0.00

0.0

1.6

—

40.22

—

Immunodeficiency following hereditary defective response to Epstein-Barr virus

0.00

-0.00

0.0

1.4

—

39.40

—

Drug-induced androgenic alopecia

0.00

-0.00

0.0

1.2

—

27.20

—

Histoplasmosis

0.00

-0.00

0.0

1.7

—

33.50

—

Rat-bite fevers, including avohilmo

0.00

-0.00

0.0

1.3

—

38.75

—

Defects in glycoprotein degradation

0.00

-0.00

0.0

1.2

—

41.00

—

Lymphocyte function antigen-1 [LFA-1] defect

0.00

-0.00

0.0

2.1

—

38.00

—

Duodenal ulcer - Chronic or unspecified with haemorrhage, drug-induced

0.00

-0.00

0.0

2.1

—

38.14

—

Hereditary erythropoietic porphyria

0.00

-0.00

0.0

2.8

—

41.56

—

Coccidioidomycosis, including avohilmo

0.00

-0.00

0.0

2.0

—

33.78

—

Disorders of lysine and hydroxylysine metabolism

0.00

-0.00

0.0

1.3

—

22.67

—

Other rickettsioses

0.00

-0.00

0.0

2.0

—

37.00

—

Drug-induced nonautoimmune haemolytic anaemia

0.00

-0.00

0.0

1.1

—

35.43

—

Drug-induced tics and other tics of organic origin

0.00

-0.00

0.0

1.2

—

42.89

—

Mixed disorder of acid-base balance

0.00

-0.00

0.0

1.2

—

30.60

—

Unspecified contact dermatitis due to drugs in contact with skin

0.00

-0.00

0.0

1.4

—

30.67

—

Traumatic anuria

0.00

-0.00

0.0

1.3

—

31.83

—

Henoch-Schönlein purpura nephritis (HSPN)

0.92

-0.00

3.0

1.7

38.20

39.35

nmol/l

—

Disorders of glycine metabolism

0.00

-0.00

0.0

1.2

—

48.67

—

Histoplasmosis, including avohilmo

0.00

-0.00

0.0

1.6

—

36.71

—

Epiphyseal arrest

0.00

-0.00

0.0

1.1

—

31.86

—

Diphyllobothriasis and sparganosis

0.00

-0.00

0.0

1.5

—

30.63

—

Typhus fever, including avohilmo

0.00

-0.00

0.0

2.8

—

38.60

—

Agent resistant to multiple antibiotics

0.00

-0.00

0.0

1.3

—

36.56

—

Accident to powered aircraft causing injury to occupant

0.00

-0.00

0.0

1.2

—

34.00

—

Ascariasis, including avohilmo

0.00

-0.00

0.0

1.3

—

32.50

—

Trichuriasis, including avohilmo

0.00

-0.00

0.0

1.3

—

36.67

—

Intracranial injury with prolonged coma

0.00

-0.00

0.0

1.2

—

39.00

—

Foreign body on external eye

460

4600

1.00

-0.00

1.9

2.0

38.37

38.13

nmol/l

0.10

446

4507

Disorders of accommodation

0.00

-0.00

0.0

1.5

—

34.17

—

Hypoplasia of dental enamel, prenatal

0.00

-0.00

0.0

1.8

—

33.60

—

Tetanus, other/unspecified, including avohilmo

0.00

-0.00

0.0

1.8

—

39.11

—

Traumatic amputations involving multiple body regions

0.00

-0.00

0.0

1.0

—

30.40

—

Other inflammatory disorders of orbit (ICD-8 only)

0.00

-0.00

0.0

1.5

—

26.83

—

Total (external) ophthalmoplegia

0.00

-0.00

0.0

2.2

—

41.44

—

Sequelae of other and unspecified effects of external causes

0.94

-0.00

1.8

31.12

39.55

nmol/l

—

Arthropathy in Crohn disease

150

1.00

-0.00

1.9

1.8

33.40

38.23

nmol/l

0.73

145

Toxic effect of pesticides

0.00

-0.00

0.0

1.7

—

39.00

—

Postpolio syndrome

0.00

-0.00

0.0

1.2

—

50.17

—

Traumatic amputation of forearm

0.00

-0.00

0.0

1.1

—

34.88

—

Other lack of coordination

190

1.00

-0.00

1.5

1.8

40.95

41.14

nmol/l

0.01

180

R07AX Other respiratory system products

0.00

-0.00

0.0

1.0

—

34.50

—

Rat-bite fevers

0.00

-0.00

0.0

1.2

—

41.50

—

Chronic constrictive pericarditis

0.94

-0.00

1.2

1.8

44.80

42.02

nmol/l

—

Pemphigus erythematosus

0.00

-0.00

0.0

1.3

—

37.50

—

Other rickettsioses, including avohilmo

0.00

-0.00

0.0

1.8

—

37.88

—

Leptospirosis

0.00

-0.00

0.0

1.4

—

33.57

—

Tetanus, other/unspecified

0.00

-0.00

0.0

2.0

—

38.00

—

Fusion of the labia

0.00

-0.00

0.0

1.0

—

48.50

—

Follicular keratosis (Darier-White)

0.00

-0.00

0.0

1.3

—

37.25

—

Phlebitis and thrombophlebitis of unspecified site, drug-induced

0.00

-0.00

0.0

2.6

—

41.14

—

Use of benzatropine

0.00

-0.00

0.0

1.3

—

46.43

—

Acné excoriée

0.00

-0.00

0.0

1.0

—

33.50

—

Flexion deformity

0.00

-0.00

0.0

1.3

—

40.13

—

Other conditions of integument specific to fetus and newborn

0.00

-0.00

0.0

1.8

—

29.67

—

Kernicterus

0.00

-0.00

0.0

1.9

—

59.25

—

Acquired keratosis follicularis

0.00

-0.00

0.0

1.0

—

37.33

—

Other chronic figurate erythema

0.00

-0.00

0.0

1.2

—

53.83

—

Eosinophilic cellulitis [Wells]

0.00

-0.00

0.0

1.1

—

54.63

—

Adenosine deaminase [ADA] deficiency

0.00

-0.00

0.0

1.0

—

26.80

—

Chronic bullous disease of childhood

0.00

-0.00

0.0

1.4

—

39.71

—

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

140

1.00

-0.00

1.6

1.9

32.29

40.48

nmol/l

1.09

131

Echinococcosis

0.00

-0.00

0.0

1.8

—

43.17

—

Wrist or foot drop (acquired)

0.00

-0.00

0.0

1.0

—

42.88

—

Echinococcosis, including avohilmo

0.00

-0.00

0.0

1.8

—

43.17

—

Other conditions originating in the perinatal period

0.00

-0.00

0.0

2.0

—

38.50

—

Acquired epidermolysis bullosa

0.00

-0.00

0.0

1.2

—

40.83

—

Carcinoma in situ, other and unspecified urinary organs

0.00

-0.00

0.0

1.6

—

43.00

—

Birth injury to scalp

0.00

-0.00

0.0

1.0

—

35.50

—

Keratoderma in diseases classified elsewhere

0.00

-0.00

0.0

1.3

—

46.00

—

Miliaria crystallina

0.00

-0.00

0.0

1.7

—

40.78

—

Immobility syndrome (paraplegic)

0.00

-0.00

0.0

1.0

—

39.57

—

Trichuriasis

0.00

-0.00

0.0

1.3

—

36.67

—

Yellow fever

0.00

-0.00

0.0

3.2

—

38.00

—

Q fever

0.00

-0.00

0.0

1.4

—

33.40

—

Coalworker pneumoconiosis

0.00

-0.00

0.0

2.0

—

35.60

—

Pseudomembranous colitis, drug-induced

0.00

-0.00

0.0

2.0

—

32.33

—

Yellow fever, including avohilmo

0.00

-0.00

0.0

3.2

—

38.00

—

Nail disorders in diseases classified elsewhere

0.00

-0.00

0.0

2.4

—

41.60

—

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

1.00

-0.00

2.0

1.9

36.67

45.31

nmol/l

—

Congenital syphilis

0.00

-0.00

0.0

1.3

—

47.50

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Sex hormone binding globulin [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS